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Chapter 1.1 
1.1 INTRODUCTION TO HEPATIC LIPASE 
Hepatic lipase is synthesized and constitutively secreted by liver parenchymal cells (1-3), and is 
subsequently bound extracellularly in the space of Disse of the liver (4-6). The protein is also found 
in adrenals, ovaries and testes (7-10). However, in adrenals and ovaries an altered, shorter mRNA 
is expressed and no mature HL protein is synthesized (3, 9, 11, 12). Thus, liver parenchymal cells 
may uniquely synthesize and secrete a fully active HL. HL affects the metabolism of several 
lipoproteins and is thought to protect against the development of atherosclerosis (Chapter 1.1.1). 
Therefore it is of importance to understand the mechanisms which regulate HL expression. Several 
cell types serve as a model system for secretion ofHL (13-17). The studies described herein were 
performed with the human-derived HepG2 cell-line and freshly isolated rat hepatocytes. 
1.1.1 ROLE OF HEPATIC LIPASE IN LIPOPROTEIN METABOLISM 
Hepatic lipase plays an important role in lipoprotein metabolism. As depicted in figure 1, HL is 
involved in the metabolism oflhe high density lipoproteins (HDL), intennediate density lipoproteins 
(IDL) and chylomicron-renmants (see for review (18-20)). HL hydrolyses phospholipid and 
triacylglycerol present in high and intermediate density lipoproteins. This was recently confirmed 
by the changes in lipoproteins concentrations, which occurred after over-expressing of human 
HL in rabbits (21), mice (22), and in tIL-deficient mice (23). The phopholipase Acactivity ofHL 
stimulates the delivery of cholesterol(esters) from HDL to rat liver cells (24-27). Hence, HL may 
facilitate the selective uptake of cholesterol by transforming HD~ to HDL, (28, 29) and lor 
pre-ill HDL (30, 31). Further, HL is involved in the removal of both chylomicron and VLDL-
remnant particles by the liver (32-37). m.... may delay the development of premature atherosclerosis, 
as chylomicron remnants are implicated in the progression of coronary artery disease (38). 
Moreover, elevated HDL levels are reciprocally related to the prevalence of coronary artery disease 
(39,40). Hence, by contributing to reverse cholesterol transp0l1, and by the lowering of atherogenic 
remnant particles in the circulation, HL is thought to protect against the development of premature 
atherosclerosis. Indeed, post-heparin HL activity was lower in patients with than without stenotic 
coronary arteries (41). HL activity inversely correlated with progression of coronary atherosclerosis 
in patients on a lipid-lowering diet (42). In line with this, transgenic mice over expressing HL were 
shown to accumulate less cholesterol in the aortic wall than non-expressing littermates (22). Further, 
HL deficiency was shown to correlate with hyperlipidaemia (36, 43-47). The elevated level of 
plasma triglycerides, associated with HL deficiency (48, 49), is an independent risk factor for 
coronary heart disease (50). In several human patients, HL deficiency is associated with premature 
atherosclerosis (45, 51). 
1.1.2 ACTIVITY OF HEPATIC LIPASE 
HL is involved in the conversion ofIDL to LDL (21,52) and of HD~ to HDL:J and pre-p HDL (28-
31). In addition, HL is involved in the removal of both chylomicron and VLDL remnant particles 
by the liver (32-37). HL may exert its action on lipoprotein metabolism via its enzymatic activity 
Of by acting as a ligand towards lipoproteins. Some studies have shown the involvement of HL 
activity in chylomicron remnant clearance (33, 53). On the other hand, several studies indicated that 
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The action of hepatic lipase, which is located in the space of Disse in the liver affects endogenous (VLDL) and 
exogenous (chylomicrons) lipoprotein metabolism. The effect of hepatic lipase on the turnover of HDL and its 
containing cholesterol is another important physiological action. Of the other proteins involved in the lipoprotein 
metabolism only lipoprotein lipase (LPL) is indicated. VLDL, Very Low Density Lipoprotein; LDL, Low Density 
Lipoprotein; IDL, Intermediate Density Lipoprotein; HDL. High Density Lipoprotein; TG, triglycerides; Chol, 
cholesterol; CEo cholesterolesters; FFA, free fatty acids. (Adapted from Sheperd(J. Shepherd (1994) Drugs 47, supp1.2, 1-10) 
the effect of HL on remnant clearance is independent of its activity, and that HL may serve as a 
binding site for lipoproteins (34. 35, 54-57). 
Active HL hydrolyses triacylglycerol and phospholipids. The triglyceridase (TGase) activity 
of HL is insensitive to high salt concentrations, which enables discrimination between LPL and HL 
TGase activity (1). The enzyme activity of HL has a pH optimum of 8.0-8.5. Activity of HL may 
be measured by a triacylglycerol hydrolase assay at pH 8.5 in 0.6 M NaCI using a gum acacia-
stabilized, glycerol(['H] or ["C])trioleate emulsion as substrate (I). For HL activity in a liver cell-
homogenate this assay must be performed with care, as not all activity could be inhibited with 
antibodies to HL. and liver cell homogenates may contain an inhibitor of the TGase activity (58). 
In vivo, the TGase activity ofHL may mainly hydrolyse TG present in the HDI-:, subfraction (18, 
59, 60). The phospholipase At (PLase) activity of HL is mainly directed towards 
phosphatidylethanolamine and phosphatidylcholine present in HDL-particles (28, 61). Furthermore, 
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the PLuse activity of HL may facilitate the selective uptake of cholesterol(esters) from HDL in the 
liver (26, 27). 
The TGase and PLase activity ofHL are thought to be independent of any co-factor. This 
is unlike other members of the lipase family. which depend on cofactors for activity. Pancreatic 
lipase is active only in the presence of colipase (62-64), and LPL is activated by apoIipoprotein CII 
(65, 66). Although no cofactor is identified for HL activity, several apolipoprotcins (Apo) were 
shown to affect the enzyme activity ofHL in vitro. Apolipoproteins CT, CII, cm, AI and AlI inhibit 
hydrolysis of triglyccrides and phospholipids by HL (67,68). The effects of Apo AI and All on HL 
activity are ambiguous. In vitro, Apo All could also stimulate HL activity (69). Hime et al (70) 
presented data, which showed that Apo Al stimulated the V",,, for TG and PL hydrolysis by HL, and 
that Apo AlI stimulated the affinity of HL towards TG and PL. Another apolipoprotein, which has 
been shown to affect HL is Apo E. Tilis apolipoprotein stimulates mainly the HL-mediated 
hydrolysis ofphophatidylcholine present in Apo E-rich HDL phospholipids (68, 71). Stimulation 
of HL activity by Apo E depends on low surface pressure and may involve adhesion of HL to the 
water-emulsion interface, and subsequent activation of HL (71). 
Recently. HL has been shown to possess phosphatidylethanolamine:dolichoi acyItransferase 
(PEDAT) activity (72). In contrast to the TGase and PLase activity of HL, the PEDAT-activity is 
dependent on a plasma co-factor. This co-factor has been shown to be apolipoprotein AN (73), Apo 
AN had marked effects on the properties of HL enzyme activity. Not only did it change the pH 
optimum for PEDAT -activity towards a Illore physiological one (pH 8 to 7.5), the substrate 
specificity of HL shifted from both TGase and PLase towards merely PLase activity. The presence 
of all the above described apolipoproteins may affect the actual HL activity in vivo. Whether the 
presence of Apo AIV on lipoprotein substrates will shift HL. activity towards phospholipids as the 
major physiological substrate of HL remains an important question. 
1.1.3 STRUCTURE-FUNCTION RELATIONSHIP OF HL PROTEIN 
HL is a member of the lipase super family, which includes pancreatic(-like) lipases, lipoprotein 
lipase and some drosophila yolk proteins (74, 75). The genes of human HL and LPL have similar 
intron/exon organization for the different domains of the protein. The nine exons of HL code for a 
protein of 477 amino acids (76). Sequence analysis (77) showed that Exon 1 encodes a signal 
peptide tm·geting newly synthesized protein to the ER (22 amino acids). Exon 4 codes for a region 
with binding properties to lipoproteins. Exon 5 is an evolutionary highly conserved region, which 
may be of importance for the catalytic function (74). Furthermore, exon 5 codes for Asp 176, which 
together with Ser l47 and His263 form the catalytic triad. The catalytic triad is highly conserved, and 
is similar to the triad of serine protcases (78, 79). Exons 6 and 9 encode sequences rich in basic 
amino acids, which are thought to be important for heparin binding (77). Further, exon 6 codes for 
the surface loop covering the catalytic triad. The amino-acid residues of tltis covering lid m·e less 
conserved in the lipase fantily (75).The entire amino acid sequence of human and rat HL. contains 
several putative N-glycosylation sites (four and two, respectively). The similar genetic organization 
and the strong amino acid sequence homology within the lipase superfamily indicate a cornmon 
Il 
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folding pattern. 
The three-dimensional structure of pancreatic lipase, as detennined by X-ray crystallography 
(80) has been used as a model for the three-dimensional structure of LPL and HL (81, 82). This 
model (Fig. 2) shows that HL consists of a C- and a N-terminal domain, which are connected by a 
hinge region. The N-terminal domain contains the catalytic triad, which is covered by a surface loop 
Cthe lid'). 
Numerous chimeras have been constructed with the different domains of HL and LPL to 
define the relationship between structural features and functionality. Exchange of the C-terminal 
domains suggests that this domain influences the substrate and heparin binding (83-85). The 
N-terminal domain mainly influences the kinetic parameters of the enzymes. The lid, which covers 
the catalytic triad in the N-domain may specify the substrate specificity (86, 87). The N-domain of 
LPL and Codomain of pancreatic lipase bind a cofactor (apoCIl and colipase, respectively) (85, 88), 
which activates the enzymes (62-66, 84). So far, no cofactors have been established for HL, 
although several apolipoproteins were shown to stimulate HL activity (see Chapter 1.1.2). 
?f 
cL 
PL 
Figure 2 Structure of human hepatic lipase. 
N 
c 
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'Ole structure of human pancreatic lipase (PL) with bound colipase (cL) (van TIlbcurgh.II., Sarda. L., Verger, R., CambiIJau. 
C. (1992) Nature, 359. 159.162; Winkler, F.K., A, DA and HUnzikcr, W. (1990) Nature, 343, 771.774) was retrieved from the 
3D protein database on the Internet (Brookhavcn protein databank, 21 LPA.PDB). The structure of hepatic lipase (HL) was 
deduced from the crystalline structure ofPL (Derewenda, Z.S. and Cambillau. C. (1991) J. BioI. Chern., 266, 231 12·23119), 
and was also retrieved from the Internet (Swiss model repository. LIPH_Human). 'Ille double arrow indicates the hinge 
region between the N·temlinus (N) and C·terminus (C). The lid·structure (arrow head) of PL is in 'open' conformation 
due to the presence of colipase and micelles, whereas the lid of HL covers the catalytic crypt. 
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The amino acid sequence of human and rat HL contains four and two putative glycosylation sites. 
respectively. The relative dimensions of the four N-glycan chains to Ill... is shown in the human 
model for HL (Fig. 3). The physiological relevance of N-glycosylation for the function of HL is 
discussed in more detail in chapter 1.1.4. 
1.1.4 N·GLYCOSYLATION OF HEPATIC LIPASE 
Intl'oduction to pl'otein glycosylation 
N-Glycosylation of proteins occurs co-translationally in the ER via a complex sequence of events. 
Dolichol-containing glycolipids donate the initial oligosaccharide chain (Glc,-Man,-GlcNac,) to the 
asparagine residue in the consensus sequence (Asn-X-Serffhr) (Fig. 4). The N-linked glycan chain 
is sequentially modulated by a variety of enzymes in the ER and Golgi compartment (89). 
f:, 
, 
, 
, 
, 
, 
~ 'r-,------~~~--, 
* N-glycan chains 
high mannose 
Figure 3 Impression of oligosaccharide chains on human hepatic lipase. 
To visualize the relative dimensions of glycosylation-chains on hepatic lipase (HL), an impression of glycosylatcd Ill.. 
was constructed. The structure of human HL was deduced from the crystalline structure of pancreatic lipase (Derewenda, 
Z.S. and Cambillau, C. (199l) J. BioI. Chem., 266, 23112-23119) and was retrieved from the Internet. The end of the 
C-tenninus and N-terminus, including Asn 20, is excluded from this model, because the difficult prediction of loose 
peptide structures. The high mannose oligosaccharide was obtained from the structural data of the glycosylated adhesion 
domain of human CD2 (Brookhaven protein databank, IGYA). The in vivo glycosylated Asn-residues were localized in 
the HL structure, and the high mannose oligosaccharides were placed arbitrarily near the Asn residues. The asterisk 
marks the glycosylation site Asn 57. which is essential for secretion of active HL. TIle solid arrows point to glycosylation 
sites preserved in HL and LPL of different species, and the broken arrows point to the additional glycosylalion sites of 
human HL. 
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The oligosaccharides are divided into high-mannose, hybrid and complex-type chains (Fig. 5). The 
enzyme endo-P.N-acetylglucosaminidase H (Endo H) has proven to be useful in monitoring the state 
of glycosylation. Bndo H cleaves high-mannose oligosaccharides from a protein, but is inactive 
towards complex oligosaccharide .chains. Specific inhibitors of the different steps during 
oligosaccharide remodelling (Fig. 4) have permitted research on the role of glycosylation in 
intracellular protein traffic and on the function of the various glycan chains (90, 91). 
The majority of secreted proteins in mammals are N-glycosylated (92). The addition and modulation 
of the oligosaccharide chains is cell-type and protein specific (93, 94). Glycan chains can modulate 
the intrinsic biologicallbiochemical properties of proteins (92, 94, 95). For example, the negative 
charge of the sialic acid residues increases the solubility,'and may affect the adhesive properties of 
the glycoprotein. Decreased galactosylation of IgG is related to human diseases, like rheumatoid 
arthritis (93). In addition, desialysation of glycoproteins may lead to internalisation via the 
asialoglycoprotein receptor, and subsequent degradation of the protein (96, 97). 
Intracellularly, N-glycosylation can affect maturation and secretion of proteins. This was 
clearly shown for the different glycosylated forms of aI-acid glycoprotein. which are secreted with 
different rates (98, 99). Glycosylation may assist the initial folding of proteins, and subsequently 
may stabilize their conformation. Although generally glycosylation and folding reactions are co-
operative, they can also compete in vivo (100). 
The oligosaccharide chain is an important factor in binding of glycoproteins to intracellular 
chaperones. In the absence ofN-glycosylation the influenza vims hemagglutinin associates with the 
chaperone BiP, which retains the protein in the ER (101, 1(2). When glycosylated, the 
hemagglutinin associates with calnexiu, which may release the fully folded protein after removal 
of the last glucose residue of the oligosaccharide chain (see (2) in figure 4) (103). Calnexin and 
calreticulin bind the mono-glucosylated glycan chains, and retain glycoproteins in the ER until they 
are correctly folded (103-105). A wide variety of glycoproteins associate with calnexin andlor 
calreticulin (104), including the proteins ai-antitrypsin and al-antichymotrypsin. For these proteins 
it was shown that proper glucose trimming is important for secretion by HepG2 cells (106). In 
HepG2 cells several secretory glycoproteins have different half times of interaction with 
calnexin (107). Other factors than glycan chain binding, like ATP- or calcium-binding may affect 
the association of glycoproteins with calnexin (108). 
N-Glycosylation may direct glycoproteins to different localizations. Phosphorylation of a 
mannose residue in the oligosaccharide of a protein in the Goigi causes lysosomal targeting (109). 
Furthermore, N-glycosylation may act as an apical sorting signal, as demonstrated for growth 
hormone. When non-glycosylated the growth hormone was secreted from both sides of Madin-
Darby canine kidney cell layers, but when glycosyluted it was secreted mainly from the apical 
site (110). 
Glycosylation of HL 
HL carries two (rat) to four (human) oligosaccharide chains (9, 111-113). Mature rat HL has an 
apparent molecular weight of 58 kDa, and bears two complex-type oligosaccharide chains (9, 16. 
17, III). Intracellularly, an additional HL-form with an apparent molecular weight of 53 kDa 
resides, which is Endo H sensitive and carries high-mannose type chains (9, 16, 17, Ill). The 
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Processing of the glycan chains is a complex sequence of events. Initially the oligosaccharide is donated to the protein 
by a transferase. When cells are incubated with runicamycin glycosylation is blocked at this stage. The first step of 
oligosaccharide processing is trimming of the glucose residues by glucosidase I (1) and glucosidase II (2). N-
mClhyldeoxynojirimycin (MdN) and caslanospcrmine are frequently used to inhibit these glucosidases. After the glucose 
residues are removed, several of the mannose residues are cleaved ofr. The first mannose is removed by the mannosidase 
located in the ER (3), which is inhibited by l~deoxymannojirimycin (dMM). Before the next mannose is cleaved off the 
protein is transported to the cis-Golgi slacks (4). Transport of the protein depends on correct folding, and may be 
inhibited by association of the protein with calnexin. The assembly of the transport vesicle may also regulate the 
transport of glycoproteins. In the Golgi, three of the protruding mannoses are cleaved off from the oligosaccharide chain 
by Golgi mannosidase I, which is also sensitive to dMM. TIlen, a GleNac residue may be added 10 the oligosaccharide 
by N-acetylglucosamine transferase I (6), Thereafter the oligosaccharide is sensitive to cleavage of Iwo additional 
mannoses by mannosidase II (7). Swainsonine is known to inhibit Golgi mannosidase II. These processes are common 
for all glycoproteins. Frequently, the oligosaccharide is further processed (8) to a complex type chain (Fig. 5). Vesicular 
transport of proteins occurs from ER to Golgi (4), between cis, medial and trans Golgi-stacks and towards the cell 
membrane. TIlis transport can be blocked by CCCP, monensin and colchicin, respectively. When cells are incubated 
with brefeldin A the anterograde vcsicle transport between ER and Golgi is selectively inhibited, and the ER and Golgi 
compartments fuse. (Adapted from Molccular biology oflhe Cell (Third edition, Chapter 13; Alberts, B., Bmy, Lewis J., Raff, 
M., Robbcrts, K., Watson, J.D.), Elbcin (Elbcin, A.D. (1991) Pascb J., 5, 3055-3063) and Fuhnnann et al (Fuhrmann, U., Bause, 
E. and Ploegh, H. (1985) Biochim. Biophys. Acta, 825, 95-110) 
nonglycosylatcd HL protein has an apparent molecular weight of 47 kDa (17, III, 114). The two 
glycosylation siles found in rat (Asn 56/57 and Asn 3751378) are preserved in HL and LPL of 
different species (75). The dimension of high-manllose glyc!m chains relative to the structure of HL 
is shown in the human model for HL (Fig. 3). 
Glycosylalion affects protein folding and may therefore alter the enzyme activity ofRL Only 
a few glycoproteins are known to depend on glycosylation for their biological activity (95). Over-
expression of the a-subunit of human chorionic gonadotropin results in over-glycosylation. and 
prevents proper dimerization with the p-subunit (115). Thus, over-glycosylation prevented 
formation of active heterodimers. Moreover, LPL depends on glycosylation for formation of an 
active dimer (1l6-118). Enzymatically active human HL, secreted by stably transfected Chinese 
15 
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Figure 5 Structure of different glycan chains. 
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Depicted are the main classes ofN-linked oligosaccharides found attached to mammalian glycoproteins. High-mannose 
oligosaccharides gain no new sugars in addition to the original oligosaccharide, while hybrid and complex 
oligosaccharides often obtain more N-acetylglucosamine, and galactose, sialic acid and sometimes fucose residues, Asn: 
Asparagine; GlcNac: N-acetylglucosamine; Gal:galactose; NANA: N-acetylneuraminic acid (sialic acid); Fuc: fucose. 
(Adapted from Kornfeld (Kornfeld. R, and Kornfeld, S. (1985) Annu, Rev, Biochcm" 54. 631-664» 
hamster ovary cells is in the dimeric form (119). In addition. gel-filtration experiments yielded. in 
some cases, a dimeric form of human and rat HL (120-122). For rat HL, however, glycosylation-
dependent dimerization may be of no importance as its active unit is a monomer (123). However, 
dimerization of HL might be of imp0I1ance for the fIL-mediated removal of remnant particles from 
the circulation. In this process, HL acts as a ligand and catalytic enzyme activity is not required 
(Chapter 1.1.2). 
In addition to folding. HL function may be affected by differences in complexity of 
glycosylation. Complex-type glycan chains can contain several sialic acid residues (Fig. 5), which 
add negative charge to the protein. Binding of HL to the extracellular matrix is an non-covalent 
interaction. which is dismpted by heparin. polyanions and 0.3 M salt (124) and. therefore. may be 
affected by negatively charged sialic acids. 
N-Glycosylation of HL transfected in Xenopus laevis oocytes affected the secretion, but not 
the activation of HL (114). However, other studies have shown that N-glycosylation is required for 
secretion of a fully active lipase (14. 112. 113. 125). Occupation of only the Asn 56/57 with an 
oligosaccharide is sufficient for secretion of active HL or LPL (112. 126. 127). Furthermore. proper 
processing of the oligosaccharide in the ER is required for both HL and LPL to become catalytically 
active (58.125. 128-130). As described in the introduction to protein glycosylation. maturation of 
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proteins may depend on glycosylation-mediated association.with chaperones. Hence, glycosylation 
affects the intracellular trafficking of HL, which might be mediated by association with chaperones 
such as calnexin. 
The importance of the intracellular pathway is demonstrated in the mice syndrome ddkld 
(131, 132). Cldlcld is characterised by a combined deficiency of HL and LPL expression, whereas 
no mutations in either genes of the ddkld mice occur. Further, no mutations in the eDNA of HL 
could be identified (133). Several reports showed that both lipase genes are transcribed into mRNA 
and that there is synthesis of HL protein in liver, and of LPL protein in extra hepatic tissues. 
However, LPL and HLremained intracellularly, mainly in the rough ER (130, 134, 135). In addition, 
the inactive LPL in adipocytcs of ddleld mice acquires activity when the ER and Goigi fuse upon 
incubation of the cells with brefeldin A (136). This suggests that there is impaired transport or 
maturation of the proteins. 
1.2 REGULATION OF HEPATIC LIPASE EXPRESSION 
Expression of HL is under hormonal and dietary control. Several hormones are known to decrease 
the HL activity. HL is lower in woman than in man, probably due to estrogen. In postmenopausal 
women, estrogen-supplementation decreases the expression of HL activity (29). In rats, HL activity 
is reduced moderately by estradiol (137-139). Further, glucocorticoids and catecholamines have 
been shown to lower the expression of HL activity in rats (140-142). ACTH lowers the expression 
ofHL activity both in rat and human liver (124, 143, 144). Among the positive modulators of tIL 
expression arc androgenic steroids, which have been shown to increase the HL activity in humans 
(145-148). Thyroid hormone increases HL expression in the human derived Hep02 cells (149), 
whereas in hypothyroid rats HL is down regulated (150). Insulin, EOF and growth hormone have 
been shown to induce activity of HL in rats (138, 150-152). 
HL is constitutively secreted by liver parenchymal cells. Regulation of HL expression may 
occur at several levels, which are depicted in figure 6. First, the transcription of the HL gene into 
mRNA may be rate limiting for synthesis ofHL protein. Second, the stability ofHL mRNA, and the 
translation velocity may determine the amount of HL protein synthesized. Next, the intracellular 
processing of HL, including glycosylation, folding and activation of HL protein, may affect the 
secretion of active HL. Further, regulated extracellular binding of HL may be a mechanism to 
control HL activity in the liver. Last, the uptake and subsequent recycling or degradation of HL may 
determine the expression of HL activity. 
Tl'anscl'iptionall'egulation of hepatic lipase expression 
Pmt of the hormonal and dietary regulation of HL expression in human and rat liver is at the level 
of transcription. The C3P and CIEBP, HNF-4 and HNF-I responsive elements identified in the 
human andlor rat HL promoter region may account for the liver specific transcription ofRL (153-
156). Several negative regulatory elements are present in the upstream regulatory region and rust 
exon ofthe human HL gene (153, 155, 156). HL expression may be modulated by the cholesterol 
homeostasis of hepatocytes: The rat HL gene contains a putative sterol responsive clement in its 
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Figure 6 Potentially regulated steps in hepatic lipase expression. 
Schematic representation of processes. which may determine the expression ofHL activity in the liver {more details in 
text of chapter 1.2}. Depicted are the synthesis and secretion of active HL in parenchymal liver cells. the adjacent space 
of Disse and the sinusoidal endothelial cell Jayer. 
promoter region (154). In addition, cholesteroVcholate fed rats have decreased HL mRNA levels 
(157,158). Mevinolin-treatment of HepG2 cells, and thus inhibiting the cholesterol biosynthesis of 
these cells, increases HL mRNA and activity (159). Further, inhibition ofHMG-CoA rednctase in 
cultured rat hepatocytes increased HL activity significantly (160). Modulation of HL expression by 
cholesterol homeostasis might be a kind of feed back mechanism, as HL plays a role in the reversed 
transport of cholesterol to the liver. 
The 5' flanking region ofrat HL gene contains putative elements for AF-l (apolipoprotein 
factor I), cAMP and AP-2, OCT-I, C/EBP, sterol, estrogen, glucocorticoid and thyroid hormone 
receptors (154). In line with this, glucocorticoids, estrogens, vasopressin, and thyroid hormone are 
shown to decrease the transcription of the HL gene in rats (138, 140, ISO, 161). However, not 
all changes in HL activity are parallelled by expression of HL mRNA levels. Hence, 
post-transcriptional regulation may also determine the HI... expression in the liver. 
Post-transcriptional regulation of hepatic lipase expression 
Post-transcriptional regulation is suggested by the short term effects of insulin and catecholamines 
on HI... activity (138, 141, 142). In addition, substitution treatment of orchidectonllzed rats with sex 
steroids leads to a decrease in HL activity, while the HL mRNA is increased (139). Growth hormone 
stimulates the synthesis of HL mRNA in hypothyroid rats, but the total HL activity in the liver 
remains decreased (150). In fenofibrate-treated rats the extracellular HL activity in the liver seems 
to follow the decrease in HL mRNA levels. Intracellularly, however, HL activity increased, 
suggesting fenofibrate may have post-translational effects in addition to the inhibition of 
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transcription (162). Mevalonic acid decreases the secretion ofHL by HepG2 cells. but has no effect 
on HL mRNA levels. In this case, isoprenylation of a regulatory protein has been hypothesized to 
mediate the reduction ofHL secretion (159). Further. TNF-" production by Kupffer-cells in mice 
decreases the HL activity significantly with no alterations ofmRNA levels (163). These conditions. 
in which changes in HL activity are not parallelled by levels of mRNA demonstrate that HL 
expression in vivo is also regulated on a post-transcriptional level. 
Figure 6 shows the multiple sites for post-transcriptional regulation of HL expression. For 
some regulators the nature of post-transcriptional effects is defined. Fenofibrate may affect the 
intracellular processing andlor secretion ofRL (162). The heparin-induced secretion of HL activity 
by liver hepatocytes is mediated by a decreased internalization of HL. and subsequent lower 
degradation (16). The corticotrophin-induced decrease of Ill., expression is due to a reduction ofHL 
binding sites in the liver (124. 144). The mechanisms by which other post-transcriptional modulators 
affect HL expression remain to be investigated. 
1.3 SCOPE OF THIS THESIS 
HL affects lipoprotein and cholesterol metabolism (Chapter 1.1.1). HL may be an important factor 
directing cholesterol transport to the liver. When HL activity in liver is low and up regulated in the 
adrenals and reproductive organs, HL may direct transport to these cholesterol-utilizing organs (7). 
Expression of HL activity is regulated at a transcriptional and post-transcriptional level (Chapter 
1.2). Post-transcriptional regulation can cause rapid changes of HL activity, which may facilitate 
redirection of cholesterol-fluxes. Further, post-transcriptional regulation of HL activity may be 
important in the post-prandial state, when remnants and dietruy cholesterol in the plasma are rapidly 
elevated. Our objective was to study the post-transcriptional regulation more closely. We studied 
HL expression in rat hepatocytes and in human-derived HepG2 ceBs under conditions where 
regulation at the post-transcriptional level had been implicated. We hypothesized that in these 
conditions N-glycosylation and oligosaccharide processing (Chapter 1.1.4) playa role in regulating 
HL expression. 
Post-transcriptional regulation 
Our first approach was to study the effect of catecholamines on HL activity. Rat hepatocytes treated 
with adrenaline secrete less HL than cells in which the protein de novo synthesis is blocked with 
cycloheximide. This observation led to the hypothesis that at least part of the inhibitory effect was 
at the post-translational level. In chapter 2 of this thesis experiments are described in which we 
studied in detail the mechanism by which adrenaline decreases the HL activity. 
Second, we focussed on the discrepancy between mRNA levels and HL activity in 
hypothyroid rats supplemented with growth hormone. Growth hormone-supplementation of 
hypothyroid rats results in normalization of Ill.. mRNA, but the HL activity in the liver is not 
restored, which implicates post-transcriptional regulation. The results of this study are described in 
chapter 3. 
Third, we studied the effects of fenofibrate treatment of rats on the secretion and maturation 
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of HL. The non-heparin releasable HL pool in the liver after fenofibrate treatment was elevated, 
whereas mRNA levels and Ill., activity in the total liver was decreased. These findings suggested 
that fenofibrate had post-transcriptional effects on HL secretion. We examined this hypothesis in 
chapter 4. 
N-linked glycosylatioJl of HL 
Secretion of a catalytically active HL requires N-linked gJycosylation. Besides glycosyiatioll. proper 
processing of the glycan chains, in particular trimming of the terminal glucose residues in the ER 
appears to be crucial for gaining activity. We examined the role of N-linked glycosylation in the 
secretion and activation of human m... in HepG2 cells (Chapter 5.1) and of rat HL in suspensions 
of freshly isolated hepatocytes (Chapter 5.2). 
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Adrenaline inhibits hepatic lipase secretio1l 
2.1 ACUTE EFFECTS OF ADRENALINE ON HEPATIC LIPASE SECRETION 
BY RAT HEPATOCYTES. 
ABSTRACT 
Catecholam.ines are responsible for the daily changes in hepatic lipase (HL) expression associated 
with feeding and fasting. \Ve have studied the mechanism by which adrenaline decreases :m... 
secretion in suspensions of freshly isolated rat hepatocytes. Adrenaline acutely inhibited HL activity 
through activation of the ((cadrenergic pathway. The cells had significantly less HL activity in the 
presence of adrenaline versus cycloheximide, where protein de novo synthesis is completely 
blocked. The specific enzyme activity of secreted HL was not affected. Intracellular HL activity was 
decreased by adrenaline-treatment. Pulse-labelling with e5S]methionine showed that the de novo 
synthesis of the 53 kDa Endo H-sensitive :m... protein was unaffected by adrenaline. During 
subsequent chase of the control cells, the 53 kDa form was converted to a 58 kDa Endo H-resistant 
HL protein, which was rapidly secreted into the medium. In the presence of adrenaline, formation 
of the 58 kDa protein was markedly reduced whereas the 53 kDa protein disappeared at a rate 
similar to the rate of controls. This suggests that part of the HI... protein was degraded. In contrast 
to adrenaline, inhibition of HI... secretion by colchicine was accompanied by an intracellular 
accumulation of HL activity and of the 58 kDa protein. \Ve conclude that adrenaline inhibits :m... 
secretion posttranslationally by retarding the maturation of the 53 kDa HL precursor into an active 
58 kDa protein. possibly by stimulating degradation of newly synthesized HL protein. 
INTRODUCTION 
Hepatic lipase (Ill.) .is synthesized and constitutively secreted by liver parenchymal cells and 
subsequently bound extracellularly in the liver (1-3), Here, it plays an important role in lipoprotein 
metabolism. HI... hydrolyses phospholipid and triacylglycerol present in high- and intermediate-
density lipoproteins and chylomicron remnants, and facilitates the selective uptake of cholesterol 
from high density lipoproteins and the removal of remnant particles by the liver (see Jackson et al 
for review (4)). Thus, by contributing to reverse cholesterol transport and to the decrease of the 
atherogenic remnant particles in the circulation, HL is thought to protect against the development 
of premature atherosclerosis. Indeed, post-heparin HI... activity was lower in patients with versus 
those without stenotic coronary arteries (5). In addition, HI... activity was inversely correlated with 
progression of coronary atherosclerosis in patients on a lipid-lowering diet (6). The factors that 
determine the level of HL activity in liver arc poorly understood. 
The amount of HL activity present in the liver of rat and man is under hormonal and dietary 
control (7-10). An important role is played by the "stress" hormones, glucocorticoids and 
catccholamines, which all reduce HL expression (11, 12). Catecholamines and long-term treatment 
with corticosteroids are associated with profound changes in plasma lipoprotein turnover and the 
development of atherosclerosis (11-15), Decreased HL may contribute to the changes in lipoprotein 
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metabolism. The catecholamines were recently shown to be responsible for the daily changes in the 
HL expression in rat (16), Depending on the feeding condition, HL activity in the liver changes over 
a twofold to threefold range, and is lowest during fasting periods. 
Whereas most hormones including glucocorticoids have been shown to alter HL expression at 
the level of transcription (12), the mechanism by which catecholamines decrease HL expression is 
less clear. In contrast to the other hormones, the catecholamines have an acute effect on HL 
secretion, which can be demonstrated in suspensions of freshly isolated hepatocytes (11, 16), Cells 
treated with adrenaline secrete less Ill.. activity than cells in which protein de novo synthesis is 
completely blocked with cycloheximide (16). This observation led to the hypothesis that at least part 
of the inhibitory effect occurs at the post-translational level. In the present study, the mechanism by 
which adrenaline lowers secretion ofHL activity was addressed dircctly. \Ve show here that HL de 
novo synthesis is unaffected by adrenalinc. Instead, intracellular processing of newly synthesized 
HL into a mature protein is inhibited and degradation is increased. 
IVlATERlALS AND METHODS 
Materials 
Cycloheximide and CHAPS were purchased from Boehringer Mannheim (Mannheim, Germany). Benzamidine and 
amino acids were from Merck, (Darmstadt, Germany). Adrenaline was obtained from Centrafarm (Etten-Leur, The 
Netherlands) and prazosin from Pfizer (Brussel, Belgium). Trasylol was from Bayer (t."fijdrecht, 'IllC Netherlands) and 
heparin from Leo Pharmaceutical Products (Weesp, The Netherlands). Ham's FlO and methionine-free ~1EM were from 
Gibco (Paisle, U.K.). Endo H was from Genzyme (Cambridge, MA, U.S.A). Glycerol tri{9,IO(n)-JH]oIeate was 
purchased from Amersham (Amersham, U.K.) and Tran-JSS-Iabel, 1100 Ci/mmoI. was trom ICN (Costa Mesa, CA, 
U.S.A.). All other chemicals were from Sigma (SI. Louis, i\-lO, U.S.A.). 
HepaloC)'le isolation and incubation. 
Male Wi star rats (250 to 300 g body weight) were fed ad libitum with a standard chow diet (Hope Farm, Wilnis, TIle 
Netherlands). IIcpatocytes were isolated by in situ perfusion with collagenase type I and nonparenchymal cells were 
removed by differential centrifugation according to the method of Seglen (17). The cells were washed with Ham's FlO 
mediulll containing 25 UlmI of heparin to remove residual extracellularly bound HL. The cells were resuspended at 3 
to 5x 10" cells/ml Ham's FlO medium containing 25 Ulml of heparin and 20% heat~inaetivated dialysed bovine serum 
(I). The cell suspensions were incubated at 37°C under an atmosphere of95% 0/5% COl in a shaking water bath. Cell 
viability ranged from 85 to 95%, as determined by Trypan blue exclusion and remained essentially unaltered throughout 
the incubation. 
At the indicated times, 0.5 ml-samples were collected from the incubation media and put on ice. Cells and media 
were separated by centrifugation (5 s, 1O,OOOg, 4°C) and the cell-free media were used for analysis of secreted HL. For 
analysis of intracellular HL, the cells were washed twice \\ith Ham's FlO medium and then resuspended in the original 
volume of PBS containing 4 mM CHAPS, 25 UlmI of heparin, and the protease inhibitors leupeptin (I }.tg/ml), antipain 
(I f.Jg/ml), chymostatin (11Jg!ml), pepstatin (I pglml), benzamidine (I mM), TrasyloI (10 IU/ml) and EDTA (I mM) 
(18, 19). The cells were lysed by sonification (10 s, ar amplitude 14 p with the MSE Soniprep 150), either immediately 
or after overnight storage at -SOpe. Thereafter, the homogenates were centrifuged (10 min, IO,OOOg, 4°C) and the 
supernatants were used for further analysis. 
HL acth'ity and protein 
HL activity wa,> determined by a triacylglycerol hydrolase assay at pH 8.5 in 0.6 M NaCI using a gum acacia-stabilized 
glycerol eHJtrioleate emulsion as substrate (I). Assays were performed for 30 min at 30Pe. Enzyme activities are 
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expressed as mU (nmoles of free fatty acids released per min). Lipase activity in the cell-free media was completely 
inhibited by goat anti-HL IgGs (20). Of the lipase activity present in the cell homogenates, approximately 0.17 ± 0.03 
mUlI06 cells was resistant to immuno-inhibition with anti-HL; this value was not affected by any of the incubation 
conditions used (data not shown). For determination of intracellular HL activity, this value was subtracted from the total 
lipase activity in the cell homogenates, 
The amount of HL protein in cell-free media was measured by a 30Iid-phase ELISA, in which HL is sandwiched 
between goat polyclonal and a mixture of monoclonal anti-HL IgG's, as described previously (20). Absorbance was re,1d 
against a standard curve prepared by serial dilutions of rat HL. The laller was prepared from post-heparin rat liver 
perfusates by aft1nily chromatography on Sepharose-heparin. HL activity was eluted with a linear 0.2 to 1.0 ~\'I NaCI 
gradient in 1% BSA; peak fractions were pooled and kept at -80°C until use. 
Protein de no\,o synthesis 
Freshly isolated hepatocytes were pre incubated for 30 min in methionine-free MEM containing 25 VIm! of heparin and 
20% heat-inactivated dialysed bovine serum in the absence of adrenaline. Then. 50 IlCi/m! ofTran_3sS_label was added 
with or without adrenaline. After 10 min, the incubation was stopped on ice and cold methionine was addcd at a tinal 
concentration of I mM. TIle cells were collected by centrifugation (2 min, 50g, room temp.). After washing once in 
Ham's FlO medium, the cells were lysed in lysis buffer (1 % Triton X~IOO. 0.1 % sodium deoxycholate, 25 U/Ill! hcparin. 
I mM methionine and 1 mM cysteine. and the cocktail of protease inhibitors described above) (18). After 30 min on 
ice, the Iysates were centrifuged for 10 min at 1O,000g and 4°C. and the supernatants were used for immunoprecipitation 
of r35S]HL (see below). After separation of the immunoprecipitated proteins by SDS-PAOE. the HL bands were 
quantified by overnight exposure to a phosphor screen in the OS363 l\'folccular Imager system from 
Bio-Rad (Richmond, OA, U.S.A,). 
To determine overall protein de novo synthesis, 25 III of the Iysates were spotted onto Whatman 3MM filter paper 
(Whatman, Maidstone. UK). Al1er boiling in 5% TCA, the filters were washcd successively with ethanol:ethcr (I: 1) and 
ether, and radioacth·jty in the TCA-precipitable material was determined by a I-hour exposure in the OS363 ~\-'Iolecular 
Imager system. 
Pulse-chase experiments 
Cells were pulse-Iobelled in the absence of adrenaline with 80 IlCi/ml of Tran-35S-label for 5 to 10 min, as described 
earlier. After washing and resuspending the cells. the incubation was continued in Ham FlO mcdium containing 25 V/ml 
of heparin, 20% bovine serum and I mM cold methionine in the absence or presence of adrenaline, After the indicated 
chase times, the incubations were stopped on ice and l),sisbuffer was added. In some experiments, cells and media were 
first separated by centrifugation and then the cells were lysed in lysis buffer as described earlier. 
Immu noprecipita tions 
HL protein was immunoprecipitated by goat po!yclonal anti-HL IgGs immobilized onto Sepharose (20). Twenty mg of 
the goat antibody preparation was coupled per 1 gram ofCNDr-activated Scpharose 4B (Pharmacia. Uppsala, Sweden) 
according to the manufacturers instructions. Similarly, non-immune IgGs from a control goat were also immobilized 
onto Sepharose. Samples (0.5 to I ml) of cell-free media and cell Iysates were tirst incubated for 2 h at 4°C with 50 /11 
of a 50%-slurry of immobilized non immune IgGs. After removal of the beads by centrifugation (20 s. 10,ooog, 4°C), 
the samples were incubated overnight at 4°C with 50 JJI of a 50%-slurry of the immobilized anti-HL IgGs. The beads 
were collected by centrifugation and then washed twice with I ml of successively PBS, I r.,'1 NaCI in PBS, 0.2% Tween-
20 in PBS, and finally PBS (all at 4°C). The bound proteins were released by boiling in Laemmli sample buffer without 
t3-mercaptoethanol. After removal of the beads the proteins were reduced with t3-lllercaptoethanol and then resolved by 
SDS-PAGE on 10% gels. Radioactive bands were visualized by fluorography using Amplify (Amersham). and their 
molecular masses wcre estimated using broad-range markers from Bio-Rad electrophoresed in parallel. To quantify the 
radioactivity in the protcin bands, the dried gels were analysed by a 24-hour exposure in the GS363 Molecular Imager 
system. 
Transferrin was immuno-precipitated from the cell-free media as outlined above, using 10 ~iI of a I: 10 diluted anti-
serum against rat transferrin (a kind gift from Prof, Dr. H.G. van Eijk, Rotterdam, The Nctherlands) followed by 20 1-11 
of a 50% slurry of protein A-Sepharose (Pharmacia. Uppsala, Sweden). 
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DcglycosyIntion with Endo H 
Following pulse-chase labelling and immunoprecipitation, e5S]HL was removed from the Sepharose-beads and 
denatured by heating for 5 min 95°C in 50 ruM NaPi buffer (pH 6.0) containing 0,5% SDS. Aliquots (10 pi) were 
incubated with or without 80 mU/ml Enda H for 16h at 3rC in NaPi buffer with 0.2% SDS. Samples were heated for 
5 min 9S<'C in Laemmli sample buffer and subjected to SDS-PAGE and the phosphor imaging with the Molecular 
Imaging system. Sensitivity to Endo H was evidenced by increased electrophoretic mobility (18). 
Statistics 
Statistical significances were determined by two-way ANOVA, followed by Student-Newman-Keuls test (21). 
RESULTS 
Secretion of HL activity and protein 
HL activity in suspensions of freshly isolated rat hepatocytes was reduced by adrenaline in 
a concentration-dependent manner (Fig. I). In the presence of I f-IM adrenaline secretion 
was inhibited by 30%; maximal inhibition of 50% was obtained with 100 JlM adrenaline. This effect 
100 
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Figure 1 Effeds of different adrenaline 
concentrations on secretion of Ia activity. 
Freshly isolated hepatocytes were incubated in control 
mediulll, or in the presence of difterenl amounts of 
adrenaline, either alone (filled bars) or with I JlM 
prazosin (open bars) or 111M propranolol (hatched bar) 
added at time zero. After one hour samples were 
collected on ice and the cell-free media were assayed for 
HL activity. Data are expressed as percentage of control 
(1.31 ± 0.53 mUIIO~ccIls) and are mean ± S.D. for 3 
independent experiments. 
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was completely abolished by co-incubation with I flM of the "I-blocker prazosin but not with 
I flM of the p-blocker propranolol. A 50% inhibition ofHL secretion was also obtained with IO flM 
phenylephrine, a selective "I-agonist. Therefore, the effect of adrenaline was mediated by 
ai-adrenergic receptors. 
Throughout the first 90 min of incubation with adrenaline, HL activity was secreted at a 
constant rate of approximately 0.63 ± 0.18 mU/hflO' cells (mean ± S.D.; n ~ 5), compared to 1.16 ± 
0.26 mUIhlIO' cells in control suspensions (Fig. 2). Already 30 min after addition of adrenaline, HL 
activity in the medium was significantly lower than in parallel controls, indicating that adrenaline 
acted almost immediately. This time course of secretion differed markedly from that observed with 
cycloheximide (IO flg/ml), which completely and instantaneously blocked protein de novo 
synthesis (19). With cycloheximide the secretion ofHL activity initially continued unaffected, but 
plateaued after 60 min (Fig. 2). This lag period apparently reflects the intracellular transport time 
of newly synthesized HL protein. At the 30 and 60 min time points, extracellular HL activity was 
significantly lower with adrenaline than with cycloheximide (p<0.05). Under all conditions tested, 
secretion of HL protein as measured by ELISA parallelled the extracellular appearance of HL 
activity. Hence, the specific enzyme activity of secreted HL remained unaffected by incubation with 
adrenaline (Fig. 2, insert). 
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Figure 2 Acute inhibition 
of HL secretion. 
Hepatocytes were incubated in 
control medium (0) and in 
medium containing IO flM 
adrenaline (e)' or 10 flg/ml 
cycloheximide (0) added at the 
start of the incubation. At the 
times indicated samples were 
collected and cell-free media 
were assayed for HL activity and 
HL protein. The data on HL 
activity represent mean ± S.D. of 
5 independent experiments. At 
all time points the difference 
between adrenaline and control 
data wa,> statistically significant 
(p<0.05). At 30 and 60 min time 
points, the adrenaline data were 
also significantly different from 
the cycloheximide data (p<O.05). 
Insert: 
Effect on the specific HL 
activity, calculated from the 
HL activity and amount of HL 
protein in the cell-free media. 
Data are expressed as % of 
control and are representative 
for 3 similar experiments. 
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Figure 3 Effect of adrenaline on intracellular HL. 
Cells were incubated in control medium (0), or in medium containing 10 pM adrenaline (e) or 100 JlM colchicine(A). 
At the indicated times samples were taken for dClcnnination of intracellular lipase activity. Data arc the mean ± S.D. 
(n=3). Statistically significant differences were found between control and adrenaline-treated cells at 60 and 90 min 
(p<O.05). Insert: immunoprecipitated HL from cells labelled for 10 min with [HSJmethionine and chased for 60 min 
in the absence (C) or presence of 10 pM adrenaline (A) or 100 ~1 colchicine (CO). At the end of the incubation, HL 
was immunoprecipitaled from the cell Iysates and resolved by SDS-PAGE and fluorography; the molecular weight of 
the bands is indicated in kDa. 
Intracellular HL activity and protein 
Freshly isolated hepatocytes contained 0.57 ± 0.17 mU of HL activity 110' cells of HL activity 
(mean ± SD; n = 4), which was constant throughout the 90 min incubation (Fig. 3). In the presence 
of adrenaline, HL activity decreased during the first 30 min to 60% of control values. Upon 
prolonged incubation, intracellular Ill., activity remained constant at this low level. Hence, the 
adrenaline-induced reduction in HL secretion was accompanied by a loss rather than increase in 
intracellular HL activity. In contrast, the Ill., activity in cycloheximide-treated cells continued to fall 
to negligible levels after 90 min (Table I), An intracellular accumulation of Ill., activity could 
be induced by treating cells with 0.1 M colchicine, which inhibits protein secretion 
posttranslationally (22, 23). Herein, intracellular HL activity almost doubled in about 90 min of 
incubation (Fig. 3). Secretion of HL activity (and protein) was inhibited to a similar extent as by 
10 flM adrenaline (Table I). 
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Since the ELISA for HL protein proved urneliable on celllysates, we used 35S-labelling followed 
by immunoprecipitation with anti-HI... IgGs as a relative measure for intracellular HL protein. Cells 
that had been pulsed for 10 min with e5S]methionine, were chased for 60 min in the absence or 
presence of adrenaline (Fig. 3; insert). In control ceIls, intmceIlular r35S]HL mainly migrated at the 
53 leDa position, whereas a faint band was visible at 58 leDa (Fig. 3, insert). The 58 leDa band 
comigrated with HL present in extracellular media and therefore represents mature HI.... In contrast 
to the 58 leDa band, the 53 kDa band was Endo H-sensitive (see later) and thus corresponds to the 
high-mannose-type HL precursor (18). IntraceIlular r35S]HL was not affected by adrenaline, despite 
the inhibition of HL secretion. In the presence of adrenaline, intracellular r35S]HL mainly migrated 
at the 53 kDa position. In colchicine-treated cells, inhibition of HL secretion and the increase in 
intracellular HL activity coincided with the accumulation of C5S]HL at the 58 kDa position. These 
observations suggest that intracellular HL activity is associated with the mature 58 kDa HL protein 
rather than with the 53 kDa precursor protein. 
Table I Distinct effects 011 illtracellulal' and secreted HL activity. 
Medium Cells 
Treatment mUll 0' cells % mUIIO' cells % 
Control 1.87 ± 0.63 100 0.55 ± 0.26 100 
Cyc10hexintide 1.16 ± 0.41 62 0.10 ± 0.14 18 
Adrenaline 0.94 ± 0.45 50 0.29 ± 0.28 52 
Colchicine 0.56 ± 0.13 30 1.10 ± 0.33 200 
Cells were incubated in control medium. or in medium containing either 10 f-Iglml cycloheximide, 10 f.1M adrenaline. 
or roo 11M colchicine. After 90 min, samples were collected on ice, and the HL activity in the cell-free media and cell 
homogenates was measured. Data are expressed as the mean ± S.D. (n==3), or as percentage of control. HL activity in 
the treatment groups were all significantly different from the controls (p<O.05). 
Effect on HL translation 
Parenchymal cel1s were incubatcd with e5S]methionine for 10 min with or without adrenaline. 
Thereafter, the incorporation of radioactivity into m.... protein and into total TeA-precipitable 
material was detennined. In control cells, approximately 0.02% of the 3sS-radioactivity in total TCA 
precipitable material was present in HL protein (the 53 pIus 58 leD. bands) (Table 11). With I 0 ~M 
adrenaline incorporation of 35S-label into HL protein was slightly, but not significantly lower than 
in control cells. Similar values were found in cells incubated with the combination of adrenaline and 
prazosin. Overall protein synthesis was not affected by adrenaline. This demonstrated that the short 
tcrm effects of adrenaline on inhibition ofm... expression are not mediated at the level of translation. 
Effect on intracellular HL processing 
In fSS]methionine pulse-chase experiments, cells were pulsed in the absence of adrenaline and then 
chased with or without adrenaline. After a 5 min pulse, a protein band with an apparent molecular 
mass of 53 leDa was immunoprecipitated with anti-HL IgGs from the total cell suspensions (Fig.4A). 
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Table 2 Effect of adl'enaline on protein and HL de novo synthesis. 
HL(cpm/mJ) 
total protein (cpm/IlI) 
control 
33 ± 13 
144 ± 46 
adrenaline 
31 ± 12 
145 ± 43 
adrenaline + prazosin 
30 ± 10 
131 ± 43 
Hepatocytes were pulsed with e5S1methionine for to min with or without 10 pM adrenaline, either alone or in 
combination with IIJM prazosin. TllCreafter the radioactivity in total TeA-precipitable material amI inullulloprecipitated 
HL (the 53 plus 58 kDa bands on SDS-PAGE) was determined. Data represent the amount of 3sS-labelled protein, which 
was calculated in terms of cpmfml) cell suspension by taking into account the different times of exposure to the phosphor 
screens. Data are expressed as mean ± SD of3 independent experiments, each performed in duplicate. No statistically 
significant differences were found between the treated values and controls (p>O.05) 
During the chase, tlus band gradually shifted towards the 58 kDa position. In similar pulse-chase 
experiments, when HL was immunoprecipitated sep~uately from cell lysates and cell-free media, 
we observed that the 53 kDa band was the major intracellular protein. 
The J5S-labelled 53 kDa protein was never observed extracellularly. The 58 kDa protein was 
rapidly secreted into the medium (Fig. 43; a and b). Upon incubation oflhe 53 kDa bcUld with Endo 
H, the apparent molecular weight decreased to about 50 kDa, demonstrating that the 53 kDa protein 
represented Endo H-sensitive HL protein bearing high-mannose type oligosaccharide chains. In 
contrast, the appm'ent molecular weight of the 58 kDa band was not affected by Endo H-treatment, 
and thus represents the mature, complex type HL protein. \Vhen adrenaline was included in the 
chase medium, less of the 58 kDa band appeared (Fig. 4A). "S-Iabelled HL remained predominantly 
in the 53 kDa form. Secretion of [J5S]IIL was markedly reduced in the presence of adrenaline 
compared to control (Fig. 4B; panel b). Concomitantly, the secretion rate of e5S]transferrill, a 
glycoprotein unrelated to HL, was not affected by adrenaline, or even slightly increased (Fig. 43; 
panel c). This finding argues against a general effect of adrenaline on glycoprotein secretion. 
Figure 5 shows the quantitative analysis of the pUlse-chase experiments. Although. the 
appearance of the 58 kDa band was markedly reduced by adrenaline compared to control cells, the 
disappearance of radioactivity from the 53 kDa band was hardly affected. As a result the total 
radioactivity in HL protein gradually decreased, so that at the end of the chase, total 35S-radioactivity 
in HL protein was approximately 25% lower in the adrenaline-treated sllspensions than in the 
controls. The radioactivity lost from the adrenaline-treated suspensions was not recovered in any 
immunoreactive protein, and may reflect complete degradation. This observation suggests that 
adrenaline induces the degradation of newly synthesized HL protein. 
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Figure 4 Chase experiments in presence or 
absence of adrenaline. Hepatocytes were pulsed 
with e5S)methionine for 5 min in the absence of 
adrenaline. After washing the cells in fresh medium the 
cell suspension was divided in two. One part was 
incubated in control medium and the other part was 
incubated in medium containing 10 jlM adrenaline. At 
the times indicated samples were collected and HL was 
immunoprecipitated from the whole suspensions (A). 
(B)Suspensions were first separated into cells and media, 
then HL was immunoprecipitated from the celllysates 
(a) and cell-free media (b); then transferrin was 
irnmunoprecipilated from the same cell-free media (c). 
Samples were resolved by SDS-PAGE and fluorography. 
Data represent 4 similar experiments. 
(C) Effect of Endo H on the mobility of the 53 kDa and 
58 kDa bands in SDS-PAGE. The apparent molecular 
weight of the bands is indicated in kDa. 
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Figure 5 Effect of Adrenaline on the maturation of HL into a 58 kDa protein. 
Experiments were perfonned as outlined in the legend to figure 4A. The 35S_labelled bands of immulloprecipitated HL 
on SDS-PAGE were analysed quantitatively. The data show the disappearance of the 53 kDa protein, the appearance 
of the 58 kDa protein and the sum of both signals for the chase in the absence (0) or presence of 10 ~M adrenaline (e). 
Data are expressed as a percentage of the total radioactivity in the HI.. bands at the start of the chase (14 ± 5 cpm/ml cell 
suspension) and are the mean ± SD of 3 similar experiments. 
DISCUSSION 
OUf study confirms previous rep0l1s that adrenaline acutely inhibits secretion of HL activity by rat 
hepatocytes (11, 16, 24). Up to 50% inhibition was observed within 60 min of exposure to I to 
100 pM of adrenaline, which was mediated through activation of the ai-adrenergic pathway. We 
show here that the acute inhibition of HL expression occurs mainly posttranslationally, and that HL 
de novo synthesis is not affected by adrenaline. This contrasts with the effect of adrenaline on 
lipoprotein lipase expression in 3T3 adipocytes, which was recently reported to be mediated at least 
in pari by a reduced translation of the LPL mRNA (25, 26). 
Adrenaline has been previously hypothesized to affect HL secretion at the posttransiational 
level (16, 24). In line with this, we found that secretion ofRL activity in the presence of adrenaline 
was significantly lower than with cycloheximide, where protein de novo synthesis is completely 
blocked. Which posttransiational event in the maturation of:m.. protein is sensitive to inhibition by 
adrenaline is unknown. Neither the specific catalytic activity of secrctcd HL protein, as determined 
by ELISA, nor its mobility on SDS-PAGE were affected by adrenaline. Pulse-chase experiments in 
which adrenaline was added after the pulse showed that the extracellular appearance of e5S]:m.. was 
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retarded compared to controls levels. After a 30 min-chase, secretion of ["S]Hi. was 25 to 30% 
lower than in the controls, similar to the observed effect on secretion of HL activity. In the presence 
of adrenaline, maturation of the 53 kDa Endo H-sensitive protein into the mature 58 kDa Endo H-
resistant HL protein occurred at a lower rate than in control celJs; after 45 min intracellular eSS]HL 
was mainly in the immature form. At this time, recovery of total 3sS-label in HL protein was only 
75% of that in parallel controls, thus suggesting that adrenaline increases intracellular degradation 
of HL protein. Retardation of HL maturation may render the 53 kDa HL more susceptible to 
degradation. 
The decreased secretion of HL into the extracellular medium was not accompanied by an 
intracellular increase in HL activity. On the contrary, intmcellular HL activity was markedly lower 
than in control cells. We recently showed that in rat hepatocytes, HL is initially synthesized as an 
inactive protein in the rough endoplasmatic reticulum (RER). Subsequent oligosaccharide 
processing by RER glucosidases is necessary for the protein to leave the RER and to become 
catalytically active (19, 20). Here, we show that intracellular Hi. activity is mainly associated with 
the presence of the 58 kDa protein form (Fig. 3). In adrenaline-treated cells, Hi. protein was 
predominantly in the 53 kDa precursor form, which was found to be associated with a low specific 
enzyme activity. Taken together, our data indicate that adrenaline acts at an eady stage during the 
maturation of HL by inhibiting the processing of the inactive precursor into the mature active 
protein. 
How the extracellular presence of adrenaline is signalled to the posttranslational 
modification of HL remains unclear, but the mechanism presumably involves binding to tX 1-
adrenoceptors and the subsequent increase in intracellular calcium. Indeed, secretion of HL activity 
is also inhibited by other ea-mobilizing agonists such as vasopressin and angiotensin II as well as 
by the Ca-ionophore A23187 (11,27). These calcium signals may affect vesicular transport from 
RER to the Golgi complex, thus inhibiting maturation and secretion of HL. However, this mode of 
action would be expected to affect overall constitutive secretions. In light of our results with 
transferrin, tlus possibility appears unlikely. Alternatively, a factor required for the maturation of 
a limited number of glycoproteins including HL may be involved. Such a factor has been implicated 
in mice suffering from combined lipase deficiency (28, 29). In these mice, Hi. and lipoprotein lipase 
are normally synthesized in liver and non hepatic tissues, respectively, but the protein accumulates 
in an inactive, high-mannose type form within the RER without being secreted (30). No other 
glycoproteins appear to be affected in this syndrome. A factor that specifically interacts with Hi. in 
the RER and is impaired by the cld mutation may be the target of adrenaline. Further studies are 
required to delineate the mechanism by which catecholamines interfere with posttranslational 
processing of HL. 
Acknowledgments 
We would like to thank C. Kalkman for expert technical assistance. The work was supported by 
grant nr 91.075 from the Dutch Heart Foundation. 
40 
Chapter 2.1 
REFERENCES 
1 Jansen, H.. Kalkman, C., Zonncvcld, AJ. and Hilismann, W.e. (1979) Secretion oJfriac)'lg/ycerol hydrolase 
activit)' by isolated PllfCllcilYlllai rat liver cells; FEBS Lett., 98, 299-302 
2 Persoon, N.L., HUlsmann, W.C. and Jansen, H. (1986) Localizatioll a/the salt-res/slam heparill-releasable lipase 
ill the rat liver, adrel/al alld omT)'; Eur. J. Cell BioI., 41, 134-137 
3 Hixenbaugh, E.A. and Paavola, L.G. (1991) Heterogeneity alllol/g omriall blood vessels: endogel/ous hepatic 
lipase is concentrated ill blood vessels of rat corpora II/tea; Anat. Rec., 230, 291-306 
4 Jackson, RL. (1983) Lipoprofeilllipase alld hepatic lipase; in The Enzymes (Boyer, P.O., ed.), Vol. 16,3 cd., pp. 
141-181, Academic Press, New York. 
S Barth, J.D., Jansen, B., Hugenholtz, P.G. and Birkenhager, J.C. (1983) Post-heparilllipases, lipids alld related 
hormolles ill mellllndergoing coronary arteriography to assess atherosclerosis; Atherosclerosis, 48, 235-24l 
6 Barth, J.D., Jansen, H., Kromhout, D., Reiber, J.H., Birkenhiiger. J.C and Arntzcnius. A.C (1987) Diet alld the 
role oflipoproteills, lipases, and thyroid hormones ill corOllary lesion growth; J. Cardiovasc. PharmacaL. 10, S42-46 
7 StaeIs, B., Jansen, H .• van Tal, A .• Stahnke. G .. Will, H .• Verhoeven, G. and Auwerx. J. (1990) Del'eiopmellt, food 
iI/take. alld ethil/ylestradiol illfluence hepatic triglyceride lipase alld LDL-receptor mRNA lel'els ill rats; J. Lipid Res .. 
31,1211-1218 
8 Kihara, S .• Wolle, J .• Ehnholm. C. Chan, L. and Oka, K. (1993) Regulation of hepatic triglyceride lipase by thyroid 
hormone ill HepG2 cells; 1. Lipid Res., 34. 961-970 
9 Hoogerbrugge. N., Jansen, H .• Staels, B., Seip, M.J. and Birkenhiiger. J.C. (1993) Growth hormone normalizes 
hepatic lipase in hypothyroid rat liver; Metabolism, 42, 669-671 
10 Schoonderwoerd, K.. Verhoeven, A.J.M. and Jansen, H. (1994) Rat lil'ercollfaills a /imited mllllber ofbilldillg sites 
for hepatic lipase; Biochem. J., 302, 717-722 
11 Schoonderwoerd, K.. HUlsmann. \V.C and Jansen, H. (1984) Regulatioll oflil'er lipase. Il. /lIl'O/l'ement of the alpha 
I-receptor; Biochim. Biophys. Acta. 795, 481-486 
12 Jansen, H., van Tol, A., Auwerx, J., Skretting. G. and Siaels, B. (1992) Opposite regulatioll of hepatic lipase alld 
lecithill: cholesterol acyltransferase by glllcocorticoids ill rats; Biochim Biophys Acta, 1128, 181-185 
13 Nashel, DJ. (1986) Is atheroscleroses a complicatioll oflong-tenn corticoid treatment?; Am. J. Med., 80. 925-929 
14 Mackintosh, V. and Rcdgravc, T.G. (l991) Effects of adrenaUne alld noradrenaline 011 clearallce of 
triacy/glycerol-rich lipoproteins from plasma: studies with chylomicron-like ltjJid emulsions in rats; Clin. Exp. 
Pharmacol. Physiol., 18, 137-143 
15 Hauss, \V.H., Bauch, HJ. and Schulte, H. (1990) Adrenaline ami noradref/alille as possible chemical mediators 
ill the pathogenesis of arteriosclerosis; Ann N Y Acad Sci, 598, 91-101 
16 Peinado·Onsurbc, J., Solcr, C, Galan, X., Povcda, fl., Soley, M., Llobera, M. and Ramirez, I. (1991) Involvement 
of catecholamilles i1l the effect offastillg all hepatic elldotheliallljmse actMty ill the rat; Endocrinology, 129,2599-
2606 
17 Seglen, P.O. (1976) Preparation of isolated rat lh'er cells; Methods Cell. BioI., 13,29-83 
18 Cisar, L.A. and Bensadoun, A. (1987) Characteri'(.atioll of the intracellular processing and secretioll of hepatic 
lipase ill FU5AH rat hepatoma cells; Biochim. Biophys. Acta, 927, 305-314 
19 Verhoevcn, AJ.M. and Janscn, H. (1990) Secretion of rat hepatic lipase is blocked by inhibition of oligosaccharide 
processing at the stage of glucosidase /; J. Lipid Res., 31, 1883- 1893 
20 Verhoeven, AJ.M. and Jansen, H. (1991) Secretion-coupled increase ill the catalytic actMty of rat hepatic lipase; 
Biochim. Biophys. Acta. 1086,49-56 
21 Snedecor. G.W. and Cochran. W.G. (1980) Statistical Mcthos, Iowa State University Press, Ames JA. 
22 Redman, CM., Banerjee, D., Howell, K. and Palade, G.E. (1975) Colchicine inhibitioll of plasma protein release 
frolll rat hepatocytes; J. Cell BioI., 66, 42-59 
23 Patzelt, C, Brown, D. and Jeanrenaud, B. (1977) Inhibitory e.ffect of colchicine 011 amylase secretioll by rat parotid 
glands. Possible localization in the Golgi area; J. Cell BioI., 73, 578-593 
24 Peinado-Onsurbc, J., Soler, C, Soley, M., L1obera, M. and Ramirez, I. (1992) Lipoproteilllipase alld hepatic lipase 
actMties are differe1ltially regulated ill isolated hepatocytesfrom lIeol/atal rats; Biochim. Biophys. Acta, 1125.82-89 
25 Ong, J.M., Saffari. B., Simsolo, R.B. and Kern, P.A. (1992) Epinephrine inhibits Iipoproteilllipase gene expression 
ill rat adlj)ocytes through lIIultiple steps in posllrallscriptional processing; Mol. Endocrino!., 6, 61-69 
26 Yukht, A., Davis, R.C., Ong, 1.1'.1., Ranganalhan, G. and Kern, P.A. (1995) Regulatioll of /ipoproteill lipase 
lralls/alion by epineplwine ill 3t3-11 cells. /importance of the 3' ullfrallslated region; J Clin Invest, 96, 2438-2444 
27 Soler, C, Galan, x., Peinado-Onsurbe, J., Quintana, I., Llobera, 1'.1., Soley, M. and Ramirez, I. (1993) Epidermal 
growth factor illtetjeres wilh the effect of adrenalille 011 gillcose prodllction alld Oil hepatic lipase secretioll ill rat 
hepatocytes; Regul. Pept., 44,11-16 
28 Olivecrona, T., Bengtsson-Olivecrona, G., Chernick, S.S. and Scow, R.O. (1986) Effect of combined lipase 
deficiency (cld/cld) 011 hepatic alld lipoproteill lipase actMties inlil'er alld plasma ofllewbom mice; Biochim. Biophys. 
Acta, 876, 243-248 
29 Masuno, H., Blanchette-Mackie, EJ., Chernick, S.S. and Scow, R.O. (1990) Synthesis ofillactil'e 1I01lsecrelable 
41 
Adrenaline inhibits hepatic lipase secretioll 
high mmlllose-type lipoprotein lipase by cultllred brown adipocytes oj combined lipase-deficient cld/cld mice; J. BioI. 
Chern.,265,1628-1638 
30 Davis, R.C., Ben-Zeev, 0., Martin, D. and Doolittle, M.H. (1990) Combilled lipase deficieJlc)' ill the mOllse. 
Evidel/ce ajimpaired lipase processing and secretioll; J. BioI. Chem .• 265. 17960-17966 
42 
CHAPTER 2.2 
Maturation and secretion of rat hepatic lipase is inhibited by 
am-adrenergic stimulation through changes in Ca2+-homeostasis. 
Thapsigargin and EGTA both mimic the effect of adrenaline. 
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2,2 MATURATION AND SECRETION OF RAT HEPATIC LIPASE IS INHIBITED BY 
am-ADRENERGIC STIMULATION THROUGH CHANGES IN CA"-HOMEOSTASIS, 
THAPSIGARGIN AND EGTA BOTH MIMIC THE EFFECT OF ADRENALINE, 
ABSTRACT 
In rats, the daily changes in hepatic lipase (HL) activity in the liver follow the diurnal rhythm of the 
catecholamines. To study the underlying mechanism, the effect of adrenaline on maturation and 
secretion of HL was determined in freshly isolated rat hepatocytes. Adrenaline (10 11M) acutely 
inhibited the secretion of HL. This effect was abolished by 0.1 11M prazosin, but not by 1 ~tM 
propranolol, indicating the involvement of the ai-adrenergic pathway. Prazosin was at least 
lOoo-fold more potent than WB4IOI, a selective "lA-antagonist. Adrenaline had no effect on HL 
secretion in hepatocytes pretreated with chloroethylc1onidine, an irreversible alB-selective 
antagonist. Inhibition ofHL was not induced by 10 11M methoxamine, a alA-selective agonist. Thus, 
adrenaline inhibited HL secretion through activation of the al-adrenoceptors subtype B, which have 
been shown to signal through Ca2+ as well as cAMP. A similar reduction in HL secretion was 
induced by the Ca2+-mobilizing hormones angiotensin II (100 nM) and vasopressin (12 nM), the 
Ca"-ionophore A23187 (2 ~M), and by thapsigargin (l flM), which inhibits the ER Ca"-ATPase 
pump. HL secretion was unaffected by elevating cAMP with IO ~M forskolin or I ~M 8-Br-cAMP. 
These results suggest that the alB-adrenergic effects on HL expression are mainly mediated through 
elevation of intracellular Ca2+-. Chelation of extracellular calcium and subsequent lowering of 
intracellular calcium with EGTA also inhibited HL secretion. In pulse-chase experiments, adrenaline 
was shown to inhibit the maturation ofHL from the 53 kDa, Endo H sensitive precursor to the Endo 
H resistant, catalytically active protein of 58 kDa. In addition, adrenaline induced intracellular 
degradation of newly synthesized HL. Similar post-translational effects, bOlh qualitatively and 
quantitatively, were observed with A23187, thapsigargin and EGTA. \Ve conclude that the 
inhibition of HL maturation and increase in intracellular degradation induced by catecholamines, 
A23187, thapsigargin and EGTA is evoked by changes in Ca2+ -homeostasis, possibly through 
lowering ER-Ca2+. 
INTRODUCTION 
Hepatic lipase (HL) plays an important role in lipid metabolism. HL hydrolyses phospholipid and 
triacylglycerol present in high and intermediate density lipoproteins, and facilitates the selective 
uptake of cholesterol from high density lipoproteins and the removal of remnant particles by the 
liver (see for review (1»). HL may affect lipoprotein metabolism via its enzymatic activity (2), or 
by its ligand function towards lipoproteins (3-6). By contributing to reverse cholesterol transport and 
by lowering atherogenic remnant particles in the circulation, HL is thought to protect against the 
development of premature atherosclerosis. A low HL has been shown to be a risk factor for 
premature atherosclerosis (7, 8). In addition, HL activity inversely correlated with progression of 
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coronary atherosclerosis in patients on a lipid-lowering diet (9). In line with this, HL transgenic mice 
were shown to accumulate less cholesterol in the aortic wall than non-expressing littermates (10). 
Catecholamines are responsible for the diurnal changes in HL activity observed in rat liver, 
with HL being low when plasma catecholamines are elevated (II). In freshly isolated hepatocytes 
adrenaline decreases HL secretion via activation of ((l-adrenoceptors (11-13), which are generally 
thought to exert their action via intracellular calcium. Recently, several subclasses of this receptor 
have been identified and shown to signal differentially (14-17). The "lA-adrenergic receptor signals 
by stimulating Ca2+-influx from the extracellular medium and mediates a tonic response (l8, 19), 
The arsubclasses B, C and D induce a rapid IP) formation and subsequent release of Ca2+ from 
intracellular stores (20, 21). In addition to calcium mobilization, the latter subclasses were also 
shown to elevate cAMP (21, 22). Hepatocytes from different species express different subclasses 
of u J -adrenergic receptors. Rats, mice and hamsters mainly express ulB-adrenoceptors (23). In 
isolated rat hepatocytes, the "lB-adrenoceptors were reported to directly stimulate cAMP 
accumulation, rather than indirectly in response to elevated calcium (22). The cAMP accumulation, 
induced by the ai-receptors, depends on the maturity of the rats from which the hepatocytes are 
isolated (24). This may indicate age-related changes in ul-adrenoceptor subclass expression. The 
isolation procedure may also cause changes in expression of ulB-adrenoceptors by rat liver ceBs 
(25). Therefore, we decided to re-investigate the signalling pathway involved in the adrenaline-
induced reduction of HL secretion in isolated hepatocytes. 
In earlier studies, we showed that adrenaline acutely decreases the maturation of HL and 
increases degradation of newly synthesized HL protein (13). To distinguish between the various 
(tj-adrenoceptors, we incubated hepatocytes with compounds known to have different affinities for 
the "I-subtypes (26). We show here that the "I-adrenoceptor subclass B mediates the inhibitory 
effects of adrenaline on HL expression. Although u1B-stinllllation induces elevated Ca
2
+ and cAMP 
levels, the post-translational effects of adrenaline on HL expression appear to be only mediated by 
Ca2+. In order to study the mechanism of action, the role of intracellular calcium in the inhibition 
of HL secretion by freshly isolated hepatocytes was studied. 
MATERIALS AND METHODS 
l\Jatcrials 
Adrenaline was obtained from Centrafarm D.V. (Etten-Leur, The Netherlands) and prazosin from Pfizer (Brussel. 
Belgium). Propranolol, thapsigargin, angiotensin II, vasopressin, 8-brOillo-cAMP and EGTA were purchased from 
Sigma (S1. Louis, MO, U.S.A.). Methoxamine, WB4101 and chloroethylclonidine were from Research Biochemicals 
International (Natick, MA, U.S.A). A23187 was from Boehringer Mannheim (Mannheim, Germany). Benzamidine and 
amino acids were purchased fTOm Merck (Darmstadt, Germany). Trasylol was from Bayer (Mijdrechl, The Netherlands) 
and heparin from Leo Pharmaceutical Products (Weesp, The Netherlands). Protein A-Sepharose and CNBr-activated 
Sepharosc 4B were obtained from Pharmacia (Uppsala, Sweden). Ham's FlO and methionine-free MEM were from 
Gibeo BRL (paisle, U.K.). Glycerol tri[9, 10(n)_3H}o!eate (5-20 Cilmmol) was purchased from Amersham (Amersham, 
U.K.), Tran-35S-label (1IOOCilmmol) was from ICN (Costa Mesa, CA, U.S.A.). Broad range markers for SDS-PAGE 
came from Bio-Rad (Richmond, CA, U.S.A.). All other chemicals were from Sigma. 
Hepatocyte isolation and incubation 
Hepatocytes were isolated from male Wislar rats (200g-300g) by in situ perfusion with collagenase type I. whereafter 
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non-parenchymal cells were removed by differential centrifugation according to Seglen (27). The cells were washed with 
Ham's FlO medium containing 25 Vlml of heparin to remove residual extracellularly bound HL. Then the cells were 
resuspended at 3-5*1It cells/ml in Ham's FlO medium containing 25 Vlml of heparin and 20% heat-inactivated. dialysed 
bovine serum (28). The cell suspensions were incubated at 37°C under an atmosphere of95% 0/5% CO2 in a shaking 
water bath. Cell viability ranged from 85 to 95%, as determined by Trypan blue exclusion and remained essentially 
unaltered during all incubations. At the indicated times. 0.5 ml-samples were collected from the incubations and put on 
ice. Cells and media were separated by centrifugation (5 s, 10 OOOg. 4°C) and the cell-free media were used for analysis 
of secreted HL. 
HL activity and protein 
HL activity was determined by a triacylglycerol hydrolase assay at pH 8.5 in 0.6 M NaCI using a gum acacia-stabilized 
glycerol[lHJtrioleate emulsion as substrate (28). Assays were performed for 45 min at 30°C. Enzyme activities are 
expressed as mD (nmoles of me fatty acids released per min). The lipase activity in the cell-free media was completely 
inhibited by goat anti-HL IgGs (29). 
The amount ofHL protein in cell-free media was measured by a solid-phase ELISA as described previously 
(29). with minor modifications, HL was sandwiched between goat polyclonal and rabbit polyclonal anti-HL JgGs. 
Absorbances were read against a standard curve prepared by serial dilutions of partly purified rat HL. 111C laller was 
prepared from post-heparin rat liver perfusates by affinity chromatography on Sepharose-heparin. HL activity was eluted 
with a linear 0,2-1,0 M NaCI gradient in 1% BSA; peak fractions were pooled and kept at -80°C until use. 
Pulse-chase experiments with [",sS]methionine 
Pulse-chase experiments were performed as described before (13), In short, freshly isolated hepatocytes were pre-
incubated for 30 min in methionine-free MEM containing 25 D/ml of heparin and 20% heat-inactivated, dialysed bovine 
serum, After a 5 min pulse with 80 IlCilml of Tran}5S-label. cold methionine was added at a final concentration of I 
ruM, After washing twice by centrifugation (2 min, 50g. room temperature) and resuspending in Ham's FlO, the cells 
were incubated further in Ham FlO medium containing 25 U/ml of heparin. 20% serum and I mM cold methionine. 
After the indicated chase times the incubations were stopped on ice. The whole cell suspension was lysed with I % Triton 
X-lOO, 0.1 % sodium deoxycholate, 25 D/ml heparin. 1 mM methionine and the protease inhibitors leupeptin (I J.Wml), 
antipain (l J.lg/ml), chymostatin (I J.lg/ml). pepstatin (I J.lglml), benzamidine (l mM), Trasylol (10 !U!ml) and EDTA 
(I ruM). After a 3D-min incubation on ice, the lysates were centrifuged for 10 min at 10 OOOg at 4°C, and the 
supernatants were collected. These post-nuclear supernatants were used for immunoprecipitation. 
Immunoprecipitations 
HL protein was immunoprecipitated by goat polyclonal anti-HL IgGs immobilized onto Sepharose (29). Twenty mg of 
the goat antibody preparation was coupled per I gram ofCNBr-activated Sepharose 4B according to the manufacturers 
instructions, The post-nuclear supernatants (I ml) were incubated overnight at 4°C with 50 /11 of a 50%-sluny of the 
immobilized anti-HL IgGs, The beads were collected by centrifugation, and then washed twice with I ml of successively 
PBS. I M NaCI in PBS, 0,2% Tween-20 in PBS, and finally PBS (aU at 4°C), The bound proteins were released by a 
5-min incubation at 95°C in Laemmli sample buffer without B-mercaptoethanol. After removal of the beads the proteins 
were reduced with B-mercaptoethanol and then resolved by SDS-PAGE on lO%-gels. Protein bands were visualized by 
staining with Coomassie Brilliant Blue, and their molecular masses were estimated using broad range markers run in 
parallel. To visualize and quantify the radioactivity in the bands. the dried gels were analysed by phosphor imaging using 
CS-screens and the GS363 Molecular Imager (Bio-Rad, Richmond. CA. U,S.A.). 
Transferrin was immunoprecipitated from the cell free media as outlined above, using 10 III of a I: 10 diluted 
antiserum against rat transferrin (a kind gift from Dr H.G, van Eijk. Rotterdam, TIle Netherlands) followed by 20 111 of 
a 50% sluny of protein A-Sepharose (13). 
Statistics 
Statistical significances were detennined by one-way analysis of variance (one-way-ANOVA). followed by the Student-
Newman-Keuls test (30). 
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RESULTS 
Characterisation of the aradrenoceptor subtype involved in HL secretion 
In the presence of heparin, freshly isolated hepatocytes secreted 1.34 ± 0.19 mU/lO' cells of HL 
activity (mean ± S.D.; n=3) into the medium in onc hour. When adrenaline (10~) was present 
from the start of the incubation, the secretion of HL activity and HL mass decreased to 
approximately 60% of control (Table I). Propranolol (I ~M), which was included in these 
experiments to exclude possible interference by the p-adrenergic pathway, did not alter the secretion 
of HL activity and mass in control, nor in adrenaline-treated hepatocytes (13). On the other hand, 
the response to adrenaline was abolished by co-incubation with 1 ~lM prazQsin, confirming the 
involvement of the aI-adrenergic receptor pathway. 
Table I Secretion of HL activity ill the presence of different "l"adl'enel'gic (ant)agonists 
HL activity HL mass HL specific activity 
Treatment (%) (%) (%) 
Control 100 100 100 
Adrenaline (I 0 ~M) 57 ± 6' 4S±6' 119 ± 15 
Adrenaline (10 ~M) + prazosin (1 ~M) 9S±6 91 ±24 lOS ± 31 
Adrenaline (10 ~M) + WB4101 (l0~) 67 ± 7' 51 ± 13' 131 ± 30 
Adrenaline (I 0 ~) 
+ chloroethylclonidine (I 00 ~M) 97 ± II 103 ± 10 94 ± 14 
Methoxamine (I 0 ~) 91 ± 12 96± IS 95 ± II 
Freshly isolated hepatocytes were incubated with I J.ili1 propranolol in control medium and in medium containing the 
indicated compounds. Part of the hepatocytes were preincubated with chloroethy1clonidine for 20 min and then 
adrenaline was added. After 60 min, samples of the cell-free media were assayed for HL activity and mass. Data are 
expressed as percentage of control (1.34 ± 0.19 mU/l06 celis and 2004 ± 4.9 mUljlg respectively) and represent mean 
± S.D. (n=3). Statistically significant differences from control are indicated by the asterisks (p<O.05). 
To distinguish between the various ul-adrenoceptor subtypes. we incubated freshly isolated 
hepatocytes with adrenaline and propranolol in combination with antagonists that have different 
affinities for the "I-adrenoceptor subtypes (26). In the presence of I ~M WB4101, an "IA-
antagonist, the effect of adrenaline on secretion of HL activity and HL mass was hardly affected 
(Table I). Adrenaline was less effective when higher concentrations (up to 100 ~M) of WB410 I 
were added (Fig. 1). Adrenaline was inactive in the presence of only 0.1 11M prazosin. 
demonstrating that prazosin was at least lOoo-fold more potent than \VB4101. Adrenaline had no 
effect on HL secretion when hepatocytes were pre-incubated with 100 ~tM chloroethy1clonidine, an 
irreversible uIB-selective antagonist (Table J). Moreover, the effect of adrenaline on secretion of HL 
activity and HL mass was not mimicked by 10 11M methoxamine, an ulA-selective agonist. Under 
all conditions tested. the specific enzyme activity of secreted HL was not significantly 
changed (Table I). These findings indicate that adrenaline inhibited HI. secretion by hepatocytes 
through activation of the uJ-adrenoceptors subtype B. 
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Figure I Secretion of HL activity 
in the presence of different 
concentrations of a.-adrenergic 
antagonists. 
Freshly isolated hepatocytes were incubated 
with 1 pM propranolol in control medium 
(C) and in medium containing 10 11M 
adrenaline either alone or in combination 
with different concentrations of WB410l 
(+) or prazosin (e). After 60 min of 
incubation the cell-free media were assayed 
for HL activity. 
The effect of adrenaline is mediated by changes in intracellular calcium 
In hepatocytes of adult rats arn-adrenoceptors are shown to signal simultaneously through 
Ca2+-mobilization and cAMP accumulation (22). We therefore studied through which signal 
adrenaline induces inhibition of HL secretion. When hepatocytes were incubated with the Ca2+_ 
ionophore A23187 (2 flM), the HL activity and HL mass secreted into the cell-free medium was 
reduced to levels comparable to that with adrenaline (Table ll). Thapsigargin (lflM), which elevates 
intracellular Ca2+ by mobilizing Ca2+-stores from the ER (31), also induced a 40% fall in HI... activity 
and HL mass in the medium. In addition, the Ca2+-mobilizing hormones angiotensin II (100 nM) and 
vasopressin (12 nM) reduced secretion ofHL similar to adrenaline. On the other hand, secretion of 
HL activity and HL mass was not affected by incubation with 10 flM forskolin or I flM 8·Dr-cAMP. 
Under all conditions tested, the specific enzyme activity of the secreted HL was not significantly 
affected (Table II). These results imply that the ctlB-adrenergic effect of adrenaline on HL secretion 
is mainly mediated by the Ca2+ signal. 
Opposite changes in intracellular Ca2+ levels inhibit the secretion of HL 
As shown above, elevation of intracellular Ca2+ by A23187, thapsigargin, angiotensin IT or 
vasopressin results in a similar inhibition of HL secretion as with adrenaline. Chelation of 
extracellular Ca2+ with EGTA has also been shown to inhibit secretion of HI... activity (32). To 
establish at which concentration of extracellular free Ca2+ HL secretion is affected, freshly isolated 
hepatocytes were incubated for one hour in medium containing 0.3 mM Ca2+ and different 
concentrations of EGTA. Secretion of HL activity (Figure 2) and HL protein (not shown) 
48 
Chapter 2.2 
Table II 
Secretion of HL activity is inhibited by increasing intracellular Ca" but not cAMP levels 
HL activity HL mass HL specific activity 
(% ) (%) (%) 
Control 100 100 100 
Adrenaline (10 ~M) + propranolol (I ~) 57 ± 6' 48 ±6' 119 ± 15 
A23187 (2 ~M) 67 ± 17' 56 ± 5' 120 ± 19 
Thapsigargin (1 ~M) 57 ± 10' 56 ± 2' 102 ±27 
Angiotensin II (100 uM) 72± IS' 63 ±4' 114 ± 28 
Vasopressin (12 nM) 70 ± 10' 59 ±3' 119 ± 20 
Forskolin (1 0 ~M) 96±6 77 ± 19 125 ± 32 
8-Br-cAMF (1 ~) 92± 18 74 ±6 124± 22 
Hepatocytes were incubated for 60 min in the presence of the compounds indicated, whereafter the cell-free media were 
assayed for HL activity and mass. Data are expressed as percentage of control (1.47 ± 0.62 mUllOfj celis and 2004 ± 4.9 
mU/flg respectively) and represent mean ± S.D. for 3-5 independent expecimenls. Asterisks indicate statistically 
significant differences from control (p<O.05). 
was unaffected by EGTA up to 0.4 mM. Between 0.4 and 0.5 mM EGTA, secretion of HL abruptly 
fell by 40%. A further increase in EGTA concentration (up to I ruM) had no additional inhibitory 
effect. Calculation of free Ca2+-concentrations (33, 34) in the media show that the threshold value 
was between 300 and 160 nM free extracellular Ca2+. Half maximal reduction in HL secretion was 
observed at approximally 200 nM free Ca2+, which is close to intracellular Ca2+ concentrations 
rep0!1ed for rat hepatoc)1es (22, 35-37). Apparently, the inhibitOl)' effect ofEGTA on HL secretion 
occurs when the free extracellular Ca2+ -concentration falls to levels close to or below 
intracellular Ca2+. 
Effects of adrenaline, thapsigargin and EGTA on HL maturation 
The inhibitory effect of the Ca2+ -mobilizing hormones, as well as of A23187, thapsigargin and 
EOT A are evident within the first hour of incubation. During this period, mainly pre-synthesized 
HL is secreted (13, 29). Thus, the acute effects on HL secretion are mainly post-translationaL In 
pulse-chase experiments with e5S]methionine. the mechanism by which adrenaline, thapsigargin, 
A23187 and EGTA lower HL secretion by rat hepatocytes was compared. To study post-
translational processing of HL, hepatocytes were pulsed with e5S]methionine for 5 min in control 
medium. During the chase, equal patiS of the cell suspension were incubated without any addition, 
or with either adrenaline, A23187, thapsigargin or EOTA. 
After a 5-min pulse, HL was immunoprecipitated as a 53 kDa, Endo H sensitive protein (13, 
38). During the chase in control suspensions, the 53 kDa protein gradually decreased (Figure 3A,B). 
In parallel the mature, Endo H resistant HL-protein of 58 kDa was formed. Total C\5S]HL, which 
was determined by the sum of the radioactivity in the 53 and 58 kDa protein, was not altered during 
the 45-min of chase, indicating that there was no degradation of HL under these conditions. \Vhen 
adrenaline (10 l-lM) was present during the chase, the intracellular 53 kDa protein disappeared at a 
rate similar to control (Figure 3A,B; Adr). However, the appearance of the mature 58 kDa protein 
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Figure 2 Effect of chelating extracellular Ca" on secretion of IlL activity. 
Freshly isolated hepatocytes were incubated in Ham's FlO medium containing 0.3 mM Ca2+ and different concentrations 
ofEGTA. After 60 min the cell-free media were assayed for HL activity. Data are expressed as percentage of control 
(1.54 ± 0.80 mu/Ht cells) and represent mean ± S.D. for 2-6 independent experiments. TIle numbers indicate the free 
extracellular calcium concentrations (oM) calculated for these conditions (33, 34). 
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Figure 3 Maturation of IlL in the 
presence of adrenaline, thapsigargin 
orEGTA. 
Hepatocytes were pulsed with eSS]methionine for 5 
min in the absence of any agent. After washing the 
cells in fresh medium, part of the cell suspension 
was incubated in control medium, and an other part 
was incubated in medium containing either 10 jlM 
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was retarded compared to control cells. After 45 min of incubation, total ["S]HL was 30% less than 
in control incubations. The loss in total [35S]HL during incubation with adrenaline was not recovered 
in any immunoreactive protein, and may reflect complete degradation. Overall, the results indicate 
that adrenaline inhibited the maturation of HL protein and increased the degradation of HL. 
When hepatocytes were chased in the presence of I ~M thapsigargin,the "S-Iabelled 53 kDa 
protein disappeared at a similar rate as in control 01' adrenaline-treated cells (Figure 3A,B; TSG). 
The fommtion of the 58 kDa protein was retarded compared to control cells to an extent similar to 
adrenaline-treated cells. At the end of the chase with thapsigargin, total e5S]HL was decreased to 
about 70% of control. With 2 ~ A23187 (not shown) or with 0.5 mM EGTA (Figure 3A, B) the 
effects on the disappearance of the 53 kDa protein, the appearance of the 58 kDa protein, and loss 
of total e5S]HL were superimposable to those observed with thapsigargin and adrenaline. In contrast 
to secretion of [35S]HL, the secretion of e5S]transferrin was unaffected up to 45 min of incubation 
with either adrenaline, thapsigargin or EGTA (Figure 3C). 
DISCUSSION 
In freshly isolated hepatocytes secretion of HL was shown to be inhibited by adrenaline through 
activation of the ct1-adrenoceptor pathway (11-13). Rat liver was reported to be enriched in the ctlB-
subtype (23, 39). In our isolated rat hepatocytes WB41OI, illl "lA-antagonist, was at least 1000-fold 
less potent than prazosin in preventing the effect of adrenaline on HL secretion. When pre-incubated 
with chloroethylclonidine, an am-antagonist, the adrenaline-induced inhibition of HL secretion was 
completely abolished. The effect of adrenaline was mimicked by phenylephrine (13), bnt not by the 
selective alA-agonist methoxamine. Thus, adrenaline inhibited the secretion ofHL via activation 
of the alB-adrenergic receptors. This adrenoceptor SUbtype was recently described to signal 
simultaneously through elevation of intracellular Ca2+ and cANIP (22). Several observations suggest 
that the effect of adrenaline is mediated via Ca2+ rather than cAMP. First, similar inhibition of HL 
secretion was observed with the Ca2+ -mobilizing hormones vasopressin and angiotensin II. In 
addition, the Ca2+-ionophore A23187 and thapsigargin had similar effects on the secretion ofHL. 
Second, the effect of adrenaline could not be mimicked by elevating cAMP with forskolin or 8-Br-
cAMP. cAMP may be important for potentiating the IPrinduced Ca2+-release from the ER (40,41). 
However, co-incubation of hepatocytcs with forskolin and adrenaline showed that the forkolin-
mediated elevation of cAMP did not modulate the inhibitory effect of adrenaline on HL secretion 
(not shown). 
The acute effects of the Ca2+-mobilizing hormones, A23187, thapsigargin and EGTA on HL 
secretion are mainly post-translational. They are evident within the first hour, during which mainly 
pre-synthesized HL is secreted (13, 29). Pulse-chase experiments with e5S]methionine showed that 
adrenaline, A23187, thapsigargin, as well as EGTA retard the maturation of the 53 kDa, higb 
mannose precursor to the mature 58 kDa HL protein, and stimulate the intracellular degradation of 
HL. Thus, the mechanisms by which Ill., secretion was inhibited by these agents were highly similar. 
Maturation and secretion ofHL was inhibited when the intracellular Ca2+-concentration was 
increased by incubation with Ca2+-mobilizing hormones, A23187 and thapsigargin, suggesting that 
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the intracellular Calt-concentration itself may influence the processing of HL. However, HL 
maturation was inhibited similarly when the free extracellular Ca2t was reduced with EGTA to 
concentrations close to or below intracellular Cal +, Under these conditions, intracellular Ca2t may 
be reduced, and EGTA may inhibit HL processing by lowering intracellular Ca2t, These results 
imply that, besides elevation of intracellular Ca2+, also the lowering of intracellular Ca2t mimics the 
effect of adrenaline on maturation and secretion of HL. EGT A may induce a different process than 
the Ca2t-mobilizing agents, which leads to a similar inhibition ofHL maturation and increase in HL 
degradation. Alternatively. this apparent contradiction may be resolved by considering the cffects 
on Ca2f--levels in the ER. The ulB-adrenoceptor stimulates the release of Ca2+ from IP3-sensitive 
stores, such as the ER (20-22). The Ca2+-ionophore A23187 will carry Ca2+ across the ER 
membrane along the gradient ofCa2+, thereby lowering ER-Ca2+ (42,43). Thapsigargin increases 
intracellular Ca2+ by inhibition of the Ca2+ -ATPase in the ER membrane; Ca2+ is no longer retrieved 
from the cytosol and the Ca"-level in the ER decreases (31, 43). Incubation of hepatocytes with 
EGTA depletes non-mitochondrial Ca"-pools, including the ER (43). Therefore, the decreased 
Ca2+-level in the ER, induced by incubation of hepatocytes with adrenaline, A23187, thapsigargin 
and EGTA, may evoke the effects on HL processing. 
In which order the retardation of HI .. maturation and degradation of HL protein occurs is 
unclear. Lowering ER-Ca2+ may increase the degradation process by increasing the activity of 
Ca2+-sensitive proteases in the ER. Maturation of ai-antitrypsin and the asialoglycoprotein-receptor 
was also reported to be decreased by lowering Ca2+ in the ER (44, 45). In contrast, secretion and 
maturation of the glycoprotein transferrin was not affected by adrenaline, thapsigargin or EGTA. 
Depletion of ER-Ca2+ WHS also shown to selectively increase the degradation of tmnsfected T-cell 
antigen receptor-p and CD3-o, but not of CD3-y and CD3-E-P dimers in CHO cells (46). 
Alternatively, the effects on HL processing may be mediated by processes other than the 
Ca2+-dependent stimulation of protcases in the ER. A low Ca2+-level in the ER may change the 
affinity of HL for possible chaperones, whereafter HL may become more susceptible to 
ER degradation. Several chaperones resident in the ER are reported to be calcium-dependent (47). 
The existence of a chaperone with selectivity towards HL and other lipases was implicated from 
mice suffering from combined l.ipase deficiency (48, 49). Thus, a specific Ca2+-sensitive chaperone 
may be involved in HL maturation. We conclude that the inhibition of HL maturation and increase 
in intracellular degradation by catecholamines, A23187, thapsigargin and EGTA are mediated by 
changes in Ca2+-homeostasis, possibly through lowering ER_Ca2+. 
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Adrenaline-induced degradation of hepatic lipase in rat hepatocytes 
is sensitive to the protease inhibitor ALLN. 
Bernadette P. Neve, Adrie J.M. Verhoeven, Ina Kalkman and Hans Jansen. 
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2.3 ADRENALINE-INDUCED DEGRADATION OF HEPATIC LIPASE IN RAT 
HEPATOCYTES IS SENSITIVE TO THE PROTEASE INHIBITOR ALLN. 
ABSTRACT 
Adrenaline acutely decreases the expression of HL in freshly isolated rat hepatocytes. Pulse~chase 
experiments showed that in the presence of adrenaline the rate of disappearance of the immature, 
Endo H-sensitive 53 kDa HL protein was similar to control. However, the appearance of the 
mature, EndoH-resistant HL protein of 58 kDa was impaired compared to control. The amount of 
total ["S]HL (the radio~ctivity in the 53 kDa plus 58 kDa protein) was decreased, indicating 
degradation of newly synthesized HL protein. Thus, adrenaline reduces maturation of HL and 
increases degradation. The adrenaline-mediated degradation ofHL was not sensitive to chloroquine 
or leupeptin, and therefore appears to be extra-lysosomal. 
Other protease inhibitors we studied were ALLN, TPCK, E-64, PMSF and chymostatin. 
Only ALLN partly reverted the adrenaline-mediated degradation of HL protein. In the presence of 
40 flg/ml ALLN, the adrenaline-induced disappearence of the 53 kDa immature protein was 
retarded. The appearance of the mature 58 kDa remained inhibited, as was the secretion of HL 
protein and activity. 
CCCP, which inhibits HL maturation by decreasing ER-to-Golgi transport had no effect on 
HL degradation. In the presence ofCCCP, ["S]HL accumulated as a 53 kDa HL protein, which was 
slowly converted to the 58 kDa form after 30 min of chase. The total ["S]HL remained constant 
during the 45~min chase. Thus, inhibition of HL maturation in itself does not trigger HL 
degradation.We conclude that the adrenaline-induced degradation of HL is mediated by 
ALLN-sensitive proteases. 
INTRODUCTION 
Hepatic lipase (HL) is synthesized and constitutively secreted by liver parenchymal cells (I, 2), 
whereafter it binds extracellularly in the space of Disse in the liver (3, 4). HL is involved in the 
metabolism of high and intermediate density lipoproteins and chylomicrons (5, 6), and facilitates 
the selective uptake of cholesterol from high density lipoproteins and the removal of remnant 
particles by the liver (7,8). HL may affect lipoprotein metabolism via its enzymatic activity (9), or 
act as a ligand towards lipoproteins (10, II). Deficiency ofHL is associated with elevated levels of 
plasma triglycerides and large HDL particles, and increased the risk for coronary heart 
disease (12-15). Further, a low HL has been shown to be a risk factor for premature atherosclerosis 
(16, 17). HL is thought to protect against the development of atherosclerosis, by contributing to 
reverse cholesterol transport and by reducing atherogenic remnant particles in the circulation. In line 
with this, overexpression of HL in transgenic mice was shown to decrease the accumulation of 
cholesterol in the aortic wall (18). 
Catecholamines are associated with profound changes in plasma lipoprotein turnover and 
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the development of atherosclerosis (19, 20). Decreased HL activity may contribute to the changes 
in lipoprotein metaboHsm. In freshly isolated hepatocytes adrenaline decreases the HL activity via 
the "IB-adrenoceptor (21-24). Catecholamines are responsible for the diurnal changes in HL activity 
observed in rat liver, with HL being low when plasma catecholamines are elevated (22). In earlier 
studies we have shown that adrenaline has profound post-translational effects on the expression of 
HL in rat hepatocytes. Adrenaline acutely decreases the maturation ofHL and increases degradation 
of newly synthesized HL protein (23). To gain more insight in the effect of adrenaline we studied 
the degradation process more closely. We show that the degradation of HL protein takes place early 
in the secretion pathway I and that the adrenaline-mediated degradation of HL was sensitive to the 
protease inhibitor ALLN. 
MATERIALS AND METHODS 
Materials. 
Adrenaline was obtained from Centrafarm (Etten-Leur, The Netherlands) and heparin from Leo Pharmaceutical 
Products (Weesp, The Netherlands). Chloroquine, leupeptin, ALLN, TPCK and chymostatin were purchased from 
Sigma (St. Louis MO, U.S.A.). E64, cycloheximide and CHAPS were from Boehringer Mannheim (Mannheim. 
Gennany). CCCP was from Calbiochem (La Jolla CA. U.S.A). Ham's FlO and methionine-free MEM were obtained 
from Gibeo BRL (Paisle, U.K.). Glycerol tri[I- 14C]oleate (50-80 mCilmmol) was purchased from Amersham 
(Amersham. U.K.), whereas Tran-J5S-label (1100 Cilmmol) was from ICN (Costa Mesa CA, U.S.A.). PMSF. 
benzamidine and amino acids were from Merck (Darmstadt, Germany). Trasylol was from Bayer (Mijdrecht, The 
Netherlands) Protein A-Sepharose and CNBr-activated Sepharose 4B were obtained from Pharmacia (Uppsala. 
Sweden). Broad range markers for SDS-PAGE came from Bio·Rad (Richmond CA. U.S.A.). All other chemicals were 
from Sigma. 
Hepatocyte isolaHon and incubation. 
Hepatocytes were isolated from male Wistar rats (± 250g) by in situ perfusion with collagenase type I and non-
parenchymal cells were removed by differential centrifugation according to SegJen (25). Cells were washed with Ham's 
FlO medium containing 25 U/ml of heparin to remove residual extracellularly bound HL.lllcreafter, the hepatocytes 
were resuspended at 3-5~ l<f cells/ml in Ham's FlO containing 25 U/ml of heparin and 20% heat-inactivated, diaJysed 
bovine scrum (I). TIle cell suspensions were incubated at 37°C under an atmosphere of95% 0/5% CO2 in a shaking 
water bath. When indicated ALLN, TPCK, E-64, PMSF and chymostatin were added from IOOO-foid stocks in DMSO; 
other agents were addcd from stock solutions in PBS. Cell viability ranged from 85 to 95%, as determined by Trypan 
blue exclusion and remaincd essentially unaltered during all incubations. 
At the indicated times, 0.5 ml-samples were collected from the incubations and put on ice. Cells and media 
were separated by centrifugation (5 sec, 10ooog, 4°C) and the cell+free media were used for analysis of secreted IlL. 
For analysis of intracellular IlL, the cells were washed twice with Ham's FlO and then resuspended in the original 
volume of PBS containing 4 roM CHAPS. 25 U/ml of heparin, and the protease inhibitors Icupeptin (1 pg!ml), antipain 
(I pg/ml), chymostatin (l pg/ml), pepslatin (l pg/ml), benzamidine (l mM), Trasylol (10 IV/ml) and 
EDTA (I mM) (2, 26). The cells were lysed by sanification (to sec, amplitude 14 Il, MSE Soniprep 150) either 
immediately, or after oyernight storage at -80aC. These homogenates were centrifuged (10 min, 10 ooog, 4°C) and the 
supernatants were used for analysis of intracellular HL. 
HL activity and protein 
HL activity was determined by a triacylglycerol hydrolase assay at pH 8.5 in 0.6 M Nael using a gum acacia-stabilized 
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glycerol tri[14C]oleate emulsion as substrate (I). Assays were performed for 45 min at 30°C. Enzyme activities are 
expressed as mU (nmoles of free fatty acids released per min). The lipase activity in the cell-free media was completely 
inhibited by goat anti-rat HL IgOs, whereas approximately 80% of the intracellular lipase activity was sensitive 10 
inhibition (23). 
The amount ofHL protein in cell-free media was measured by a solid-phase ELISA as described previously 
(26), with minor modifications. HL was sandwiched between goat polyclonal and rabbit polycional anli-HL IgOs. 
Absorbances were read against a standard curve preparcd by serial dilutions of partly purified rat HL. The latter was 
prepared from post-heparin rat liver perfusates by affinity chromatography on Sepharose-heparin. HL activity was 
eluted with a linear 0.2-1.0 M NaCI gradient in 1% BSA; peak fractions were pooled and kept at -80°C until use. 
Pulse-chase cXIlcriments witb rSSlmclhionine. 
Pulse-chase experiments were performed as described before (23). In short, freshly isolated hepatocytes were pre-
incubated for 45 min in methionine-free MEM containing 25 U/ml of heparin and 20% heat-inactivated, dialysed 
bovine serum. After a 5-min pulse with 80 jlCilml ofTran_35S_label, cold methionine was added at a final concentration 
of I mM. After washing twice by centrifugation (2 min, 50g, room temperature), the cells were resuspended in 
Ham's FlO. TIle cell suspension was divided into equal parts, and the incubation was continued in Ham's FlO 
containing 25 U/ml of heparin, 20% serum, 1.3 mJ,,1 methionine and the agents under study. After the desired chase 
time, the incubations were stopped on ice and lysis buffer was added. The whole cell suspension was lysed with 
1% Triton X-loo, 1% sodium deoxycholate, 25 Vlml heparin, I mM methionine and the protease inhibitors described 
above. After a 3D-min incubation on ice, the Iysates were centrifuged for 10 min at 10 OOOg and 4°C, and the post-
nuclear supernatants were used for imnlllnoprecipitation of HI.. 
Immulloprccipilalion of IlL 
HL protein was immunoprccipitated by goat polyclonal anti-HL JgOs immobilized onto Sepharose (27). Twenty Olg 
of the goat antibody preparation was coupled per 1 gram of CNBr-activalcd Sepharose 4B according to the 
manufacturers instructions. The post-nuclear supernatants (1 1ll1) were incubated overnight at 4°C with 50 !-II of a 
50%-slurry of the immobilized anti-HL JgGs. The beads were collected by centrifugation, and then washed twice with 
I 011 of successively PBS, I M NaCI in PBS, 0.2% Tween-20 in PBS, and finally PBS (all at 4°C). TIle bound proteins 
were relea5ed by a 5-min incubation at 95°C in Laemmli sample buffer without B-mercaptoethanol. After removal of 
the beads the proteins were reduced with G-mercaptoethanol and then resolved by SDS-PAGE on 10%-gels. Protein 
bands were visualized by staining with Coomassie Brilliant Blue, and their molecular masses were estimated using 
broad range markers run in parallel. To visualize and quantify the radioactivity in the bands, the dried gels were 
analysed by phosphor imaging using CS-screens and the OS363 Molecular Imager (Bio-Rad, Richmond, CA, U.S.A.). 
Statistics 
All data were expressed as mean ± SD. Statistical significances (p<O.05) were determined by one-way-ANOYA, 
followed by the Student-Newman-Keuls test (28). 
RESULTS 
Effects of adrenaline on HL expression 
Hepatocytes were pulsed with C5S]methionine for 5 min in the absence of adrenaline. Newly 
synthesized [35S]HL migrated as a 53 kDa protein (Fig. lA) that was Endo H sensitive (2, 23). After 
the pulse, cells were chased for the indicated times in the absence or presence of lOIlM adrenaline. 
In control cells the 53 kDa band matured into the Endo H resistant HL of 58 kDa.\Vhen adrenaline 
was present during the chase, the 35S-radioactivity of the 53 kDa protein decreased at a similar rate 
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(A) Freshly isolated hepalocytes were pulsed with e5S]metilionine for 5 min in the absence of adrenaline. After washing, 
the cell suspensions were chased in medium with (+) or without (-) adrenaline (Adr). At the indicated time. samples were 
collected and HL was immunoprecipilated from the whole cell suspension. The [3sS]HL was analysed by SDS-PAGE 
and phosphor imaging. The 35S-radioactivity in the 53 kDa band (down) and 58kDa band (up) is depicted underneath 
the phosphor image. The total eSS]HL is represented by the total bar for the control (dark gray bar) and adrenaline (light 
gray bar) incubation. Radioactivity is expressed as percentage of total [HS}HL in the control incubation after 5 min 
pUlse. The apparent molecular weight of the HL bands is indicated in kDa. 
(D) Hepatocytes were incubated in control medium (Can), in medium containing 10 JlM adrenaline (Adr), or in medium 
containing 10 Jlg/ml cycloheximide (CHX). After 60 min, the incubation was stopped on ice, and the cell-free media 
and cell-homogenates (intracellular) were assayed for HL activity. Data are mean ± S.D of 3 independent experiments. 
Statistically significant differences from control are indicated by an asterisk (p<O.05). 
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as in control incubations. However, less of the 58 kDa protein was formed. The total radioactivity 
of both HL proteins remained constant during the chase in control medium, but was decreased to 
75 ± 6% (n=4) when chased in the presence of adrenaline. These results confirm that adrenaline 
retards the maturation of Ill.. protein and suggest that adrenaline induces the intracellular 
degradation of newly synthesized HL protein (23). 
The effect of adrenaline on the secretion of HL activity was measured after the freshly 
isolated hepatocytes were one hour incubated in heparin~containing medium. Control cells secreted 
0.90 ± 0.13 mU/IO' cells ofHL activity into the medium (Fig. IE). IntracelJularly, the HL activity 
remained constant at 0.71 ± 0.07 mUIlO' cells. When adrenaline (10 11M) was present from the start 
of the incubation, the secretion of HL activity decreased to 58 ± 9% of control. These changes were 
paralelJed by changes in HL protein, as determined by ELISA (not shown). Simultaneously, 
intracellular HL activity decreased to 55 ± 6% of control (Fig IB). \Vhen incubated in the presence 
of 10 fLg/ml cycloheximide, which completely blocks de novo protein synthesis the secretion of HL 
activity was reduced to 75 ± 5% of control, whereas intracellular HL activity was decreased to 
78 ± 4% of control. The extra- and intracellular HL activity in the presence of adrenaline was 
significantly lower in the presence of adrenaline than in parallel incubations with cycloheximide. 
Taken together, these data indicate that the acute effects of adrenaline on HL are predominantly at 
the post-translational level (23). 
Role of lysosomal degradation in the adrenaline~lllediated effects on HL expression 
To study the potential involvement of the lysosomes in the adrenaline-induced effects on HL 
expression, hepatocytes were pulsed with f5S]methionine for 5 min in control medium. Thereafter 
the cells were chased in the absence or presence of 10 11M adrenaline with or without 0.5 11M 
chloroquine or 10 l1g1mlleupcptin. After 45 min of chase, chloroquine and leupeptin alone had no 
effect on the 35S-radioactivity in the 53 kDa and 58 kDa HL proteins (Fig. 2A). In the presence of 
adrenaline, the fall in 35S-label in the 53 kDa protein and the reduced formation of 58 kDa [35S]HL 
were also unaffected. The total ["S]HL protein (53 plus 58 kDa form) was reduced by 25 ± 9%, 
23 ± 4% and 32 ± 4% in the presence of adrenaline alone, or in combination with chloroquine or 
leupeptin, respectively (n=2-3). Hence, the adrenaline-induced disappearance of 35S-labelled 53 kDa, 
the retarded maturation of the 58 kDa and the decrease of total ["S]HL were unaffected by 
co-incubation with chloroquine or leupeptin (Fig 2A). 
In control cells the HL activity secreted into the medium and the intracellular HL activity 
was not affected by the presence of either chloroquine or leupeptin (Fig. 2B). \Vhen adrenaline was 
present, the HL activity secreted into the medium was decreased to 57 ± 11 % of control in the 
absence and presence of chloroquine or leupeptin. Secretion of HL protein, as determined by 
ELISA, decreased in parallel to the enzyme activity, suggesting that the specific enzyme activity 
of the secreted HL was unaltered (not shown). Intracellularly, the adrenaline-induced fall in HL 
activity was also unaffected by chloroquine or leupeptin, and remained 57 ± 9% of control (Fig.2B). 
Thus, disrupting the lysosomal degradation with chloroquine or Ieupeptin did not aIter the effects 
of adrenaline on HL protein, suggesting that the degradation is extra-lysosomal. 
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Figure 2 Effect of lysosomal degradation inhibitors on HL ill the presence of adrenaline 
(A) Hepatocytes were pulsed with [35S1methionine for 5 min in the absence of adrenaline. Thereafter the cells were 
incubated in control medium (Con) or in medillm containing 0.5 ~tM chloroquine (eQ) or 10 Jlg/mlleupeptin (LP), in 
the absence (-) or presence (+) of 10 pM adrenaline (Arlr). Samples were collected aftcr 45 min. TIle [35SJHL was 
immunoprecipitatcd from the whole cell suspension and analysed by SOS-PAGE and phosphor imaging. TIle upper part 
of the figure shows a phorphor image of a representivc experiment. The apparent molecular weight of the HL bands arc 
indicated in kDa. TIle quantified data are depicted in bars underneath the corresponding phosphor image. Shown are 
the 33S~radioaclivity in the 53 kDa band (down) and in the 58kDa band (up) separately, the total [3sSrlll .. (53 plus 58kDa 
protein) is indicated by the length of the total bars. 
(D) Hepatocytes were incubated in control medium (Con) or in medium containing 0.5 11M chloroquine (eQ) or 
to !lgfmlleupeptin (LP), in the absence (-) or presence of to!J.M adrena1ine. After 60 min, the incubation was stopped 
on ice and the cell-homogenates were assayed for HI.. activity. Data represent mean ± S.D of 3 similar experiments. 
Significant differences arc indicated by an asterisk (P<0.05j NS=not significant). 
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Role of Intracellular proteases 
To study the role of intracellular proteases in HL degradation CSS]methionine-pulsed cells were 
chased in the presence of either the serine-plus cysteine protease inhibitors TPCK or PMSF, the 
cysteine inhibitor E-64, the calpain I protease inhibitor ALLN, or the chymotrypsin inhibitor 
chymostatin. The cells were chased for 45 min in the absence or presence of adrenaline in 
combination with the protease inhibitors all at a final concentration of 40 Ilg/ml. After 45 min of 
chase, the 3sS-radioactivity of the immature protein of 53 kDa was 30 ± 8% of the total [3sS]HL 
(53 kDa plus 58 kDa), and that of the mature, Endo H resistant 58 kDa protein was 70 ± 8% 
(Fig.3A). When the cells were chased with adrenaline, the "S-radioactivity of the 53 kDa plus 
58 kDa HL was decreased to 31 ± 3% of control. Most of this decrease was accounted for by the 
retarded formation of the mature 58 kDa HL protein. The 53 kDa HL protein was hardly affected 
compared to control (24 ± 6 vs 30 ± 8 for adrenaline-treated and control cells, respectively). The 
amount of radioactivity recovered in the 58 kDa HL protein in adrenaline-treated cells was not 
affected by any of the protease inhibitors used. However, more 3sS-labelled 53 kDa protein was 
immunoprecipitated when the cells were incubated in the presence of ALLN in addition to 
adrenaline (39 ± 7% vs 24 ± 6 for with and without ALLN, respectively; Fig.3A). Further, the 
53 kDa [35S]HL protein slightly increased with co-incubation of adrenaline with TPCK or PMSF, 
but the differences were not statistically significant. In the presense of ALLN and adrenaline, the 
total "S-Iabel in the 53 and 58 kDa HL protein was 85 ± 17% of control (n=4). This was 
significanly lower than the recovery in control cells, but significantly higher than in cells treated 
with adrenaline alone. Apparently, ALLN partly prevented the adrenaline-induced degradation of 
newly synthesized HL protein. 
The HL activity present in the medium of adrenaline-treated celis reduced to 57 ± 10% of 
control, which was similar to co-incubation with either ALLN, TPCK, E-64, PMFS or chymostatin 
(Fig 3B). The HL mass in the medium, as determined by ELISA paralleled the enzyme activity, 
suggesting that the specific enzyme activity of secreted HL was unaffected (not shown). The 
intracellular HL activity was 49 ± 8% of coutrol in the presence of adrenaline, whether or not 
co-incubated with the protease inhibitors. Thus, relative accumulation of the 53 kDa, e5S]HL 
protein in the presence of ALLN and adrenaline was not accompanied by an increase in intracellular 
HL activity. 
Effects of CCCP on the maturalion of HL 
Degradation ofHL may result from activation of proteases, or from the inhibition in maturation and 
subsequent longer exposure to proteases. To clarify the sequence of events, we prevented the 
maturation of HL by inhibiting ER to Golgi transport with CCCP. Hepatocytes were preincubated 
in control medium, or in the presence of 10 11M CCCP. Then, the cells were pulsed with 
eSS]methionine for 5 min and chased in either control or CCCP-containing medium (FigA, ll= I). 
After the 5-min pulse with or without CCCP, newly synthesized 35S-1abelled HL migrated as a 
53 kDa protein. During the subsequent chase in the presence ofCCCP, significantly less 58 kDa was 
formed compared to control. Only after 45 min, a 58 kDa band could be immufloprecipitated, 
indicating that the maturation of HL was indeed retarded. After 45 min of chase, f 5S]IIL was 
equally divided over the 53 and 58 kDa form, whereas in control suspensions eSS]HL mainly 
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Figure 3 Effect of protease inhibitors on HL in the 
presence of adrenaline 
(1\) Hepatocytes were pulsed with ["Sjmethionine for 5 min in the 
absence of adrenaline. After washing the cells, part of the cell suspension 
was incubated in control medium, while the other part was incubated in 
medium containing 10 11M adrenaline. In addition, 40 Ilg/mi of either 
ALLN, TPeK, E~64, PMSF or chymostatin (ehSI) was added. After 
45 min the samples were put on ice and HL was immunoprecipilalcd 
from the whole cell suspensions. The [35S]HL was analysed by SDS-
PAGE and phosphor imaging. Data are expressed as percentage of the 
total radioactivity of the HL bands in the incubation without adrenaline 
(n=3-6). TIle amount of J5S-labelled 58 kDa and 53 kDa HL-protein are 
depicted in bars whereas the broken line depicts the level of [35S]HL in 
incubations with (Adr), or without adrenaline (Can). 
(D) A typical phosphor image of incubations in the presence of ALLN. The apparent molecular weight of the HL bands 
are indicated in kDa. 
(C) Hepatocytes were incubated in control medium (Con) or medium containing 10 p1'I adrenaline (Adr). In addition, 
40 pglml of the above described protea~e inhibitors were added. After 60 min, the cell-free media and cell homogenates 
(intracellular) were assayed for HL activity. 'Ole broken line depicts the level of HL activities in incubations with (Adr) 
and without (Con) adrenaline. Data represent mean ± S.D. of three independent experiments. In A and C, statistically 
significant differences from the incubation with adrenaline alone are indicated by an asterisk (p<O.05). 
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consisted of mature, 58 leDa HL protein. The total amount of ["S]HL (53 leDa plus 58 kDa) 
remained constant during the chase in the presence of CCCP (100 ± 6%), as in control suspensions. 
Hence, incubation with CCCP resulted in retardation of maturation from a 53 kDa into a 58 kDa HL 
protein. However, degradation of newly synthesized HL protein was not induced by CCCP. 
Chase time (min) 
o 15 30 45 
Con 
CCCP 
DISCUSSION 
Figure 4 Effect of CCCP on the 
maturation of HL protein. 
Hepatocytes were preincubatcd for 45 min with or 
without 10 11M CCCP in methionine-free medium. 
Thereafter 80 IlCUml of e5S1methionine was added. 
After 5 min, the cells were washed and further 
incubated in control medium (Con) or in medium 
containing 10 11M CCCP. At the times indicated, 
samples were withdrawn and put on ice. HL was 
inununoprccipitated from the whole cell suspensions 
and analysed by SDS-PAGE and phosphor imaging. 
The apparent molecular weight of the bands is 
indicated in kDa. 
Pulse-chase experiments with C5S]methionine showed that adrenaline retards the maturation of the 
53 kDa, high mannose precursor into the 58 kDa HL protein. Further, adrenaline induced the loss 
of total immunoreactive eSS]HL during the chase, suggesting an enhanced intracellular degradation 
of newly synthesized HL. In control incubations no degradation of HL was detected, which may be 
due to the presence of heparin in the extracellular media (2). The effects of adrenaline on secretion 
ofHL activity and intracellular HL activity of freshly isolated hepatocytes are evident within the first 
hour of incubation, during which mainly pre-~ynthesized HL is secreted (23, 27). When protein de 
novo synthesis was blocked with cycloheximide, HL activity in the media and cells was also 
decreased, but to a lesser extent than with adrenaline. This underlines the post-translational nature 
of the acute adrenaline effects, as reported before (22, 23). 
In pulse-chase experiments neither chloroquine nor leupeptin, both inhibitors of lysosomal 
degradation had any effect on the adrenaline-mediated decrease of total HL protein. Thus, 
degradation of newly synthesized HL may take place extra-lysosomal. The disappearance of the 
53 kDa ["S]HL was partly prevented by ALLN. Formation and secretion of catalytically active HL 
in the presence of adrenaline was not affected by ALLN. The immature "S-Iabelled 53 kDa 
HL protein accumulated in the presence of AU..N, suggesting that the degradation occurs before the 
53 kDa HL protein has matured into the 58 kDa, active Ill.. protein. Therefore, degradation probably 
takes place early in the secretion pathway. 
The effect of ALLN on the adrenaline-induced degradation may indicate the involvement 
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of the cytosolic proteasome, which have been shown to be inhibited by ALLN (29). This would, 
however, require translocation of HL from the ER or Golgi compaliment to the cytosol. Several 
secretOlY proteins are reported to be translocated from the ER to the cytosol, and than degraded by 
the proteasome (30). If HL would be translocated into the cytosol, inhibition of the proteasomal 
degradation with ALLN is unlikely to restore normal processing in the ER or Golgi lumen, which 
might explain the lack of restoration of HL maturation. 
Alternatively, the adrenaline-induced degradation may involve cysteine-endoproteases in the 
ER, which have also been shown to be sensitive to ALLN (31-33). The ER-60 protease has recently 
been implicated in the degradation of apolipoprotcin B 100 (34). 
In which order the retardation of HI.. maturation and degradation of HL protein occurs in 
the adrenaline-treated cells is unclear. Degradation of HL may result from the stimulation of 
proteases degrading the immature protein before maturation occurred. Altematively. HL maturation 
may be inhibited, leaving the immature protein longer exposed to proteases. Inhibiting protein 
transport from ER to Golgi by CCCP (35) resulted in accumulation of immature 53 kDa HL protein 
without stimulating HL degradation. The accumulation of 53 kDa HL in the ER may not be 
sufficient to initiate degradation, implying that adrenaline specifically induces the degradation 
process. On the other hand, CCCP may induce a fall in cytoplasmic ATP, which may inhibit 
degradation by the protease. 
In earlier studies, we found that the effects of adrenaline are mediated at the level of calcium 
in the ER (24). Degradation of HL may be increased by stimulation of calcium sensitive proteases. 
ALLN is known to inhibit cysteine proteases, which arc calcium sensitive (36). Furthermore, low 
ER calcium has been shown to stimulate degradation of several other proteins (37). Alternatively. 
a low ER calcium may change the affinity ofHL to possible chaperones, whereafter HL may become 
more susceptible to degradation. Several chaperones resident in the ER are reported to be calcium-
dependent (38). Inhibiting the degradation may not restore the normal interaction between HL and 
the chaperone, and thus not restore maturation. The existence of a chaperone with selectivity 
towards HL and other lipases was implicated from mice suffering from combined lipase deficiency 
(39, 40). Thus. a specific Ca2+ -sensitive chaperone may be involved in HL maturation. 
We conclude that the adrenaline-induced degradation ofHLis sensitive to AILN. In contrast 
with the effects of adrenaline on HL, the retarded maturation of HL protein by CCCP was not 
accompanied by degradation of newly synthesized HL protein. Where the adrenaline-mediated 
degradation occurs, either in the ER or cytosol, and whether chaperones are involved remains to be 
established. 
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3 GROWTH HORMONE RESTORES HEPATIC LIPASE MRNA LEVELS BUT THE 
TRANSLATION IS IMPAIRED IN HEPATOCYTES OF HYPOTHYROID RATS. 
ABSTRACT 
During hypothyroidism hepatic lipase (HL) activity is decreased. The low HL may be due to thyroid 
hormone insufficiency or to the concomitant fall in growth hormone (GH) activity. We studied HL 
expression in hepatocytes freshly isolated from hypothyroid rats with and without additional 
GH-substitution. In all animals HL mRNA was detected by RT -PCR in the hepatocytes, but not in 
the non-parenchymal cells. In hypothyroid cells HL mRNA levels were reduced by 40%, and the in 
vitro secretion of HL-activity and HL-protein was decreased by about 50%. In cells from 
GR-substituted hypothyroid rats, HL mRNA level was normalised, but the secretion ofRL remained 
low. The specific enzyme activity of secreted HL was similar under all conditions. The discrepancy 
between HL mRNA and HL secretion in GH-supplemented rats may be due to (post)transiational 
effects. Therefore we studied the HL synthesis and maturation in hepatocytes from hypothyroid and 
GH-substituted rats. Pulse-labelling experiments with [3sS]methionine showed that the incorporation 
of CSS]methionine into HL protein was lower both in hypothyroid cells and in GH-supplemented 
cells than in control cells. During the subsequent chase, the intracellular processing and transport 
of newly synthesized HL protein in the hepatocytes from hypothyroid rats, whether or not 
supplemented with GH, was similar to control cells. \Ve conclude that in livers of hypothyroid, 
GH-substituted rats translation of HL mRNA is inhibited despite restoration of HL mRNA levels. 
INTRODUCTION 
Hepatic lipase (HL) is involved in the metabolism of several lipoprotein fractions, high density 
lipoproteins, intermediate density lipoproteins and chylomicron-renmants (1-3). HL may function 
via its enzymatic activity (see for review (3,4)) or by its ligand function towards lipoproteins (5-8). 
A low HL has been implicated in the development of premature atherosclerosis (9-11). Therefore, 
factors that influence HL expression are of importance. During hypothyroidism HL activity is 
strongly decreased, which at least partly explains concomitant changes in lipoproteins and the 
atherogenicity of this condition (12-14). 
By what mechanism thyroid hormone exerts its influence on HL activity is not clem'. In rat 
liver, HL mRNA levels are lowered during experimentally induced hypothyroidism, However, in 
hypothyroidism not only thyroid hormones are low but the synthesis, secretion and activity of 
growth hormone (GH) is also impaired (see for review (15)), It is not clear to what extent Ill.. 
activity is lowered by the decrease of thyroid hormone levels itself or by the accompanying 
deficiency of GH. Earlier we have shown that GH-sllbstitlltion of hypothyroid rats leads to a 
complete restoration of the Ill.. mRNA level in whole livers, suggesting that it is mainly the 
GH-deficiency that leads to the lowering ofHL mRNA (16). 
In spite of the restoration of the HL mRNA levels, HL activity in the liver remained 
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depressed during OR substitution (16), In order to explain the apparent inconsistency of RL 
expression at the mRNA and enzyme-activity level, we examined the effect of OR in hypothyroid 
rats more closely. We studied the in vitro secretion ofHL activity by liver parenchymal cells isolated 
from hypothyroid animals, with and without GH-substitution and performed pulse-chase 
experiments with [35S]methionine to study the intracellular transport of HL protein. 
MATERIALS AND METHODS 
l\'1aterials. 
Vegetarian chow was obtained from Puyk Diervoeders (The Netherlands). Human grO\\1~ hormone (Norditropina ) was 
a generous gift from Novo-Nordisk NS (Gentofte, Denmark). 2-Mcrcapto-l-methyl-imidazole (methimidazole) was 
from Janssen Chimica (Beerse, Belgium), Trasylol was from Bayer (Mijdrecht, TIle Netherlands) and heparin from Leo 
Pharmaceutical Products (Weesp, The Netherlands). Benzamidine and amino acids were from Merck (Darmstadt, 
Germany), Ham's FlO and methionine-free MEM were from Gibco BRL (Paisle, U.K,). Glycerol tri{9,1O(Il)-JH]0Ieate. 
[a_12P]dCTP (3000 Cilmrnol) and Amplifyq were obtained from Amersham (Amersham, U,K.), RNase A and 
Tl, T7 RNA polymerase, restriction enzymes and DNA size marker VI were from Boehringer Mannheim (Mannheim, 
Germany); pBJuescript KS' was from Stratagene (La Jolla, CA, U,S,A.). TranYS-label (1100 Cilmmo!) was from ICN 
(Costa Mesa, CA, U,S.A.) and both Percoll and CNBr-activated Sepharose 4B were from Phannacia (Uppsala, Sweden), 
All other chemicals were from Sigma (SI. Louis, MO, U.S,A,), 
Animal trcatment. 
Male Wistar rats (220 ± IO gram), were housed at 21 ~c on a 12 hour light cycle. To avoid the possible intake of any 
thyroid hormone, the animals were fed vegetarian chow, a mixture of grains, herbs and seeds. Both chow and drinking 
water were available ad libitum, Hypothyroidism was induced by the addition of 0.05% (w/v) 2-mercapto-l-methyl-
imidazole to the drinking water, resulting in serum T4 levels below I nM in all animals after 14 days of treatment (17). 
To one group of hypothyroid rats human growth hormone (GH) was administered subcutaneously for 10 days (twice 
a day 0.1 IU per 100 g bodyweight. dissolved in 0.1 ml 0,9% NaC!) (16,18,19). Before use, animals were fasted 
overnight. 
Cell isola lion and incubation. 
Rat liver cells were isolated by recirculating perfusion of tile liver in situ with 0,1 % collagenase in Krebs-Ringer buffer 
and parenchymal cells were obtained by differential centrifugation (20). In some experiments the hepatocytes were 
further purified by centrifugation through 60% Percoll, whereas non-parenchymal cells were collected from the 25-50% 
Percoll interfase (21). Cell viability. detennined by Trypan blue exclusion, ranged from 85 to 95%, For in vitro secretion 
experiments the cells were resuspended to 3-5* 106 celIslml in Ham FlO containing 25 Wml of heparin and 20% heat-
inactivated, dialysed bovine serum (22). The cell suspensions were incubated at 37°C under an atmosphere of 5% 
C0j95% 02 in a shaking water bath. At the indicated times, 0.5 m1-samples were collected on icc. Cells and media were 
separated by centrifugation (5 sec, 10 OOOg, 4°C) and the cell-free media were used for analysis of secreted HL. 
HL mRNA measurements. 
Expression ofHL mRNA was determined by RT-PCR and RNAse protection assays, Total RNA was prepared from 
isolated parenchymal and non-parenchymal cell fractions by the method ofChomczynski and Sacchi (23). In RT-PCR, 
1 )1g of total RNA was reverse-transcribed using 0Iigo(dT)16' followed by amplification in 25 cycles (95 °c ~ 55°C -
72 °C; 1 min each) using the HL-specific primers HL-I (5'-GTG GGC ATC AAA CAG CCC-3', nl 697-714; numbering 
according to Komaromy and Schotz (24» and HL-2 (5'-CAG ACA ITG GCC CAC ACT G-3', nt 1292-1274), as 
described previously (25). 
For the RNAse protection assays (26), a Psi IIPslI fragment of rat HL cDNA (bp 237-605), was cloned into 
pBluescript KS-. After linearization with Fsp I, a J2P-labeUed antisense riboprobe was prepared by in vitro transcription 
using T7 RNA polymerase. This probe (105 dpm) was hybridized in solution with 50 pg of total RNA from the 
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parenchymal cells. Subsequently, single-strand RNA was digested with RNase A and TIt and the protected fragments 
were analyzed by electrophoresis through a 6 % denaturing polyacrylamide gel. The radioactivity in the 185nl protected 
RNA-fragment was quantified by counting in the Instant Imaging system from Packard (Meridan, cr, U.S.A.). 
Hepatic lipase determination. 
To detennine the total heparin-releasable:m... activity in the liver, rat Iiyers were perfused in vitro through the portal vein 
and the perfusate was collected through the inferior vena cava. After a to min perfusion with Krebs-Ringer buffer 
(pH 7.4), the liver was perfused for 20 min with the same buffer containing 20 UlIllI of heparin. 'nlcreafter, the 
perfusates were collected on ice and the liver was homogenized in PBS containing 5 D/ml heparin; both fractions were 
used for further analysis. 
HL activity was determined by a triacyJglycerol hydrolase assay at pH 8.5 in 0.6 M NaCl using a gum acacia-
stabilized glycerol eH]trioJein emulsion as substrate (22). Enzyme activities were expressed as mUnits (nmol of free 
fatty acids released per min). 
The amount of HL protein was determined by a solid-phase ELISA described previously (28). In short, 
microliter plale wells were coated with 20 jlg of goat anti-HL IgG. After blocking \vith gelatin. the wells were incubated 
with successively sample, a mixture of five monoclonal mouse antibodies against rat HL and alkaline-phosphatase-
conjugated goat anti-mouse IgGs. Alkaline phosphatase activity was assayed using p-nitrophenol phosphate. 
Absorbances were read against a standard curve of rat HL purified from post-heparin liver perfusates,exactly as 
described by Jensen and Bensadoun (29) with omission of the last gel-filtration step. 
[JSSjmcthlonillc incorporation studies. 
Freshly isolated hepatocytes were pre-incubated for 30 min in methionine-free MEM containing 25 Ulml ofhcparin and 
20% heat-inactivated, dialysed bovine serum. Then, 80 IlCilmI ofTran-15S-label was added. After a IO-min pulse, cold 
methionine was added to a final concentration of I mM. In pulse-labelling experiments the cells were reisolatcd and 
lysed as described below. In pulse-chase experiments, the labelled cells were washed once by centrifugation (2 min, 50g, 
room temp.) and then incubated further in Ham's FlO containing 25 U/ml of heparin, 20% serum and I mM cold 
methionine. After the indicated chase times the incubations were stopped on ice. Cells and media were separated by 
centrifugation (2 min, 50g, room temp.). The cells were washed once with Ham's FlO and then lysed in the original 
volume of PBS containing 1% Triton X-loo, 0.1 % sodium deoxycholate, 25 VIm! heparin, 1 mh1 methionine, 1 nllil 
cysteine, and a cocktail of protease inhibitors (I Ilg/mlleupeptin, I f.lglml antipain, I Ilglml chymostatin, 1 f.lglml 
pepstatin, 1 mM benzamidine, 10 IU/nd Trasylol and 1 mM EDTA) (28,30). After a 30 min incubation on ice, the 
Iysates were centrifuged for 10 min at 10 OOOg and 4°C, and the supernatants were used for immunoprecipitation. 
HL protein was immunoprecipitated from the cell-free media and cell-Iysates by goat polyclonal anti-HL IgGs 
immobilized onto Sepharose (27). Twenty Illg of the goat antibody preparation was coupled per 1 gram of CNBr-
activated Sepharose 4B according to the manufacturers instructions. Cell-free media and celilysates were incubated 
overnight at 4°C with 50 III of a 50% slurry of the immobilized anti-HL IgGs. The beatls were collected by 
centrifugation (20 sec, 10 OOOg, 4°C), and then washed twice with I 1111 of successively PBS, 1M NaCI in PBS, 0.2% 
Tween-20 in PBS, and finally PBS (all at 4°C). The bound proteins were released by boiling in Laernmli sample buffer 
without B-mercaptoethanol. After removal of the beads the proteins were reduced with B-mercaptoethanol and then 
resolved by SDS-PAGE on 10% gels. Radioactive bands were visualized by fluorography using Amplify, and their 
molecular masses were estimated using broad-range markers from BioRad (Richmond, U.S.A.) run in parallel. To 
quantify the bands, fluorographs were scanned with the HP ScanJet II CX densitometer, and the blackness of the bands 
was expressed in arbitrary units. 
Statistics. 
Differences between groups were tested for statistical significancy by one-way ANOVA followed by the Dunn's test. 
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RESULTS 
Hepatic lipase mRNA in liver parenchymal celIs, 
A parenchymal and a non-parenchymal cell fraction was isolated from control, hypothyroid and GH-
supplemented hypothyroid rats. From each cell fraction, RNA was isolated and subjected to 
RT -peR. The expected 596-bp cDNA product of the HL mRNA encoding exon 5-8 was readily 
detected in each of the parenchymal cell preparations (Fig. IA). Under the same conditions, no HL 
eDNA product was formed with RNA from the non~parenchymal cells, suggesting that expression 
of HL mRNA is restricted to the parenchymal cell fraction. Product formation with parenchymal 
cells from hypothyroid rats appeared to be slightly lower than in cells from GH-supplemented rats, 
or euthyroid controls. 
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Figure I Detection of HL mRNA in 
parenchymal and nOIlMparenchymal cells. 
RNA isolated from parenchymal (PC) and nOI1-
parenchymal (NPC) cell fractions of control rats (C), 
hypothyroid (H) and GH-supplemented (HG) rats 
was subjected to RT-PCR. The used combination of 
primers yielded a eDNA product of 596-bp 
representing the HL mRNA (A). TIle lane with DNA 
size marker VI is indicated with M. One ~g of 
total RNA from the indicated cell-fractions 
was separated by electrophoresis through 
a formaldehyde-containing agarose gel; the position 
of tile ribosomal RNA bands are indicated (B). 
Quantification of HL mRNA in the parenchymal cell fractions was performed by an RNAse 
protection assay targeted at exon 3-5 (Fig. 2A). Per microgram of total RNA, hypothyroid cells 
contained 40% less HL mRNA than controls (Fig. 2B,C). Upon GH-supplemcntation of hypothyroid 
rats, HL mRNA levels strongly increased to values above the euthyroid controls. This observation 
extends our previously reported findings based on dot-blot assays on whole liver RNA's (16) and 
confrrms that the reduction in Ill.. mRNA levels in hypothyroid rats can be completely reversed by 
GH-supplementation. 
Hepatic lip.se .ctivity in I'.t liver 
Total HL activity in livers of hypothyroid rats was only 40% of that in control, euthyroid animals 
(Table I), Upon GH-supplcmcntation, HL increased only to about 50% of controllcvels. In all three 
animal groups, the Ill.. activity in the liver was mainly present in a heparin-releasable pool. The 
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differences in Ihe heparin-releasable HLaclivity bel ween Ihe groups were quanlilively similar 10 Ihal 
in lolal liver aClivity. The residual, non-releasable HL aclivity was also decreased, although nol 
significantly. in the hypothyroid rats and remained so after GH-supplementation. Hence, GH 
substitution failed to normalize both the heparin-releasable and non-heparin releasable HL activity 
in hypolhyroid rals despite Ihe complele resloralion of HL mRNA levels. 
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Figure 2 Quantitation of HL mRNA by 
RNAse protection assay. 
Fifty Jig of RNA from yeast (Y) and from control (C). 
hypothyroid (H) and GH-supplemented (HG) 
parenchymal cells fractions were hybridized with a HL 
specific e2Plrihoprobe of 245nt (A), After digestion with 
RNAscs, the protected fragment of 185nl was run on 
a denaturing polyacrylamide gel in parallel with an 
aliquot of the undigested probe (-). A fluorograph of the 
gel was made (ll) and the radioactivity of the bands was 
counted with the Instant Imaging system from Packard 
(C; mean of2 measurements). 
Table 1. Heparin-releasable and non-releasable HL activities in rat livers. 
Condition (#) Tolal Releasable 
Conlrol (5) 6000 ± 1230 5450 ± 1I00 
* * Hypolhyroid (4) 2490 ± 430 2170 ± 400' 
* * GH-supplemenled (7) 3050± 790 2610 ± 720 
Residual 
540 ± 160 
320 ± 80 
440 ± 160 
Rat Iiyers were perfused with 20 IU/mI heparin, whereafter the liver was homogenized. HI. activity was determined both 
in the perfusate (heparin-releasable) and in the homogenate (residual). lllC total activity was calculated from the Ill. 
releasable plus residual activity. Data are expressed in mUlliver and represent mean ± S.D. of the number of experiments 
listed between brackets. Statistically significant differences from the control group are marked with an asterix (p<O.05). 
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In vitro secretion of IlL. 
In vitro secretion experiments were performed in the presence of heparin to prevent cell-surface 
association and degradation of secreted HL (30). Freshly isolated hepatocytes from hypothyroid rats 
secreted, in the presence of heparin HL activity into the medium at a constant rate of 0.93 ± 0.30 
mU/10'cells/h (Fig.3), which was significantly lower than with control cells (1.53 ± 0.58 mU/1O' 
cellslh, p<0.05; n~II). Treatment of hypothyroid rats with GH for 10 days had no effect on the HL 
activity secreted by the isolated parenchymal cells. Secretion of HL activity occurred at a rate of 
0.92 ± 0.32 mU/1O'cells/h, which was similar to the hypothyroid values (p>0.05; n~8). Under aU 
conditions tested, the extraceUular appearance of HL protein, measured by ELISA, paraUeUed that 
of HL activity. At 3h of incubation, HL secreted by hypothyroid ceUs and GH-treated ceUs had a 
similar specific activity compared to HL secreted by euthyroid controls (11.2 ± 2.2, 11.5 ± 3.5 and 
12.0 ± 3.0 mU/pg HL protein, respectively: p>0.05, n~ 5-7). This indicates that the low secretion 
rate ofHL activity by ceUs from hypothyroid and GH-supplemented rats is not due to secretion of 
inactive HL, nor to enhanced inactivation of the secreted HL. 
o 1 2 
Time (h) 
3 
Translation and post-translational processing of HL. 
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Figure 3 IlL secretion by 
isolated rat bepatocytes. 
Hepatocytes, freshly isolated from 
control (e), hypothyroid (Y) and 
GH-supplemented rats (m) were 
incubated in the presence of 2S U/ml 
heparin. At the indicated times, a 
sample was withdrawn, and the HL 
activity was determined in the 
cell-free media Data represent 
mean ± S.D. for 7 to II experiments. 
The effect of GH-substitution in hypothyroid rats on translation and post-translational processing 
ofHL was investigated using pulse-chase experiments with eSS]methionine. With hepatocytes from 
control, hypothyroid and GH-supplemented rats, 10 min pulse labeUing foUowed by 
inununoprecipitation ofHL yielded an intracellular band of 53 kDa, representing immature, Endo H 
sensitive HL (30, 31). Incorporation of [,'Sjmethionine into the HL-protein band was significantly 
lower with ceUs of hypothyroid and GH-supplemented rats than with control ceUs, as determined 
by densitometry (41 ±12 vs. 131 ± 10 in arbitrary units, p<0.05, n~5). This indicates that there was 
less HL de novo synthesis in the hypothyroid and in the GH-supplemented state than in the 
euthyroid controls. 
During the subsequent chase, the intensity of the HL-protein band decreased, while 
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Figure 4 Secretion of ["S]HL in liver parenchymal cells. 
Cells isolated from control rats and hypothyroid rats, with or without GH-substitution were pulsed with eSSJmclhionine 
for to min, and then chased in the presence of I mM methionine. At the indicated limes, the incubations were stopped 
on ice and cells and media were separated by centrifugation. From both the cell-Iysates and media, HL was 
immunoprecipitated and analyzed by SDS-PAGE. (1\) Representative fluorograph of a pulse-chase experiment with 
control hepatocyles. (8) The 35S-labelled HL bands were quantified and the relative blackness of the bands were 
expressed as percentage of the zero min timepoint. Data represent mean ± S.D. Cn :::: 5 to 6) of the intracellular ce), 
secreted CA.) and lotal HL-protein (m). 
simultaneously a 58 kDa band representing mature, EndoH resistant HI... became visible 
intracellularly as well as extracellularly (Fig.4A). In control cells the total "S-Iabel in the 53 plus 
58 kDa bands gradually fell to about 80% of the initial value during the chase, indicating that newly 
synthesized HI... protein was slowly degraded under these conditions. In cells isolated from 
hypothyroid rats, whether or not substituted with GH, the maturation of C5S]HL proceeded in a 
similar way and at a similar rate as in the controls (Fig. 4B). The total amount of e5S]HL slightly 
fell, but also here no differences with control were apparent. These observations indicate that the 
reduction in HL secretion by liver cells from hypothyroid and GH-supplemented rats was solely due 
to a 100vel' translation rate and that post-translational processing was not affected by hypothyroidism 
or GH-substitution. 
DISCUSSION 
We studied the effects of hypothyroidism and GH-supplementation on the expression or Ill.. in rats 
at several levels. In hypothyroid rats, HL mRNA levels (Fig.2), liver HL activity (Table I) and in 
79 
Effect of growth hormone on hepatic Upase e).pression in hypothyroid rats 
vitro HL secretion (Fig.3 and Table II) were all affected to a similar extent, suggesting that the 
reduction of HL expression was mainly due to a lowered transcription. Earlier findings (16), 
showing that OR completely restores HL mRNA levels in hypothyroid rat liver were confirmed 
using RNAse protection assays and isolated parenchymal cells. Remarkably, HL secretion by 
isolated parenchymal liver cells was not stimulated by in vivo GH administration, suggesting a post-
transcriptional block ofHL expression. Pulse·chase experiments using ["Sjmethionine showed that 
the newly synthesized HL protein was secreted at a similar rate by hepatocytes from control, as well 
as hypothyroid rats whether supplemented with OR or not (Fig A). As the specific enzyme activity 
of HL protein was similar in all conditions, post-translational modification affecting the catalytic 
activity appears unlikely. Moreover, the electrophoretic mobility of HL on SDS·PAOE was not 
altered. indicating that no gross post-translational changes had occurred. We conclude that the 
translation ofHL mRNA must have been impaired in the OR·supplemented, hypothyroid rats. From 
these findings it can be inferred that in the hypothyroid state both the transcription and the 
translation ofHL are reduced in parallel and that GH-substitution only restores HL mRNA levels, 
but not translational rates. Indeed, the de novo synthesis ofRL was found to be lower in hypothyroid 
cells in the presence or absence of GH-substitution compared to euthyroid controls. Thus, the low 
HL activity in the hypothyroid state results from regulation at both the transcriptional and the 
translational level. 
The thyroid hormone insufficiency causes HL mRNA levels to drop. The rat HL gene 
contains putative thyroid-responsive elements (32) suggesting that thyroid hormone itself may affect 
transcription. However, supplementation of hypothyroid rats with GH alone was sufficient to 
completely restore HL mRNA levels. GH may upregulate HL transcription, or increase the stability 
of HL mRNA. In Rep02 cells, HL expression was also found not to be directly affected by thyroid 
hormone, but rather indirectly, through its effect on other cellular processes (33). So, at least part 
of the effect of hypothyroidism on HL expression is mediated by the concomitant GH deficiency. 
We recently reported a similar regulation by OR and thyroid hormone of the LDL·receptor (LDL·R) 
mRNA in the liver. We found that in hypothyroid rats LDL-R activity and LDL-R mRNA were both 
lowered. OR·substitution also led to complete restoration of the LDL·R mRNA levels (17). Thus, 
OR has similar transcriptional effects on both RL and the LDL·R. Interestingly, both proteins are 
involved in cholesterol metabolism. Whereas LDL-R mediates the uptake of LDL-cholesterol, HL 
facilitates the selective uptake ofRDL-cholesterol (33·37). Tins suggest that liver cholesterol uptake 
may playa central role in the parallel regulation of both proteins by thyroid hormone and GH. 
Translation of RL mRNA in the hypothyroid state appears to be rate·linnted by the lack of 
thyroid hormone. As a result, the rise in HL mRNA upon GH supplementation is not matched by 
increased translation, due to the thyroid hormone deficiency. Also in hypophysectomized rats, 
addition of both GH and thyroid hormone was necessary to normalize HL activities in the liver (38). 
Row hypothyroidism prevents the translation of the RL mRNA induced by OR is not clear. Thyroid 
hormone may interfere with translation of HL mRNA either directly, or through the induction of a 
regulatory protein. The regulation by thyroid homone is probably not acute, as addition of thyroid 
hormone during incubation of parenchymal liver cells did influence neither the HL secretion, nor 
the eSS]methionine incorporation into HL protein, both in conditions with low (hypothyroidism) 
and with high (OR·supplementation) HL mRNA levels. Alternatively, the HL mRNA induced by 
80 
Chapter 3 
GH may be somehow distinct from the HL mRNA in control liver, resulting in the marked reduction 
of translational efficiency. Sequencing of the coding part ofHL mRNA, after RT-PCR did not show 
any differences with the published sequence (not shown). Whether any alterations in the 
untranslated regions or in the cap structure of the OR-induced HL mRNA occur, is unknown at 
present. The precise role of thyroid honnone and GH in the translation of HL mRNA needs further 
research. 
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4. POSTTRANSCRIPTIONAL EFFECTS OF FENOFIDRA TE ON HL EXPRESSION IN 
THE RAT 
ABSTRACT 
In rats, the fenofibrate-mediated down-regulation of HL expression is mainly induced at the 
transcriptional level. Besides regulation of HL transcription, fenofibrate has been indicated to affect 
HL post-transcriptionally. Here, we studied the effects of fenofibrate on expression of HL more 
closely. In liver homogenatcs from fenofibrate-treated rats, HL activity was 40% lower than in 
controls. After normalizing to the amount of DNA, thus partly correcting for the increased liver 
weight after fenofibrate treatment, the HL activity in liver homogenates was still 25% decreased 
compared to control. However, the pool of HL activity released after heparin perfusion of the liver 
was not affected by fenofibrate-treatment. Secretion of HL activity by isolated hepatocytes from 
fenofibrate-treatcd rats was inhibited up to 70% compared to control hepatocytes. The HL mRNA 
level in the liver was 50% decreased after fenofibrate-treatment. In accordance with tlus, pulse-
labelling of hepatocytes with [J5SJmethionine showed a decreased synthesis of HL in hepatocytes 
of fenofibrate-treated rats. The processing of pre-synthesed HL was not different from control. 
Pulse-chase experiments showed that the HL maturation was similar in hepatocytes from 
fenofibrate-treated and control rats. These results suggest that fenofibrate reduced de novo synthesis 
of HL mainly at the transcriptional level. Despite the reduced rate of HL synthesis, heparin-
releasable HL activity in the liver was not affected. Thus, additional regulation of HL expression 
may occur at the post-translational level, possibly at the level of HL turnover. 
INTRODUCTION 
Fenofibrate is a fibric acid-derivative drug (Fig.1), which has proven useful in the treatment of 
hypertriglyceddaemia and -cholesterolaemia (see for review(l-3)). In humans, fibrates are very 
effective in lowering plasma triglyceride levels, and thus may correct atherogenic profiles. In rats, 
the effects of fenoflbrate on TO-rich particles is mediated by limiting the availability of substrates 
for TG synthesis in the liver, and by inducing LPL and reducing Apo cm. Further. synthesis of Apo 
AI, All and AIV in the liver was decreased by fenofibrate-treatment in rats (4). Recently, fibrates 
have been shown to effect expression of genes involved in intracellular and extracellular 
lipid metabolism via interaction with the nuclear peroxisome proliferator-activated 
receptors (PPARs) (4). Specific DNA response elements (PPRE) have been identified for several 
activated genes. Not for all affected genes a functional PPRE has been established. 
Both hepatic lipase (HL) and lipoprotein lipase (LPL) play an important role in plasma 
triglyceride metabolism by catalysing lipolysis of lipoproteins in liver and peripheral tissues, 
respectively. In addition, HL mediates uptake of (chylomicron) remnant particles in the liver. 
Expression of these lipolytic enzymes is differentially affected by fenofibrate. Whereas LPL is 
strongly induced, treatment with fenofibrate, or other flbrate-analogs, resulted in an small increase 
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of HL expression in humans (2, 4-7). In normolipidaemic subjects the HL activity was not affected 
by fenofibrate(8). In contrast, the HL expression in rats is markedly down-regulated (9), which was 
mainly induced by a decreased transcription after fenofibrate-treatment. Whereas the LPL gene 
contains a functional PPRE, no such element has yet been identified for human or rat HL gene (4). 
In addition to transcriptional regulation, fenofibratc may also post-transcriptionally affect HL 
expression (9), To identify the mechanism of post-transcriptional regulation, we studied the effects 
of fenofibrate on HL expression in rat liver into more detail. In particular. we isolated hepatocytes 
from fenofibrate-treated rats and determined the effect on HL synthesis, intracellular processing and 
transport. 
Fenofibrate 
Figure I Structure of fenofibrate 
and of the derived, active fcnoflbl'ic acid 
Fenofibric acid 
MATERIALS AND METHODS 
Materials 
Fenofibrate was a gift from Dr. B. Staels, standard chow was purchased from Hope Farms (Wilnis, The Netherlands). 
Benzamidine and amino acids were purchased from Merck (Darmstadt, Germany). Trasylol was from Bayer (Mijdrecht, 
The Netherlands) and heparin from Leo Pharmaceutical Products (Weesp, The Netherlands). CNBr-Activated 
Sepharose4B was obtained fromPharmacia (Uppsala, Sweden). Ham's FlO and methionine-free MBM were from Gibeo 
BRL (Paisle, U.K.). Glycerol trifl- '4CJoleate (50-SO Cilmmol) and {«-31pldCfP (3 000 Cilmmol) were purchased from 
Amersham (Amersham, U.K.), Tran--35S-label (1 100 Cilmmol) was from lCN (Costa Mesa, CA, U.S.A.). Broad range 
markers for SDS-PAGE came from Bio-Rad (Richmond, CA, U.S,A.), Quiabrane was from Qiagen GmbH (Hilden, 
Germany). All other chemicals were from Sigma (St. Louis, MO, U.S.A.). 
Animals 
Male Wistar rats (± 250g) were housed under standard conditions (21°C, 12 hour light cycle) and provided with chow 
and tap-water ad libitum. Control rats were fed a standard chow, whereas treated rats were fed with standard chow 
containing 0.5% (w/w) fenofibrate for fourteen days. 
Liver perfusion and cell isolallon 
Livers of control and fenofibrate-treated rats were perfused in situ with Berry medium (140 mM NaCI, 5.4 mM KCI, 
S.18 mM MgS04, 0.8 mM Na1HP04• 25 mM NaHC03• 2.54 mM CaCI2 and 6 mM D-glucose) containing 25 VIm) 
heparin and 1% BSA. For determination of total HL activity in the liver homogenate, a small lobule was excluded from 
perfusion, cut and directly frozen in liquid nitrogen. The heparin-perfusate (80 ml) was collected on ice and frozen in 
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liquid nitrogen for latcr analysis ofHL activity. Thereafter. the liver was flushed with Berry buffer without calcium. and 
hepatocytes were isolated by recirculating perfusion of the liver in situ with collagenase type I in Berry buffer. 
Hepatocyte incubation 
Hepatocytes were isolated from control or fenofibrate-trcated rats by recirculating liver perfusion with collagenase 
type I, and non-parenchymal cells were removed by differential centrifugation according to Seglen (II). The cells were 
washed with Ham's FlO medium containing 25 WIllI of heparin to remove residual extracellularly bound HL. After 
centrifugation (2 min, 50g), I ml of pack cd cells was resuspended in 20 011 of Ram's FlO medium containing 25 Dlml 
of heparin and 20% heat-inactivated, dialysed bovine serum (10). The cell suspensions were incubated at 37°C under 
an atmosphere of 95% 0/5% COl in a shaking water bath. Cell viability ranged from 85 to 95%, as determined by 
Trypan blue exclusion and remained essentially unaltered during all incubations. At the indicated times, 0.5 ml-samplcs 
were collected from the incubations and put on ice. Cells and media were separated by centrifugation (5 s, 10 OOOg, 4°C) 
and the cell-free media were used for analysis of secreted HL activity. 
HL activity 
HL activity was determined by a triacylglycerol hydrolase assay at pH 8.5 in 0.6 M NaCI using a gum acacia-stabilized 
glycerol[HCJtrioleate emulsion as substrate (10). Assays were performed for 45 min at 30°C. Enzyme activities are 
expressed as mV (nmoles of frce fatty acids released per min). For determination of HL activity in the liver 
homogenates, part of the frozen lobules were homogenized at 25 mg wei weight/ml in PBS containing 5 V/ml heparin. 
The homogenates were centrifuged for 2 min, 10 ooog at 4°C, and 25 ~ll of the supernatant was directly used in the 
enzyme assay. Of the heparin perfusates 10 J1l was used in the assay. 
Total DNA measurements 
TIle amount of DNA was measured as dcscribed by Kapuscinski et al (12, 13) and Lee et al (14). In short, part of the 
frozen lobule was homogenised in 0.2 M NaOH. After centrifugation, the suspension was neutralized with 0.9 M HCI 
and incubated with 400 ng/mI4,6-diamino-2-phenylindolc-(HClh in 0.4 M acetate-buffer (pH 7.8) containing JmM 
EDTA, 10 !-Ig/ml BSA and 0.2% Na-azide. The fluorescence (excitation 362 om, emission 450 nm) was read and 
compared with a standard curve prepared from herring sperm DNA. 
HL mRNA analysis 
Total RNA was isolated from part of the frozen liver lobule by the method of Chomczynski and Sacchi (15). Of the 
RNA, 30 !-Ig was separated by electrophoresis in a formamide-containing 1% agarose gel and transferred to Quiabrane 
membrane. The filter was hybridized over night with a random-primed HP-Iabelled HL cDNA probe (generated by PCR 
of rat HL eDNA using the specific primers HL-I (5'-OTOOO CATCA AACAO CCC-3', nt 697-714; numbering 
according to KOn1UTon1Y and Schotz (16») and HL-2 (5'-CAGAC AITOO CCCAC ACTG-3', nt 1292-1274), as 
described previously (17, 18)). After hybridisation, the filter was washed at 42°C in successively 5 x SSC, 2 x SSC and 
0.2 x SSC containing 0.1 % SDS. The radioactivity on the membrane was analysed by phosphor imaging using a BI-
screen and the OS363 Molecular Imager (Bio-Rad, Richmond, CA, U.S.A.). After stripping, the filter was rcprobed with 
a llP-labeIled OAPDH cDNA probc. 
Pulse-chase experiments wHh [-'SSlmcthlonine 
Freshly isolated hepatocytes were pre-incubated for 30 min in methionine-free MEM containing 25 Vlml of heparin and 
20% heat-inactivated, dialysed bovine serum. After a 5-min pulse with 80 pCi/ml of Tran-35S-label, cold methioninc 
was added at a final concentration of I mM. After washing I\\;ce by centrifugation (2 min, 50g, room temperature) and 
resuspending in Ham's FlO medium, the cells were incubated further in Ham's FlO medium containing 25 VlmI of 
heparin, 20% serum and 1.3 mM methionine. After the indicated chase times the incubations were stopped on ice. The 
whole cell suspension wa" lysed with 1% Triton X-IOO, 1% sodium deoxycholate, 25 Ulml heparin, I m11 methionine 
and the protease inhibitors leupeptin (I pg/ml), antipain (l I-lg/ml), chymostatin (l I-lg/ml), pepstatin (l I-'g/ml), 
benzamidine (I 111M), Trasylol (10 IV/ml) and EDTA (I mM). After a 30-min incubation on ice, the Iysates were 
centrifuged for 10 min at 10000g and 4°C. "Il1C post-nuclear supernatants were used for immunoprecipitation. 
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InllllunopreclpHaHon of HL 
HL protein was immunoprecipitated using goat polyclonal anti-lll.. IgGs immobilized onto SeplJarose as described 
previously (19). The post-nuclear supernatants (1 ml) were incubated overnight at 4°C with 50 !-II of a 50%-slurry of 
the immobilized anti-HL IgGs. The beads were collected by centrifugation, and then washed twice with I ml of 
successively PBS, I 10.1 Nael in PBS, 0.2% Tween-20 in PBS, and finally PBS (all at 4°C). The bound proteins were 
released by a 5-min incubation at 95°C in L'lemmli sample buffer without G-mercaptoethanol. After removal of the beads 
the proteins were reduced with B-mercaptoethano! and then resolved by SDS·PAGE on 10% gels. Protein bands were 
visualized by staining with Coomassie Brilliant Blue, and their molecular masses were estimated using broad range 
markers run in parallel. The radioactivity in the dried gels was analysed by phosphor imaging using CS-screcns and the 
GS363 Molecular Imager. 
Protein de novo synthesis 
To detennine the overall protein de novo synthesis. 5 III of the Iysates from the 5 min-pulsed cells were spotted onto 
Whatman 3MM paper. After boiling in 5% TCA, the filters were washed successively with ethanol:ether (I: I) and ether, 
and the radioactivity in TCA-precipitable material was determined by a I-hour exposure to a CS-screen followed by 
analysis with the GS363 Molecular Imager system. 
Statistics 
Statistical significances (p<0.05) were determined either by a Student t-test or by a one-way ANOYA, followed by the 
. Student-Newman-Keuls test (20). 
RESULTS 
HL activity in the liver 
The HL activity in liver homogenates of control rats was 489 ± 98 mU/g wet weight (Table I). After 
fourteen days of fenofibrate-treatment the HL activity was decreased by 40% to 294 ± 40 mU/g wet 
weight. The livers of fenofibrate-treated rats were enlarged. The amollnt of DNA was 1223 ± 159 
and 1013 ± 128 Ilg/g wet weight for control and fenofibrate liver, respectively, which is not 
significantly different (p>0.05, n=4). When the HL activity was corrected for the amollnt of DNA, 
fenofibrate-treatment resulted in a 25 % lower HL activity in the liver homogenates (Table I). In 
contrast, the HI.. activity that was released from the liver by perfusion with 25 U/ml heparin was not 
affected by fenofibrate-treatment. Thus, the pool of heparin releasable HL in fenofibrate-treated rats 
remained similar to control, although HL activity per g wet weight in the liver homogenate was 
decreased. 
Table I HL activity in the livel' 
Control 
Fenofibrate-treated 
Homogenates 
mU/gww mU/~gDNA 
489 ± 98 
294 ± 40' 
0040 ± 0.04 
0.30 ± 0.07' 
Perfusates 
mU/totalliver 
2152 ± 272 
2407 ± 895 
From an isolated liver lobule a 10% (w/w) homogenate was prepared to measure the HL activity. Another part of the 
lobule was used to measure DNA. TIle remaining liver was perfused with 25 Vlml heparin and 0.1 % BSA. The perfusate 
was collected on ice and analysed for HL activity. Data are mean ± SD for 4 to 5 animals per group. Statistically 
significant differences from control are marked with an asterisk (p<0.05). 
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HL mRNA levels in the liver 
Total RNA was isolated from livers of fenofibratc-treated and control rats. The amount of total 
RNNg wet weight was decreased by fenofibrate treatment to 70% of control (Table II). When the 
amount was expressed per Ilg DNA, the difference was not statistically significant. HL mRNA was 
analysed by Northern blotting, and subsequent hybridization with a "P-labelled specific probe 
(Fig.2). The amount of HL mRNA was expressed relative to the amount of GAPDH mRNA 
measured in the same lane. After fenofibratc-treatment, the ratio of :m.... to GAPDH mRNA was 
reduced by 50% (Table II), indication a reduced HL mRNA expression. 
Table II HL mRNA in the liver 
Total RNA HLmRNA 
llglg wet weight ng/llg DNA relative units 
Control 4.7 ± 0.4 4.3 ±0.3 0.18 ± 0.04 
Fenofibrate-treated 3.0 + 0.3' 3.2 +0.3 0.09 +0.02' 
Total RNA was isolated out of90 ± 30 mg (wet weight) liver. and quantified by spectrofotometry ilt 260 11m. TIle data 
are mean ± SEM of 4 to 6 animals per group. HL mRNA was determined by Northern blot analysis. The radioactiVity 
on the membrane after hybridization with a 31P_labelied HL and GAPDH cDNA-probe was quantified by phosphor-
imaging. Data arc expressed as units of HL mRNA relative to the GAPDH mRNA signal, and nrc 
mean ± SEM (n=3). Statistically significant differences (p<O.05) from control are marked with an asterisk. 
FF Con 
HLmRNA 
GAPDHmRNA I \!!Ii !l!IJ • "'" - ./-18S 
Secretion of HL activity by hepatoeytes 
Figure 2 HL mRNA analysis 
Total RNA was isolated from part of the 
frozen liver lobule. HL and GAPDH mRNA 
were determined by Northern blot analysis. 
The 32P-mdioactivity on the membrane was 
visualized by phosphor imaging. TIle position 
of the 18S ribosomal RNA is indicated at 
the right. 
Freshly isolated hepatocytes were prepared and 1 ml of packed cells was resuspended in 20 ml 
medium. With control hepatocytes, this yielded a final cell density of 3.9 ± 0.6 * 106/ml, whereas 
with hepatocytes from fenofibrate-trcated rats this resulted in 2.9 ± 0.6 * I Q6/ml. This may reflect 
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an increase in cell size induced by fCllofibrate treatment. 
During in vitro incubation of hepatocytes from control rats in the presence of heparin. HL 
activity was secreted at a constant rote of 0.81 ± 0.16 mUlh/lO' cells (Fig.3). After 2 hours, the HL 
activity in the cell-free medium was 1.60 ± 0.32 mU/IO' cells (n=3). Secretion of HL activity by 
hepatocytes isolated from fenofibrate-treated rats was also linear with time, but slower compared 
to control. The HL activity secreted into the medium after 2h incubation was 0041 ± 0.28 mU/106 
cells, which is 25% of control. 
2.0 
I 
o. 0 30 60 90 120 
Time (min) 
Figure 3 
Secrelion of HL activity by ral hep.locyles. 
Freshly isolated hepalocytes from control (0) and 
fenofibrate-treated rats (e) were incubated in medium 
containing 25 Ulml heparin. At the indicated limes 
samples were withdrawn, and the cell-free media were 
assayed for HL activity. Data represent mean ± SD 
of 4 independent experiments. Asterisks indicate 
significant differences from control (p<O.05). 
Effect of fenofibrate on denovo synthesis and maturation of HL 
After a 5-min pulse labelling with ["Slmethionine, the immunoprecipitated ["SlHL from the total 
control cellsuspension was predomantly in the 53 kDa-form, which is Endo H sensitive (21, 22). 
e5S]HL immunopreclpitated from fenofibrate-treated cells appeared similar to control on 
SDS-PAGE (Fig. 3). However, in comparison to control, less 35S-radioactivity was incorporated 
after fenofibrate-treatment (Table III). The radioactivity of ["SlHL per cell was reduced by 55% 
of control by fenofibrate treatment. 35S-Incorporation into overall proteins, as determined by TCA-
precipitation, was decreased by approximately 20%. The differences between control and 
fenofibrate-treated cells did not reach statistically significance with the low numbers of experiments 
performed. 
During the subsequent chase with control cells, the "S-Iabelled 53 kDa protein gradually 
disappeared (Fig.4). In parallel the mature, Endo H resistant HL-protein of 58 kDa was formed. 
Total ["SlHL, which was determined by the sum of the radioactivity in the 53 and 58 kDa protein, 
remained constant during the 45-min of chase, indicating that there was no degradation of HL under 
these conditions. 
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In hepatocytes from fenofibratc-trcated rats, the disappearance of 35S-radioactivity in the 53 kDa 
protein, and appearance in the 58 kDa protein during the chase occurred to a similar extent and at 
a similar rate as in control cells. Apparently the maturation of HL was not altered in 
fenofibrate-treated rats. 
Table III Protein and HL denovo synthesis 
Total protein (* 103) 
Control 
Fcnofibrate-trcated 
cpm/ml 
50.1 ± 11.0 
29.1 ± 13.6 
cpm/IO'cells 
12.7 ± 1.4 
9.1 ± 4.5 
HL 
cpm/ml cpmllO' cells 
14.4 ± 3.2 4.1 ± 1.2 
6.0 ± 2.0 1.9 ± 0.7 
Hepatocytes isolated from control and fcnofibrate-treated rats were-pliised with r35S1methioninc for 5 min. l1tcreafter, 
the radioactivity in lotal TeA-precipitable material and immulloprecipilated HL was determined, Data represent the 
amount of 3sS_labclled protein, which was calculated in terms of cplll/ml cell suspension by laking into account the 
different times of exposure to the phosphor screens. Data are mean ± SEM of2 to 3 independent hepatocyte isolations 
per group. Each labelling was performed in duplicate. TIle power of the performed t-test «0.10) was too low to find 
significant differences. 
Controle Fenofibrate 
Chase time 0 15 3045 0 15 3045 
(min) 
90 90 
70 70 
'0 '0 
~ 30 30 
...J 10 10 I (i) 10· 10· 
i'L 30- 30· 
'0· '0-
70- 70-
90- 90· 
Figure 4 Maturation of denovo synthesized HL protein 
.... 58 
... 53 
A 58 
f 53 
Pulse-chase experiments were performed with hepatocytes isolated from control rats (Can) and fenofibrate-treated 
rats (FF). The cells were pulsed for 5 min with eSS]methionine and then chased for the indicated limes. TIlereafter, HL 
was immunoprecipitated from the lysate of the whole cell suspension, and analysed by SOS-PAGE and phosphor 
imaging. TIle figure represents a typical example of the experiments (0::::3). The apparent molecular weights of the HL 
bands are indicated in kDa. 35S-Radioactivity in the 53 kDa band (downward bars) and 58 kDa band (upwards bars) is 
depicted underneath the phosphor image. TIle radioactivity is expressed as percentage orlotal [35S]HL in the 5-min 
pulse-labelled cell suspension (53 plus 58 kDa band at chase time zero). 
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DISCUSSION 
OUf study confirms previous reports that fenofibrate markedly reduced HL expression in rat 
liver (9). In rats fed a 0.5% fenofibrate chow diet for 14 days the HL activity in liver homogenates 
was 40% lower compared to control rats. When the HL activity was expressed per fig DNA the 
decrease was 25%, indicating that the HL activity expressed per cell was decreased. The cells of 
fenofibrate~treated rats were enlarged, which is in line with increase in total liver weight reported 
by Staels et al (9). However, the pool of heparin-releasable HL activity in the liver was similar in 
control and fenofibrate-treated rats. Hence, the fall in total liver HI... activity must be attributed to 
a decrease in the non-heparin-releasable pool of liver HL. This latter pool may reflect intracellular 
HL either before being secreted or after internalization. In contrast to the study of Staels et al (9), 
the heparin-releasable HL activity in the liver of our rats was not affected by fenofibrate. The nature 
of this difference is unclear, but may reflect differences in nutritional status of the animals in both 
studies. The rats used here were fed. In fasted rats HL activity is downregulated by catecholamines 
(22, 23), which might also be the case for fenofibrate-treated rats. Alternatively, a pool of 
extracellular HL bound to sites sensitive to 25 U/ml heparin-concentrations, but not to levels used 
by others may exist. 
In parallel with the 50% reduction in HL mRNA, secretion of HL activity by hepatocytes 
from fenofibrate-treated rats was decreased up to 70% compared to control. In addition, pulse-
labelling experiments showed that the incorporation of [35S]methionine in newly synthesized HL 
was reduced by 55% in the hepatocytes of fenofibrate-treated rats. The secretion of HL activity by 
hepatocytes of fenofibrate-treated rats was linear with time. Pulse-chase experiments showed that 
HL maturation in fenofibrate-treated rats was similar to controls. Hence, maturation and secretion 
of de novo synthesized HL appear not to be affected by fenofibrate-treatment under the 
condition used. 
Despite the reduction in HL mRNA, synthesis and secretion, the total HL activity in the liver 
was only slightly reduced, which was completely attributable to the fall in the 
heparin-non releasable pool. These data agree with previous studies showing that the HL 
expression is regulated by fenofibrate at transcriptional level, but also at the post-translational 
level (9). Our data suggest that the turnover of secreted HL in fenofibrate-treated rats is markedly 
reduced in respect to control animals. Since this effect of fenofibrate was not observed previously in 
fasted rats, the turnover of Ill., may not be a restrictive factor during fasting. This is probably 
the first time that regulation of HL expression is attributed to 'decreased turnover'. And it 
may well be an additional site of post-transcriptional regulation of HL expression in the rat 
liver, besides the translation (18), maturation (23) and binding (24, 25) ofHL. 
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Secretion and intracellular activation of human hepatic lipase requires 
proper oligosaccharide processing. 
Adrie J.M. Verhoeven, Bernadette P. Neve and Hans Jansen 
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5.1 SECRETION AND INTRACELLULAR ACTIVATION OF HUMAN HEPATIC 
LIPASE REQUIRES PROPER OLIGOSACCHARIDE PROCESSING. 
ABSTRACT 
Human hepatic lipase (HL) is a glycoprotein with four N-linked oligosaccharide side chains. The 
importance of glycosylation in the intracellular activation and secretion ofHL was studied in HepG2 
cells using various inhibitors ofN-glycosylation, oligosaccharide processing and vesicular transport. 
Secretion of HL was inhibited by tunicamycin, castanosperminc, N-mcthyldeoxynojirimycin, 
carbonyl cyanide m-chlorophenyl hydrazone (CCCP), monensin and brefeldin A, but not by 
I-deoxymannojirimycin. Secretion of ai-antitrypsin, an unrelated N-glycoprotein, was inhibited by 
tunicamycin, monensin and brefeldin A but not by castanospermine, N-methyldeoxynojirimycin and 
CCCP. Intracellular HL activity was decreased with tunicamycin, castanospermine, 
N-methyldeoxynojirimycin and CCCP, but increased with monensin and brefeldin A. In the absence 
of protein de novo synthesis, HL activity secreted into the medium was 8.5 fold higher than the HL 
activity that disappeared from the cclls, suggesting a secretion-coupled activation of human HL. In 
cells pre-treated with monensin or brefeldin A, t~s factor ranged from 1.1 to 1.9, indicating that the 
apparent activation of HL had already occurred. \Ve conclude that oligosaccharide processing 
by glucosidases in the endoplasmic reticulum is necessary for transport of human HL, but not 
aI-antitrypsin, from the endoplasmic reticulum to the Golgi, where HL acquires 
triglyceridase activity. 
INTRODUCTION 
Hepatic lipase (HL) is an extracellular enzyme that belongs to the lipase gene superfamily (I), The 
enzyme is synthesized and secreted by liver parenchymal cells, and exerts its function while bound 
to the liver in the space of Disse (2, 3), HL hydrolyzes phospholipids and triacylglycerols present 
in high- and intermediate-density lipoproteins, and facilitates the hepatic uptake of remnant pru1icles 
(4-6) and of cholesterol (esters) caJTied in high-density lipoproteins (7, 8), In addition, HL may act 
as a ligand protein for remnant binding to the liver (9). By contributing to reverse cholesterol 
transport and by reducing the number of atherogenic remnants in the circulation, HL is thought to 
protect against the development of premature atherosclerosis. Indeed, a low HL activity appears to 
be associated with an increased atherosclerotic risk (10,11), In line with this, aortic accumulation 
of cholesterol was markedly reduced in cholesterol-fed transgenic mice that over-express 
human HL (12), 
HL is a glycoprotein bearing two (rat) to fOUf (human) asparagine-linked glycans (13-15), 
For the synthesis and secretion of fully active HL by rat hepatocytes, N-glycosylation is a 
prerequisite (16, 17). This was con finned by expression studies using HLcDNA constmcts in which 
the glycosylation sites had been removed by site-directed mutagenesis (14, 15), These studies 
demonstrated that occupation of Asn56/57 in human and rat HL is both necessary and sufficient for 
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secretion of catalytically active lipase (14). When glycosylation is prevented, either by tun1camycin 
or by site-directed mutagenesis. inactive HL protein accumulates intracellularly (14, 18), \Vhen 
expressed in Xenopus oocytes, however, a small portion of the non-glycosylated rat HL protein was 
found to be secreted and catalytically active (19), This observation argues against the possibility that 
N-glycosylation per se is necessary for catalytic activity. Rather, N-glycosyJation may be required 
for proper intracellular trafficking of the newly synthesized protein. 
Additional studies have shown that for secretion of fully active rat Ill. the protein must 
not only be N-glycosylated, but the glycan chains must subsequently undergo proper 
processing (17, 20). The oligosaccharides of N-glycoproteins are generally processed from 
high-mannose to complex-type chains successively by glucosidases in the rough endoplasmic 
reticulum (RER). mannosidases in cis/medial Golgi and glycosyltransferases in medial/trans 
Golgi (21). Notably. trimming of the terminal glucose residues by the RER glucosidases appears 
to be crucial for the acquisition of catalytic activity and secretion of rat HL protein (17, 20). Once 
the glucose residues have been removed, activation and subsequent secretion continues 
independently of fmiher oligosaccharide processing. Glucose trimming ofN-glycoproteins has been 
implicated in the RER quality control system for newly synthesized proteins, which prevents 
mal folded protcins from leaving the RER (22, 23). Whether the presence of terminal glucoses itself 
prevents the acquisition of catalytic activity of rat HL, or primarily interferes with transport to the 
Golgi where subsequently activation may occur, is unknown. 
In the present study, we examined the role of N-Iinked glycosylation in the secretion and 
activation of human HL by HepG2 cells. The four putative N-glycosylation sites identified in the 
HL cDNA (24) all appear to be occupied in HL secreted by these cells (14, 25). First, wc studied 
the importance of oligosaccharide processing in secretion and intracellular activation of human HL 
llsing inhibitors of glucose trimming in the RER (castanospennine and N-methyldeoxynojirimycin) 
and mannose trimming in the cis-Goigi (l-deoxymannojirimycin) (26, 27). Secondly, we determined 
in which intracellular compartment HL protein is apparently activated, by using inhibitors that 
primarily affect vesicular transport in the secretOlY pathway. CCCP and monensin inhibit transport 
of glycoproteins from the RER to the Golgi (28, 29) and from medial- to trans-Golgi (21), 
respectively. Brefeldin A blocks the transpOli of proteins into post-Goigi Comparil11ents and induces 
the redistribution of the Goigi into the RER (3~, 31). The effects of the inhibitors on expression of 
HL were compared to that of ((I-antitrypsin, an unrelated N-glycoprotcin. Thc data show that proper 
oligosaccharide processing by RER glllcosidases is esscntial for secretion of fully active HL but not 
for secretion of uI-antihypsin. Glucose trimming appears to be necessary for the translocation of 
HL protein to the Golgi compartment, where the protein apparently acquires its 
triglyceridase activity. 
MATERIAL AND METHODS 
Materials 
Castanospermine, I-deoxymannojirimycin, (+)-brefeldin A and cycloheximide were from Boehringer Mannheim 
(Mannheim, Germany), whereas N-mcthyldeoxynojirimycin and Endo-H were from Gcnzyme (Boston, MA, U.S.A.). 
Monensin and CCCP were purchased from Calbiochem (La Jolla, CA, U.S.A.). Heparin was obtained from Leo 
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Pharmaceuticals (Weesp, The Netherlands), Trasylol was from Boehringer Mannheim (Mannheim, Germany); other 
protease inhibitors and tunicamycin were from Sigma (St. Louis, MO, U,S.A.). Media, fetal bovine serum and Tran3SS_ 
label (I 100 Cilmmole) were obtained from ICN (Costa Mesa, CA, U.S,A.). Culture plastics and EIA code 3590 plates 
were from Costar (Cambridge, MA, U.S.A.). Glyceroltri[I-'4qoleate (50-80 mCilmmole) was from Amersham 
(Amersham, UK). Rabbit antibodies against human ",-antitrypsin and horse-radish peroxidase-conjugated rabbit 
anti-goal IgGs were from Dakopatts (Glostrup, Denmark). Zysorbin was from Zymed Laboratories (San Fransisco, 
CA, U.S.A.) 
HepG2 cell culture and incubation 
Human hepatoma cells HepG2 were grown as monolayer cultures in Dulbecco's nllmmum essential medium 
supplemented with 10 % fetal bovine serum (25). The cells were split 1:10 into new flasks once a week. Medium was 
refreshed once a week. For the experiments, cells were seeded into 6-wells plates. AI confluency, the medium was 
replaced by 1 ml of fresh medium containing 25 U/ml of heparin, and the incubations were started with the addition of 
inhibitors. Brefeldin A, CCCP and monensin were added from 1000-fold stock solutions in ethanol, whereas 
tunicamycin was added from a lOOO-fold stock in dimethyl sulfoxide; other inhibitors were added from lOO-fold stocks 
in PBS. The cell cultures were incubated for the indicated times 37 °c in a humidified atmosphere of95 % 015 % CO2, 
At the end of the incubation, the plates \vere placed on ice and all subsequent handlings were at 4 0c. When the cells 
were to be re-incubated, however, the plates were not allowed to cool down below room temperature. The medium was 
collected for analysis of secreted HL. TIle cell layer was washed twice with PBS and then, the cells were released from 
the plates by a 5-min incubation in PBS containing 2.5 mM EDTA. After centrifugation (15 sec, 10OOOg), the cclls were 
resuspended in 250 ~I of a 40 mM NH..jOH buffer, pH 8.1 (32) containing 25 Vlml heparin and a cocktail of protease 
inhibitors (I mM EDTA, 10 U/ml Trasylol, 0.1 111M benzamidine and 2 ~glml each of leupeptin, antipain, chymostatin 
and pepstatin). After 30 min on ice, the lysates were sonified (15 sec, 1411, MSE Soniprep 150) and centrifuged for 
10 min at 10 OOOg. The supernatants were used for analysis of intracellular HL. 
Hepatic lipase activity 
HL activity was determined by a tciacylgl)'cerol hydrolase assay at pH 8.5 in 0.6 M NaCI using a gum acacia stabilized 
glycerol [14CJtrioleate emulsion as substrate (17), Assays were performed for 2 h at 30 0c. Activities were expressed 
as mU (nmoles of free fatty acids released per min). In a tolal assay volume of 125 ~1, release of free fatty acids was 
linear with time and sample volume up to 50 ~I for the cell-free media and 10 !-II for the celllysales. 
In immuno-inhibition assays, 40 ~I of the cell-free media or 10 )11 of the cell iysates were pre-incubated for 
3 h on ice in a total volume of 50111 with 50 I1g goat anti-human HL IgGs. This antibody was raised against partly 
purified human HL from poslheparin plasma as previously described (33). After centrifugation (10 min, 10 DOOg, 4 0c), 
75111 of substrate was added to the supernatant, and the residual immunoresistant triglyceridase activity was determined. 
Hepatic lipase mass 
TIle amount of HL protein was determined by solid-phase ELISA in which the antigen was sandwiched between rabbit 
and goat polyclonal antibodies. 'The rabbit and goat antibodies had been raised against human HL purificd from 
postheparin plasma as described by Martin et aL (24) and by Persoon et al. (33), respectively. From the antisera partly 
purified JgG fractions were prepared by 50% ammoniulIlsulfate precipitation and elution through a human albumin-
Sepharose column. Polystyrene 96-well EIA plates were coated with the rabbit anti-HL IgGs. After blocking with 
1% bovine serum albumin in PBS, the wells were incubated successively with: (i) sample; (ii) 3 ~g/ml of goat anti-HL 
IgGs in PBS, and (iii) peroxidase-conjugated rabbit anti-goat IgGs at a I: 10 000 dilution in PBS. Finally, the presence 
of peroxidase was detected with 3,3,,5,5'-telramethylbenzidine (Merck, Darmstadt, Germany) as substrate. Color 
development was stopped with H2S04 (4 M, final concentration), and the absorbance at 450 nm was measured in a 
Molecular Devices microplate reader. Absorbances were read against a standard curve prepared for each plate by serial 
dilutions of a human post-heparin pool plasma. 'nle HL activity in this pool plasma amounted to 410 mU/ml, whereas 
HL protein mass was determined at 23.6 ~g/ml by reading this plasma against a standard CUf\'e of purified HL. The 
ELISA enabled accurate measurements of the amount of human HL in the range of 5 to 500 ng/ml. 
Alpha·! antitrypsin 
Synthesis and secretion of «(,-antitrypsin was measured by incorporation of eSS)methionine into immunoprecipitated 
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protein. HcpG2 cells were incubated for 3 h in methionine-free medium in the presence of inhibitors as described above. 
Then, 80 pCi of Tran35S-1abel was added to each well and the incubation was continued for another 3h. Thereafter, the 
plates were put on ice. The medium was collected into vials containing cold methionine (final concentration I mM) and 
the cocktail of protease inhibitors described above. After washing twice with cold PBS, the cells were lysed in cold PBS 
containing 1% Triton X-lOO, 1% sodium deoxycholate, 0.25% SDS, I mM methionine, 25 U/ml heparin, 10 ruM 
HEPES (pH 7.4) and the cocktail of protease inhibitors. After 30 min on ice, the lysate was collected from the plate, 
the sodium deoxycholate concentration was brought to 0.3% and the lysate was centrifuged for 10 min at 10 000 g. TIle 
supernant was used for further analysis. 
Sample-s of medium and cell lysate were incubated with formaldehyde-fixed Staphylococcus aureus membranes 
(Zysorbin) in the presence of 0.2 mgfml of human serum olbumin and centrifuged to remove material that bound 
non-specifically to protein A. The supernatants were then incubated with rabbit antibodies against human (tl~antitrypsin 
at a I: 100 dilution. Antigen~antibody complexes were precipitated by incubation with Zysorbin and were collected by 
centrifugation. Pellets were washed twice in PBS containing I % Triton x~ 100,0.25% SDS, 0.25% sodium deoxycholate 
and 1 mM PMSF, and twice in PBS. Washed pellets were resuspended in Laemmli's sample buffer, immunoprecipitated 
proteins were released by boiling for 5 min and separated by SDS-PAGE in 7.5% gels. TIle 35S_labelled proteins were 
visualized. and their radioactivity was determined, by exposure ofthe dried gels to a phosphor screen (BioRad GS-393 
Molecular Imager System, Richmond, CA, U.S.A.). 
In some experiments, immunopreeipitated proteins were released by boiling for 5 min in 0 50 O1M NaP j buffer, 
pH 6.0, containing 0.25% SDS. After removal of the bacterial membranes (5 min, 10 OOOg, 4 0q. the eluted proteins 
were incubated overnight with 40 mVlml Endo-H at 37°C in 50 mrvt NaPi , 0.1% 5DS (34). TIle digestion was stopped 
by addition of Laemmli's sample buffer, and after boiling the samples were analysed by 5DS-PAGE and phosphor 
imaging, as described carlier. Endo~H sensitivity was indicated by an increase in electrophoretic mobility. 
Protein de no\·o sYnthesis 
Incorporation of e-sS]methionine into TCA-precipitable material was taken as a measure for overall protein de novo 
synthesis. HepG2 cells were incubated with Tran3SS-label, and cell-free media and cell lysates were prepared as 
described carlier. Five-pi aliquols were spotted in duplicate onto Whatman 3M11 filters (Whatman, Maidslone, UK), 
and TeA-precipitation was performcd as previously described (17). The radioactivity on the filters was mcasured using 
the Molecular Imaging System. 
Slatistics 
Statistical significances were determined by two-way ANOVA followed by the Student-Newman-Keuls lest. 
RESULTS 
Synthesis and secretion of ill, by HepG2 cells. 
In the presence of heparin, HepG2 cells secreted lipase activity into the extracellular medium 
(Fig. lA) while intracellular activity remained virtually constant throughout the 24 h incubation 
period (Fig. IB). The lipase activity present in the extracellular medium was largely sensitive to 
immuno-inhibition with anti-human HL IgGs (Fig. 1 C), indicating that the extracellular activity 
represents HL. Of the lipase activity measured in the celilysates, however, approximately 65% was 
resistant to immuno-inhibition suggesting that HL represented only a small fraction of total 
intracellular lipase activity. When cycloheximide was added at the stmi of the incubation, secretion 
of HL activity was hardly affected during the first 3 h (Fig. IA), although inhibition of protein 
de novo synthesis occurred almost instantaneously (Fig. 1 D). Simultaneously, intracellular lipase 
activity decreased (Fig. IB) indicating that pre-existing HL was secreted from the cells during the 
incubation with cycloheximide. Between 3 and 6 h after addition of cycloheximide, secretion of HL 
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activity became completely blocked, while intracellular lipase activity continued to fall throughout 
the incubation. After 22 h. intracellular lipase activity was no longer sensitive to immunoinhibition 
with anti-HL (Fig. 1 C). Both the immunosensitive and inununoresistant fractions of intracellular 
lipase were reduced by the prolonged cycloheximide treatment of the cells. Comparison of the data 
in Fig. lA and B shows that in the absence of protein de novo synthesis much more HL activity 
appeared in the extracellular medium than was lost from the cells (0.5 vs 0.05 mU/well at 6 h 
incubation). Hence, intracellular HL is apparently activated during the secretory process. 
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Figure 1 Synthesis and secretion of hepatic lipase activity by HepG2. 
HepG2 cells were incubated in the presence of25 VlmI of heparin without (e) or with 20 J.lg/ml of cycloheximide (0). 
At the times indicated, the medium and cells were harvested and lriglyceridase activity was measured in the mcdium 
(A) and celllysates (D). (C); Cell lysates and cell+free media were prepared from HepG2 cells that had been incubated 
for 22 h without (con) or with cycloheximide (chx), and triglyceridase activity was measured before (left bars) and after 
(right bars) incubation with goat anti-HI... JgG's. (D); Effect of cycloheximide treatment on [3sS]methionine incorporation 
into TCA-precipitable material. The data points are averages of 3sS-radioactivity precipitated in duplicate from aliquots 
of cell lysates plus cell-free media; note the difference in time scale between the panels A, Band D. All data are 
rcpresentative for 2 similar experiments. 
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Effect of N-glycosylation inhibitors on secretion. 
In the presence of tunicamycin, secretion of HL activity into the medium was inhibited to a similar 
extent as with cycloheximide, both after 6-8 hand 18-22 h of incubation (Fig. 2A). With the RER 
glucosidase inhibitors CSP and MdN, secretion of m.... activity was inhibited to a similar extent as 
with tunicamycin and cycloheximide. Secretion of HL protein was reduced in parallel to that of HL 
activity (Fig. 2B). With the mannosidase inhibitor dMM, secretion of both HL activity (Fig. 2A) 
and protein (Fig. 2B) continued almost unaffected. 
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Figure 2 Effect of glycosylation inhibitors on 
secretion ofHL and aI-antitrypsin. 
HepG2 cells were incubated in the absence (con) or 
presence of20 I-lgfml of cycloheximide (chx), 10 Ilglml of 
tunicamycin (tun), tOO J.lg/ml of castanospennine (csp), 
I mM N-mcthyJdeoxynojirimycin (MdN) or 1 m1 ... 1 
deoxymannojirimycin (dMM). The extracellular 
appearance of HL (A. D) and ",-antitrypsin (C) was 
measured as outlined in the Method section. (A) HL 
activities in the extracellular medium were detennined 
after 6 to 8 h (open bars) and 18 to 22 h (closed bars) of 
incubation; data (means ± SEM; n::: 6-7) arc expressed as 
percentagc of control. which was 1.02 ± 0.10 and 2.49 ± 
0.37 mVlwell after 6 t08 hand 18 to 22 h. respectively. 
Except for dMM. the HL activity in the media containing 
glycosylation inhibitors was significantly different from 
controls at both lime points (p<0.05). (ll) HL activity and 
amount of HL protein. as determined by ELISA. both 
measured in the same extracellular media after 6 h 
incubation. (C) ",-Antitrypsin was immulloprecipitated 
from 6-h incubation media also containing Tran35S_label. 
and the radiolabelled proteins were analyzed by SDS-
PAGE and phosphor imaging. Part of the image is shown 
at the top; the molecular size of the radioactive bands is 
indicated in kDa. TIlC radioactivity in each band (in 
arbitrary units) was expressed relative to the control 
incubation. The data in panels Band C are representative 
for 2 similar experiments. 
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HepG2 cells secreted arantitlypsin into the extracellular medium, which on SDS-PAGE migrated 
as a 54 kDa protein band (Fig. 2C). In the presence of tunicamycin, secretion was markedly reduced. 
The small amount of lXI-antitrypsin in the extracellular medium migrated at an apparent molecular 
mass of 45 kDa which corresponds to the nonglycosylated protein. In the presence of CSP or MdN, 
however, the cells secreted similar amounts of ai-antitrypsin as control cells. On SDS-PAGE, the 
protein was indistinguishable from arantitrypsin secreted by control cells; the bands migrated at 
the 54 kDa position of the mature protein (Fig. 2C), and migration was also not affected by Endo H 
treatment (not shown). Secretion of "I-antitlypsin was hardly affected by incnbation of the cells 
with dMM, but the electrophoretic mobility of the protein was higher than in controls. The 
"I-antitrypsin migrated as a sharp band at approximately 49 kDa (Pig. 2C), which decreased to 
45 kDa upon Endo-H treatment (not shown). This protein therefore corresponds to the 
high-man nose type form of arantitrypsin. The most conspicuous difference between secretion of 
HL and "I-antitlypsin by the HepG2 cells was that HL was highly sensitive to the RER glucosidase 
inhibitors CSP and MdN, while aI-antitrypsin was not. 
Intracellular effects of the N-g\ycosy\ation inhibitors 
In cells treated for 6-8 h with either tunicamycin, CSP or MdN, intracellular lipase activity was 
approximately 75-80% of control cells, which is slightly higher than in the cycloheximide-treated 
cells (Fig. 3A). Immuno-inhibition assays using anti-human HL IgGs showed that the fall in 
intracellular lipase activity was almost completely due to a decrease in the immunosensitive 
part (not shown). \Vith tunicamycin, overall protein de novo synthesis was reduced to 86 ± 10% of 
control compared to II ± 4% with cycloheximide (mean ± SEM, n = 4). With CSP and MdN, 
protein de novo synthesis was only slightly reduced to 93 ± 6% and 97 ± 3% of control, respectively 
(mean ± SEM, n = 3). Upon prolonged incubation, the intracellular lipase activity did not fall any 
fmiher except for the cycloheximide-treated cells. In cells treated with dMM, intracellular lipase 
activity was maintained at control levels throughout the entire incubation (Fig. 3A). Under all 
conditions tested, the amount of HL protein in the celllysates remained below the detection limit 
of the ELISA. Hence, there is no evidence for intracellular accumulation of (inactive) HL protein 
in the cells under conditions where secretion of HL is abolished. 
Intracellular levels of ai-antitrypsin were not affected by treating the cells with either 
tunicamycin, esp, MdN or dMM. However, the electrophoretic mobility of the respective proteins 
differed markedly from control (Fig. 3B). ai-Antitrypsin from control cell lysates migrated 
predominantly as a 49 kDa, Endo-H sensitive band and a fainter, Endo-H resistant band at 
54 kDa (Fig. 3B). Treatment of the HepG2 cells with tunicamycin resulted in the intracellular 
accumulation of lXI-rultitrypsin mainly with a molecular mass of 45 kDa (not shown). In esp- and 
MdN-treated cells, ai-antitrypsin migrated predominantly as a 51 kDa, Endo-H sensitive band with 
the 49 kDa and 54 kDa band also seen in control cells as relatively minor components (Fig. 3B). 
Finally, ctl-antihypsin from dMM-treated cells migrated as a 49 kDa, Endo-H sensitive band. 
Effect of CCCP, monensin and brefeldin A. 
\Vith increasing concentrations of cecp, secretion of HL activity into the extracellular medium 
gradually fell to about 30% of control at 10 flM (Pig. 4A). The amount of HL protein fell in 
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Figure 3 Effect of glycosylation inhibitors on intracellular HL and ","antitrypsin, 
Experiments were performed as described for Fig. 2, and lipase activity (A) and radiolabellcd ",-antitrypsin (B) were 
detcnnined in celllysates prepared after 6 to 8 h (A; open bars, and D) and 18 to 22 h (A; filled bars) of incubation. Data 
(mean ± SEM, n;:: 5-6) on intracellular lipase activity were expressed as percentage of control, which was 0.24 ± 0.05 
and 0.18 ± 0.03 mU/well, respectively. Except fordMM, the HL activity in the media containing glycosylation inhibitors 
was significantly different from controls at both lime points (p<O.05). (B) immunoprecipitates prepared from the cell 
Iysates were treated without (-) or with (+) Endo-H before electrophoretic separation; the molecular mass of the 
radioactive bands (in kDa) is indicated at the left. The data are representative for 2 similar experiments. 
parallel. In contrast, secretion of ai-antitrypsin was insensitive to CCCP up to 5 pM. On SDS-
PAGE, ",-antitrypsin secreted in the presence of 5 and 10 ~M CCCP was indistinguishable from 
the protein secreted by control cells (not shown). Simultaneously, CCCP reduced the lipa,e activity 
present in the cell lysate in a concentration-dependent manner (Fig. 4B). With 5 ~M CCCP, 
intracellular lipase activity was similar to the activity in cycloheximide-treated cells. Under all 
conditions, the amount of intracellular HL protein remained below the detection limit of the ELISA. 
The amount of intracellular ",-antitrypsin was not affected by CCCP up to 5 ~M (Fig. 4B), and 
paraHelled the effect on overall protein synthesis. Intracellular ai-antitrypsin consisted of the 
49 kDa, Endo H sensitive and the 54 kDa, Endo H resistant protein band also seen in control cells 
(cf. Fig. 3B); the relative amount of the Endo H resistant band diminished when CCCP was 
increased from 5 to 10 11M. The 51 kDn protein band present in CSP- and MdN-treated cells was 
not observed in CCCP-treated cells. 
When HepG2 cells were incubated with 10 ~M monensin or 0.2 ~g/rnl BFA, secretion of 
HL activity was reduced to levels well below that observed with cycloheximide (Table I). The 
amount of HL protein in the extracellular medium was reduced in parallel. Simultaneously, 
secretion of newly synthesized ai-antitrypsin was almost completely blocked by monensin and BFA 
(not shown). In contrast to cycloheximide, the intracellular lipase activity markedly increased upon 
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Figure 4 Effect of CCCP on expression of HL and ct.-antitrypsin. 
HepG2 cells were incubated for 6 h in the presence of different concentrations of CCCP. Thereafter, the lipase activity 
(e) and amount of HL protein (0) and 3SS_1abeUed ",-antitrypsin (.) were measured in the extracellular medium (A) 
and celllysates (8). Data represent mean ± SEM for 3 independent experiments, except for the amount ofHL protein 
which was measured in I experiment. Data on HL activity are expressed as a percentage of control (0.66 ± 0.08 mU/ml); 
similarly, data on radio-activity in "I-antitrypsin (expressed in arbitrary units) are given as percentage of control. 
Table I Effect of monensin and brefeldin·A on expression of HL. 
Treatment: none cycloheximide monensin brefeldin·A 
(20 ~g/mi) (10 ~M) (0.2 ~g/ml) 
Secretion 
HL activity (mu/mi) 0.92± 0.09 0.37 ± 0.03' 0.27 ±0.02' 0.19 ± 0.02' 
HL protein (ng/ml) 13.1 <5 <5 <5 
Intracellular lipase 
Activity (mU/mi) U6 ± 0.18 0.89 ± 0.11" 1.54±0.15' 1.95 ±0.12" 
HL protein (ng/ml) <5 <5 6.4 8.8 
Overall protein synthesis 
(% of control) 100 11.2 ± 3.6' 97.8 ± 3.8 74.7 ± 11.3" 
HepG2 cells were incubated for 6-8 h with or without inhibitors in the presence of heparin. Then, cell-free media and 
celllysates were prepared for analysis of HL and lipase activity. In parallel incubations, the effect of the inhibitors on 
overall protein synthesis was determined by eSS]methionine incorporation into TeA-precipitable material. Data are 
expressed as mean ± SEM for 3-5 independent experiments. a : statistically significant difference from 
controls (p < 0.05). 
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incubation with monensin or BFA (fable I). Immunoinhibition with anti-HL IgGs showed that this 
increase occurred exclusively in the irnmunosensitive fraction (not shown), In addition, the amount 
of HL protein was also elevated to levels well above the detection limit of the ELISA (Table I). 
Overall protein de novo synthesis was not affected by monensin, whereas it was reduced 
approximately 25% by BFA. With both agents, ai-antitrypsin accumulated intracellularly as a 
49 kDa protein; the 54 kDa, Endo H resistant form was absent. The 49 kDa protein from monensin-
treated cells was completely Endo H sensitive whereas the protein from BFA-treated cells was 
partly Endo H resistant (not shown). 
Combined effect of brefeldin A and glycosylation inhibitors. 
When co-incubated with 0.2 ]lg/ml BFA, CSP (100 ]lglml) and MdN (I mM) were no longer able 
to reduce intracellular lipase activity in HepG2 cells (Table II). Instead, intracellular lipase activity 
increased upon incubation with BFA whether or not CSP or MdN were present. By ELISA, similar 
results were found for intracellular HL protein (not shown). The BFA-induced inhibition of HL 
secretion (Table II) and a I-antitrypsin secretion were not affected by co-incubation with the 
glycosylation inhibitors. With CSP or MdN, however, the intracellnlar appearance of the additional 
51 kDa form of u,-antitJypsin was observed both in the absence and presence of BFA (not shown). 
This observation suggests that the glucosidase inhibitors were still effective in the presence of BFA. 
Nevertheless, their inhibitory effect on intracellular HL activity was overcome by co-incubation 
with BFA. 
Table II 
Effect of co-incubation of glycosyiatioll inhibitors and bl'efeldill A on IlL expression. 
Treatment -BFA +BFA -BFA +BFA 
none 0.23 ±0.05 0.36 ± 0.08 1.28 ± 0.15 0.26 ±0.06 
tunicamycin 0.18 ± 0.07' 0.33 ±O.IO 0.60 ± 0.18' 0.26 ±0.09 
(10 ]lg/ml) 
castanospermine 0.17 ± 0.06' 0.32 ± 0.09 0.47 ± 0.07' 0.20±0.1O 
(100 ]lglml) 
methyJdeoxynojirimycin 0.17 ± 0.06' 0.36 ± 0.09 0.65 ± 0.18' 0.22 ± 0.08 
(lrnM) 
Hep02 cells were incubated for 6-8 h in the presence of heparin without or with brefeldin-A (0.2 fJg/ml) and 
glycosylation inhibitors. At the end of the incubation, celllysates and cell-free media were prepared for analysis of 
lriglyceridase activity. Data are expressed as mean ± SEM for 3-5 independent experiments. a: statistically significant 
difference from the controls incubated without glycosylalion inhibitor (p < 0.05). 
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Activation of HL during the secretion process. 
We noted a discrepancy between the HL activity secreted by HepG2 cells in the absence of protein 
de novo synthesis and the concurrent disappearance of lipase activity from the cells (Fig. lA and 
B). To examine this in more detail, we first incubated cells for 6-8 h without or with BFA or 
monensin in the presence of heparin. After removing the extracellular medium, the cells were re-
incubated overnight but now in the presence of cycloheximide. As shown in figure 5, the 
intracellular lipase activity of the control cells fell by about 0.06 mUlwell while the extracellular 
HL activity increased to 0.50 mU/well despite the absence of protein de novo synthesis, suggesting 
that HI... is activated during the secretion process. In seven similar experiments, this apparent 
activation was by a factor 7.8 ± 0.8 (mean ± SEM). Inhibition of secretion by BFA and monensin 
was at least partly reversible. Upon their removal from the medium, secretion of HL activity 
resumed even in the presence of cycloheximide. Now, the HL activity secreted by the BFA-
pretreated cells in the presence of cycloheximide was similar to the concomitant fall in intracellular 
lipase activity. In six such experiments the apparent activation factor was 1.3 ± 0.2 for BFA-treated 
cells, whereas 1.9 was found in an experiment with monensin-treated cells. Hence, the apparent 
activation of HL that nommlly occurs during the secretory process has already taken place in BFA-
and monensin-treated cells. 
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Figure 5 Activation of HL during 
secretion in the absence of protein de 
novo synthesis. 
HepG2 cells were pre-incubated for 6 h with 25 Vlml 
heparin in the absence (control) or presence of 
0.2 pglml brefeldin A (BFA) or 10 pM monensin 
(Man). Per treatment group, 2 wells were 
immediately harvested for measurement of 
intracellular lipase activity (left, open bars). Two 
other wells were washed free of inhibitor with PBS 
(room temperature). and incubation was continued 
overnight in fresh medium containing heparin and 
20 Ilglml of cycloheximide to prevent additional HL 
de novo synthesis. Thereafter, media and cells were 
harvested. Lipase activity was determined in the cell 
Iysates (middle, shaded bars) and the difference with 
the activity measured in the cells before the overnight 
incubation with cycloheximide was calculated 
(middle, dark bars). TIlls difference was compared 
with the HL activity that was secreted into the 
extracellular medium during the overnight incubation 
with cycloheximide (right, shaded bars). TIlC data for 
the duplicate incubations were averaged. The 
numbers above the bars indicate the ratio of secreted 
actiVity to the decrease in intracellular activity, and 
reflect the apparent activation of HL during 
secretion. 
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DISCUSSION 
Previous studies using CHO cells transfected with HL eDNA constructs have demonstrated that 
N-linked glycosylation of rat and human HL is essential for secretion of a catalytically active protein 
by these cells (14, IS). Removal of the N-glycosylation sites from rat HL cDNA results in the 
secretion of a smaJi amount of fuHy active enzyme in the Xenopus oocyte system, indicating that 
N-glycosylation is not necessary for catalytic activity per se, but rather for proper intracellular 
trafficking of newly synthesized protein (19). Here, we show for the first time that secretion and 
intracellular activation of endogenous HL by HepG2 cells not only require N-glycosylation but also 
glucose trirmning of the N-linked oligosaccharide chains by RER glucosidases. In this respect 
human HL behaves similarly to rat HL (17, 20), but differently from a number of other 
N-glycoproteins including ",-antitrypsin (Fig. 2) (34, 3S). Glucose trimming by RER glucosidases 
I and II has been implicated in the quality control system of the secretory pathway, which prevents 
mal folded or unassembled glycoproteins from leaving the RER for the Golgi (22, 23). In this model, 
glycoproteins bearing terminal glucose residues associate with the molecular chaperone calnexin, 
which assists in the folding process (22, 36, 37). Our observations suggest that the glucose trimming 
of newly synthesized HL protein is necessary for folding into a transport~competent form. In the 
presence of the glucosidase inhibitors CSP and MdN, or in the absence ofN-glycosylation, only a 
small fraction of newly synthesized HL, if any, is properly folded and subsequently transported to 
the Golgi and beyond. 
Why HL trafficking depends so much more on glucose trimming than ai-antitrypsin remains 
unclear. Unlike fll.... secretion of ai-antitrypsin was unaffected by CSP or MdN. In the presence of 
these inhibitors. maturation of ai-antitrypsin proceeded through a distinct intracellular intermediate 
of SI kDa (Fig. 3B) (34). Despite inhibition of the RER glucosidases, ",-antitrypsin appeared to be 
normally deglucosylated and further processed to an Endo H resistant form. In HepG2 cells. 
removal of gJucosylated man nose from oligosaccharides has been shown to occur through an 
endo-a-D-mannosidase present in the Golgi, thereby providing an alternate processing route for 
arantitrypsin and several other N-glycoproteins (35, 38). Utilization of this alternate route requires 
that these glycoproteins are transported from the RER to the Golgi. Apparently, the Golgi 
endo-mannosidase is not accessible to fll... protein in CSP- and MdN-treated HepG2 cells, probably 
because the presence of terminal glucose residues prevents fll... protein but not urantitrypsin from 
leaving the RER. Perhaps. ai-antitrypsin folds into a transport-competent form without the help of 
calnexins. Compared to ai-antitrypsin, the maturation of HL was also much more sensitive to 
inhibition by CCCP (Fig. 4), an H+-ionophore and mitochondrial uncoupleI'. This observation may 
indicate that folding of Ill... into a transport-competent structure requires some additional pH or ATP 
dependent steps. Alternatively, proper folding of HL may require assembly into an oligomeric form 
in contrast to the monomeric ai-antitrypsin. In tltis respect. it is noteworthy that human and rat HL 
behave like multimeric proteins on gel-filtration (39, 40). 
Our data suggest that human HL acquires catalytic activity during maturation in the secretory 
pathway. In the HepG2 cells, the enzyme activity of HL increased S-IO fold upon secretion, which 
is similar to the activation seen with rat HL (20). Several lines of evidence suggest that this apparent 
activation occurs in the cis- to medial-Golgi region. First, when HL protein is retained within the 
RER, either by treating the cells with the glucosidase inhibitors CSP or MdN (Fig. 2), or with CCCP 
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(Fig. 4), intracellular HL activity decreases compared to untreated cells although protein de novo 
synthesis is hardly affected. Secondly, the apparent activation has already occurred in cells treated 
with monensin which inhibits intra-Golgi transport (Fig. 6). Thirdly, when the contents of the Golgi-
stacks are transp0l1ed back into the RER by treating the cells with BFA, the effect ofCSP and MdN 
on intracellular activation of HL is completely reversed (Table 1I). How HL is modified in the 
cis-to-medial Goigi remains unknown. Unfortunately, our anti-human HL preparations did not allow 
reliable immunoprecipation from HepG2 celllysates and hence, analysis of the glycosylation state 
of HL in monensin- or BFA-treated cells could not be performed. It is unlikely, however. that 
trinuning of mannose residues by Golgi mannosidase I itself is the mechanism of activation, since 
in situ inhibition of this process by dMM has no effect on the intracellular activation of HL. 
The effects of the glucosidase and vesicle transport inhibitors reported here are best 
explained by a model in which glucose trimming of HL in the RER is necessary for transport to the 
Goigi where activation occurs. For LPL, which is closely related to HL, glucose trimming in the 
RER is also necessary for the acquisition of lipase activity (41-43). Whereas HL is fully active as 
a monomer (44), LPL must form a homodimer in order to become catalytically active towards 
emulsified substrates (45-47). A recent study showed that LPL could dimerize in the RER without 
acquiring catalytic activity (48, 49). Similar to HL, glucose trimming in the RER may therefore be 
a prerequisite for translocation of LPL to the Golgi, and hence for secretion of an active 
protein (42, 48). More detailed studies are necessary to elucidate the activating principle for HL as 
well as LPL protein within the Golgi. 
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Intracellular activation of hepatic lipase in rat hepatocytes requires 
transport to the Golgi compartment. 
Adrie J.M. Verhoeven, Bernadette P. Neve and Hans Jansen 
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5.2 INTRACELLULAR ACTIVATION OF HEPATIC LIPASE IN RAT HEPATOCYTES 
REQUIRES TRANSPORT TO THE GOLGI COMPARTMENT. 
SUMMARY 
Hepatic lipase (HL) is an N-glycoprotein that acquires triglyceridase activity somewhere during 
maturation and secretion. To determine where HL is activated, the effect of drugs that interfere with 
maturation and intracellular transport of HL protein was studied using freshly isolated rat 
hepatocytes. Carbonyl cyanide m-chlorophenyl hydrazone (CCCP), castanospermine, monensin and 
colchicin all inhibited secretion of HL without affecting its specific enzyme activity. Incubation with 
CCCP and castanospermine reduced intracellular HL activity and HL protein, and decreased the 
specific enzyme activity by 25-50%. With moncnsin and colchicin, intracellular HI.. accumulated 
and the specific enzyme activity was increased 2-fold to values similar to secreted HL. Pulse-
labelling with ["Slmethionine demonstrated that HL activity varied in parallel with the 58 kDa, 
endoglycosidase H-resistant HI.. protein in the secretion media, and in lysates of control, CCCP- and 
colchicin-treated cells. In monensin-treated cells, the increase in specific enzyme activity coincided 
with production of a 53 kDa, partly endoglycosidase H-resistant form ofHL. Deoxymannojirimycin-
treated cells secreted a 53 kDa, endoglycosidase H-sensitive HL with a specific enzyme activity 
similar to control HL. We conclude that activation of HL (i) occurs after transport from the 
endoplasmic reticulum to the Golgi compartment, and (ii) does not involve the development of 
cndoglycosidase H resistance. 
INTRODUCTION 
Hepatic lipase (HL) is an extracellular enzyme present in the liver of most vertebrates. The enzyme 
is synthesized and secreted by liver parenchymal cells, and subsequently bound in the space of 
Disse, where it plays an important role in plasma lipoprotein metabolism (1-3). HL hydrolyzes 
phospholipids and triacylglycerols present in high- and intermediate-density lipoproteins, and 
facilitates the hepatic uptake of remnant particles (4-6) and of cholesterol(esters) carried in high-
density lipoproteins (7, 8) is facilitated. In addition, HL may act as a ligand protein for remnant 
binding to the liver (9). In humans, a low HL activity is associated with an increased atherosclerotic 
risk (10, II). When expressed in transgenic mice, human HL was shown to markedly reduce the 
accumulation of aortic cholesterol (12). HL may protect against development of premature 
atherosclerosis by contributing to reverse cholesterol transport and by reducing the number of 
atherogenic renmants in the circulation. Expression ofHL in the liver is under hormonal and dietary 
control, which may be exerted at the level of synthesis, intracellular processing, secretion, 
extracellular binding and internalization of HL. 
When studying the post-translational control of HL expression in suspensions of freshly 
isolated rat hepatocytes, we noted that newly synthesized HL acquires catalytic activity towards 
triacylglycerols somewhere along the secretOIY pathway (13). First, the specific enzyme activity of 
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intracellular HL was 3-5 fold lower than that of secreted HL. Secondly, HL activity secreted by 
hepatocytes in the absence of protein de novo synthesis was 5-fold higher than was accounted for 
by the fall in the intracellular HL activity. Such an apparent activation was also observed for human 
HL in the HepG2 hepatoma cell line (Chapter 5.1). HL is a glycoprotein bearing two (rat) to four 
(human) asparagine-linked glycans (14-16). For the synthesis and secretion of fully active HL, 
N-glycosylation is a prerequisite (17, 18). When glycosylation is prevented, either by tunicamycin 
or by site-directed mutagenesis. inactive HL protein accumulates intracellularly (15, 19). Along the 
secretory pathway, the N-linked oligosaccharide chains are extensively processed. In rat hepatocytes 
treated with castanospermine. a selective RER glucosidase inhibitor preventing secretion of newly 
synthesized HL, inactive HL was present intracellularly; upon removal of the inhibitor, the HL 
protein acquired catalytic activity and was secreted (13). These observations show that newly 
synthesized HL protein becomes catalytically active during oligosaccharide processing after the 
terminal glucose residues have been removed by the glucosidases in the RER, and suggest that 
activation may be intimately linked to the glycosylation state of the HL protein. 
The presence of terminal glucoses on Ill... protein itself may prevent the acquisition of 
catalytic activity. However, the glucose residues on N-glycoproteins have recently been implicated 
in the protein folding and quality control system of the RER, which prevents mal folded proteins 
from reaching the Golgi (20, 21). It is possible therefore, that glucose trimming is only required for 
transp0l1 of the newly synthesized Ill... out of the RER and that activation occurs subsequently in a 
distal compartment of the secretory pathway. In line with this, inhibition of the Golgi mannosidase I 
with I-deoxymannojirimycin has no effect on either activation or secretion of HL in rat hepatocytes 
(13, 18). This suggests that once the glucose residues have been removed, activation and subsequent 
secretion proceed independently of further oligosaccharide processing. 
If glucose trimming in the RER is necessary for activation of HL protein itself rather than 
for transport of newly synthesized Ill... protein out of the RER, one would expect that inhibition of 
the transport process leads to the intracellular accumulation of active Ill... protein. The present study 
was performed to test this possibility. We determined in which intracellular compartment HL 
protein is activated, by using inhibitors that primarily affect vesicular transport in the secretory 
pathway. CCCP, monensin and colchicin inhibit transport of glycoproteins from the RER to the 
Golgi (22, 23), from medial- to trans-Golgi (24) and between the Golgi and the plasmamembrane 
(25,26), respectively. Our data show that active Ill... accumulates in monensin- and in colchicin-
treated hepatocytcs, but not in cells treated with CCCP. Hence, glucose trimming alone does not 
activate HL but is necessary for translocation of HL protein to the Golgi compartment, where the 
protein apparently acquires its triglyceridase activity. 
EXPERIMENTAL PROCEDURES 
J\:laterials 
Carbonyl cyanide IIJ-chlorophcnyl hydrazone (CCCP) and monensin were purchased from Calbiochem 
(La Jolla, CA, U.S.A.), whereas coJchicin was from Merck (Darmstadt, Germany). Castanospermine and 
I-deoxymannojirimycin were from Boehringer Mannhcim (Gennany). Endo H was from Genzyme (Boston, MA, 
U.S.A.). Protease inhibitors were from Sigma (St. Louis, MI, U.S.A.), except for Trasylol which was from Bayer 
(Mijdrecht, Holland). Tran35S-label (1100 Ci/mmole) was obtained from ICN (Costa Mesa, Ca, U.S.A.), and glycerol 
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tri[l-UC]oleate (50-80 mCilmmole) was from Amersham (Amersham, UK). Ham's FlO and methionine-free MEM 
were purchased from Gibco BRL (Breda, Holland), whereas bovine serum was from BioTrading (Wilnis, Holland). 
Heparin was from Leo Pharmaceuticals (\Veesp, Holland). Goat and rabbit anti-HL antisera were raised against rat HL 
purified from liver heparin perfusates according to Jensen & Bensadoun (27); from the antisera partly purified IgO 
fractions were prepared by precipitation in 50% ammonium sulphate followed by 17% Na2S04' as described previously 
(13). Alkaline phosphatase-conjugated goat anti-rabbit IgG was obtained from Tago (Burlingame, CA, U.S.A.), and 
p-nitrophenol phosphate was from Merck. Broad-range protein size markers were from BioRad (Richmond, CA, 
U.S.A.). All other chemicals were from Sigma. Polystyrene 96-well EIA plates (code 3590) were from Costar 
(Cambridge, MA, U.S.A.). 
Hepatocyte isolation and incubation. 
Hepatocytes were isolated from male Wistar rats (200-250 g body weight) by collagenase perfusion: non-parenchymal 
cells -were removed by differential centrifugation (2S). Cell viability was determined by Trypan blue exclusion and 
ranged from S5 to 90%. The cells were suspended at a density of 4xl06 cells/ml in l\1EM containing 25 U/ml of heparin 
and 20% of dialysed, heat-inactivated bovine serum (29). Cell suspensions were incubated at 37nC under an atmosphere 
of 5% CO/95% O2 in a shaking waler balh. The incubations were started with the addition of inhibitors. CCCP, 
monensin and colchicin were added from lOoo-fold stock solutions in ethanol; other inhibitors were added from 100-
fold stocks in PBS. At the times indicated, samples of tile cell suspension were collected on ice. The cells were separated 
from the medium by centrifugation for 5 s at IO OOOg. The cells were washed once in PBS and then resuspended at 
15xI06 celis/illi in a 40 mM NH40H buffer, pH S.I (30) containing 25 UlmI heparin and a cocktail of protease 
inhibitors (I mM EDTA, 10 UlIllI TrasyloI, 0.1 mM benzamidineand 2 )lg/illi each of leu pep tin, antipain, chymostatin 
and pepstatin). After 30 min on ice, the Iysates were sonicated for 15 s on ice (MSE Soniprep 150, amplitude 14 p) and 
centrifuged for 10 min at 10000g and 4"C. The supernatants were used for analysis of intracellular HL. Cell-free media 
and Iysates were rapidly frozen in liquid nitrogen and stored at -sonc until use. 
Hcpalic lipase acliYity. 
HL activity was determined by a triacylglycerol hydrolase assay at pH S.5 in 0.6 M NaCI using a gum acacia stabilized 
glycerol e4C]trioleate emulsion as substrate (18). Assays were performed for 30 min at 30°C. Activities were expressed 
as mU (nmoles of free fatty acids released per min). In a total assay volume of 125 Ill, release of free fatty acids was 
linear with time and sample volume up to 50 IlJ for the cell-free media and 101-'1 for the celilysates. 
In immuno-inhibition assays, 40 )11 of the cell-free media or 10 )11 of the celllysates were pre-incubated for 
I h on ice in a total volume of 501-'1 with either 100 I-'g goat non-immune IgOs or anti-rat HL IgOs. TIlereafter, 75)11 
of substrate was added to the supernatant, and the residual immunoresistant triglyceridase activity wa,> determined. The 
lipase activity in the extracellular media was completely inhibited by anti-HL IgGs whereas 85 to 95% of the lipase 
activity in the cell Iysates \vas sensitive to immuno-inhibition. 
Hepatic lipase mass. 
The amount ofHL protein was detemlined by a solid-phase ELISA in which the antigen was sandwiched between goat 
and rabbit polyclonal anti-HL IgOs. EIA plale wells were coated with 20 I-'g goat anti-HL IgGs. After blocking with 1% 
BSA in PBS, the wells were incubated successively with: (i) sample, either 50 1-11 of cell-free medium or 5 /11 of cell 
lysate; (ii) 3 )1g/ml of rabbit anti-HL IgOs in PBS, and (iii) alkaline phosphatase-conjugated goat anti-rabbit IgG at a 
I: 1500 dilution in PBS. Finally, the presence of alkaline phosphatase was detected with p-nitrophenol phosphate as 
substrate. Color development was stopped with NaOH (I M, final concentration), and the absorbance at 405 nm was 
measured in a Molecular Devices microplate reader. Absorbances were read against a standard curve prepared for each 
plate by serial dilutions of rat HL partly purified from liver heparin perfusates by affinity chromatography on Sepharose-
heparin; HL activity was eluted from the column by a linear salt-gradient and the peak fractions were pooled. After 
adding BSA to a final concentration of 10/0, aliquots were frozen in liquid nitrogen and stored at -sonc until use. 
Pulse-labelling with [MS]mcfliionine. 
Freshly isolated rat hepatocytes were incubated in methionine-free MEM in the presence of inhibitors, as described 
above. After I h, SO ).lei ofTran3sS-Iabel was added per ml of cell suspension, and the incubation was continued for 
another 2 hours. The incubations were Slopped on icc, and the cells and media were separated by centrifugation (5 s, 
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to ooog), The cell-free medium was collected in vials containing cold methionine (final concentration I mM) and the 
cocktail of protease inhibitors described above. After washing twice with cold PBS, the cells were lysed in cold PBS 
containing 1% Triton X-lOO, 1% sodium deoxycholate, 0.25% SDS, 1 mM methionine, 25 U/ml heparin, to mM 
HEPES (pH 7.4) and the cocktail of protease inhibitors. After 30 min on ice, the lysates were centrifuged for 10 min 
at 10 ooog and 4°C, and the supernatants were used for further analysis. 
IOlnlUlloprecipJfafions. 
HL protein was immunoprecipitated from cell-free media and celilysates by overnight incubation at 4°C with 50 J11 of 
a 50% slurry of goat anti-Ill.. IgGs immobilized onto Sepharose (13), The beads were collected by centrifugation (20 s, 
10 OOOg), and washed twice in successively: (i) 1% Triton X-IOO in PBS. (ii) 1 M NaCI in PBS, and (iii) PBS (all 
containing 1 mM PMSF). Finally. the beads were washed once in 50 mM NaPi , pH 6.0. TIle immunoprecipitated 
proteins were released by boiling for 5 min in 50 mM NaPi , pH 6.0 containing 0.5% SDS, and the beads were removed 
by centrifugation. The eluate was diluted in 50 mM NaPi , pH 6.0 to reduce the concentration of SDS to 0.2%. Part of 
the eluate was incubated overnight at 37°C in the presence or absence of 40 mUlml of Endo H. After addition of 
Laemmli's sample buffer and boiling for 5 min, the proteins were separated by SDS-PAGE using 7.5% gels. The gel 
was Coomassie-stained for estimation of molecular sizes, The HS-Iabelled proteins were visualized, and their 
radioactivity was determined, by exposure of the dried gels to a phosphor screen (BioRad GS-393 Molecular Imager 
System, Richmond, CA, U.S, A.), Endo-H sensitivity was indicated by an increase in electrophoretic mobility. 
O\'craH protein de novo synthesis. 
Incorporation of eSSJmethionine into TCA-precipitable material was taken as a measure for overall protein de novo 
synthesis. Incubations were performed as described above. Of the cell-free media and Iysates, 5-IJI aliquots were spotted 
in duplicate onlo Whatman 3MM filters (Whatman, Maidstone, UK), and TCA-precipitation was performed as 
previously described (18). The radioactivity on the filters was measured using the Molecular Imager System, The 
duplicate measurements, which never differed by more than 5%, were a\·eraged. 'Ille data were corrected for the TCA-
precipitable material in the media and Iysates of a control cell suspension that was put on ice before addition of TranHS_ 
label. 
Statistics. 
All data are expressed as means ± S.D, Differences were tested statistically by two--way ANQYA followed by the 
Student-Newman-Keuls test, and considered significant at p<O.05 (31), 
RESULTS 
Efrect of CCCP on HL synthesis and secretion. 
When freshly isolated rat hepatocytes were incubated for 3 h in the presence of heparin, HL activity 
in the celllysates remained almost constant at 4.3 ± 1.3 mU/mI (n=6), which equals 0.27 ± 0.08 
mUII06 cells. During this incubation, HL activity in the extracellular medium increased from 
0.4 ± 0.1 mU/ml to 9.1 ± 2.6 mU/ml. which cOlTesponds to 2.3 ± 0.6 mUll 06 cells. In the presence 
of increasing concentrations of CCCP, the extracellular appearance of HL activity gradually fell 
(Fig. IA). Complete inhibition was obtained with 20 pM CCCP and above. Intracellular HL activity 
decreased to 63 ± 10% (n=3) of controls when cells were incubated with 10 f-tM: CCCP; a further 
increase in the CCCP concentration did not have an additional effect on intracellular HL activity 
To study the effect of CCCP on de novo synthesis of HL protein, r'sS]methionine was included 
during the last hour of incubation. Figure IS shows that CCCP induced a do.se-dependent reduction 
in the J5S-radioactivity of HL protein immunoprecipilated from the media plus lysate (53+58 kDa 
bands; see later). This parallelled the effect of the inhibitor on incorporation of 35S-radioactivity 
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Figure 1 Effect of CCCP on synthesis and secretion of HL. 
Freshly isolated rat hepatocytes were incubated for 2 h in the presence of different concentrations of CCCP. At the end 
ofthe incubation, the HL activity in the cell-free medium (e) and cell Iysates (0) was measured (A). Data are expressed 
as percentage of the activity found for the control incubation, which was 7.2 and 4.3 mU/ml in the cell-free medium and 
ceJllysate, respectively. In parallel incubations, 80/lCi/ml ofTran3sS_label was added after I h of pre-incubation with 
CCCP (B). The incubation was continued for an additional hour and then cell-free media (.) and ceillysates (0) were 
prepared. HL protein was irnmunoprecipitated by overnight incubation with goat anti-HL IgGs coupled to Sepharose. 
The immunoprecipitated proteins were separated by SDS-PAGE and the radioactivity in the immunoreactive bands at 
the 53-58 kDa position in the gels were quantified by phosphor imaging. The sum of the radioactivity in the bands from 
the lysate and cell-free medium was taken as a measure for total synthesis of HL protein ( ..... ). Data are expressed as 
percentage of the radioactivity present in the corresponding bands from control media and lysate. The results are 
representative for 2 similar experiments. 
into TCA-precipitable material, and hence on overall protein synthesis (not shown). With 20 JlM 
CCCP and above, HL and overall protein synthesis were completely blocked. When incubated with 
CCCP up till 10 JlM, ["S]HL in immunoprecipitates from the celllysates was hardly affected, 
whereas ["S]HL in the extracellular media was highly sensitive to inhibition. With 10 JlM of CCCP, 
where HL synthesis was reduced by approximately 30%, the newly synthesized HL protein was no 
longer secreted into the extracellular medium but remained in the cells, in agreement with CCCP 
being an inhibitor of the RER-to-Goigi transp0l1. Therefore, CCCP was llsed at a final concentration 
of 10 JlM in further studies. 
The effect of 10 JlM CCCP on HL expression was compared with that of 100 Jlg/ml of 
castanospcrmine, which inhibits RER-to-Goigi transport of N-glycoproteins by interfering with 
oligosaccharides processing (Table I). After 3 h of incubation, both HL activity and HL protein were 
reduced in the extracellular medium of CCCP-treated cells by approximately 85% compared to 
controls, whereas with castanospermine. both parameters were decreased in parallcl by 65%. The 
specific enzyme activity of secreted HL was about 45 mU/llg, which was not significantly affected 
118 
Chapter 5.2 
by either treatment. Under the conditions used, the specific enzyme activity of HL in the control cell 
Iysates was only 50% of that in the cell-free media. Upon treating the cells with CCCP, the amount 
of intracellular HL protein was hardly affected although simultaneously, HL activity decreased by 
approximately 35% (Table I). Hence, the specific enzyme activity of intracellular HL was 25% 
lower in CCCP-treated cells than in control cells. In the presence of CSP, both HL protein and HL 
activity in the cells were significantly reduced compared to controls, but the effect on HL activity 
was stronger than on HL protein. As a result, the specific enzyme activity of residual HL fell by 
approximately 50%, which was significantly more than with CCCP-treatment (p<0.05; n~4). In 
parallel incubations, the effect of the inhibitors on protein de novo synthesis was determined. 
Incorporation of ["Sjmethionine into total TCA-precipitable material was reduced to 52.5 ± 24.4% 
and 71.2 ± 8.1 % of control by CCCP and CSP, respectively (n~ 3). 
Table I Effect of eastanospermine and CCCP on intracellular and extraeellular HL. 
HL activity HLprotein specific activity 
mUlml % ~g/ml % mU/~g % 
Cell-free media 
control 10.4 ± 1.9 100 0.20± 0.06 100 42.8 ± 8.4 100 
CCCP 1.4 ± 1.1+ 14 0.03 ±0.02 + 15 40.1 ± 15.4 94 
CSP 3.4 ± 0.6+ 33 0.07 ±0.02+ 37 44.5 ± 12.8 104 
Celllysates 
control 4.8 ± 2.1 100 0.22 ±0.07 100 23.1 ± 10.5 100 
CCCP 3.0 ±0.2* 63 0.21 ± 0.10 94 17.7± 1.3* 76 
CSP 1.8 ± 0.5* 36 0.13 ± 0.04* 61 10.9 ± 3.4* 47 
Freshly isolated rat hepatocytes were incubated for 3 h in the presence of heparin without further additions (control), 
or with 10 J1M CCCP or 100 Ilglml caslanospennine (CSP). Then, cell~rrce media and celllysates were assayed for lll. 
activity and HL protein. Data are expressed as mean ± SO for 3-5 independent experiments.* and + : statistically 
significant difference from controllysates and media, respectively (p<O.05). 
Effect of monellsill and colchicin. 
During the first 2 h of incubation, the rat hepatocytes secreted HL activity into the medium at a 
constant rate (Fig. 2A). Upon addition of 50 11M monensin, secretion of HL activity was 
instantaneously and almost completely inhibited. After 2 h, HL activity in the extracellular medium 
was 14 ± 4% (n = 4) of parallel controls. Simultaneously, the intracellular HL activity increased 
linearly with time to 250 ± 44% (n ~ 4) of control cells (Fig. 2B). Under these conditions, 
e5S]methionine incorporation into total protein was 44.2 ± 13.1 % of control (n = 3). Similar results 
were obtained when 50 11M colchicin wa'i added to the cell suspension at the strut of the incubation. 
The secretion rate of HL activity was reduced to 45 ± 9% (Fig. 2A), whereas intracellular HL 
activity gradually increased to 236 ± 34% of controls (n ~ 4) after 2 h of incubation (Fig. 2B). 
Protein de novo synthesis was reduced to 71.7 ± 16.6% of control (n = 3). Immuno-inhibition assays 
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Effect of monensin and colchicin on extracellular and intracellular HL activity. 
Freshly isolated rat hepatocyles were incubated in the absence (e) or presence of 50 JlM monensin (_) or 50 JlM 
colchicin (A.). At the indicated times, aliquots oflhe cell suspension were collected from the incubation. and HL activity 
was measured in the cell-free media (A) and celllysates (D). Data are representative for 2 similar experiments. 
using anti-HL IgGs confimled that HL was responsible for the observed changes in intracellular and 
secreted triglyceridase activity (data not shown). 
After 2 h of incubation with monensin or colchicin, the amount of HL protein in the 
extracellular medium was reduced in parallel with HL activity, as was also observed for 
castanospermine and CCCP (Fig. 3A). In the cell Iysates, the amount of HL protein increased to 
136 ± 21% and 137 ± 22% of control values (n = 4) with monensin and colchicin, respectively (Fig. 
3B). These increases in intracellular HL protein were significantly less than the concomitant change 
In intracellular HL activity (p<O.05; n == 4). As a result, the specific enzyme activity of intracellular 
Ill.. was increased with both inhibitors. 
Specific triglycel'idase activity of HL. 
The effects of the different agents on the specific enzyme activity of HL are summarized in 
figure 3C. Under all conditions, the specific enzyme activity of secreted HL remained constant at 
approximately 45 mU//1g HL. For intracellular HL, the specific enzyme activity was much lower 
than for secreted lIL, which was further reduced by 25 % and 50% upon treating the cells with 
CCCP and castanospermine, respectively. In monensin- and colchicin-treatcd cells, the specific 
activity was increased to levels close to that of secreted HL. In the presence of 1 ruM: 
I-deoxymannojirimycin, an inhibitor of Goigi mannosidase I, neither secretion of Ill.. (Fig. 3A) nor 
intracellular HL (Fig. 3B) were altered. Hence, the specific enzyme activity of intracellular and 
secreted HL was not affected by incubation with 1-deoxymannojirimycin (Fig. 3C), although the 
120 
A 
_100 
~ 
8 
'5 
e!. 50 
..J 
:I: 
* 
o CON CSP CCCP MON COL DMM 
c 
Inhibitor 
Chapfer5.2 
B 
* 
* 
* 
* 
* 
* 
o CON CSP CCCP MON COL DMM 
Figure 3 Effect of various inhibitors on 
intracellular and extracellular HL activity 
and amount of HL protein. 
Hepatocytc.s were incubated for 3 h in the absence 
(CON) or presence of 100 J-Ig/ml caslanospccmine (CSP), 
10 J-IM CCCP, 50 pM monensin (MON), 50 11M 
colchicin (COL) or I mM l-deoxymannojirimycin 
(D1vfM). At the end of the incubation, cell-free media (A) 
and cclllysates CD) were prepared and HL activity (open 
bars) and the amount ofHL protein (hatched bars) were 
measured. Data are means ± SD for 3-6 experiments and 
are expressed as percentage of control (8.8 ± 3.0 mU/ml 
and 4.3 ± 1.3 mU/ml for secreted and intracellular HL 
activity, and 0.19 ± 0.05 and 0.18 ± 0.03 J-Iglml for 
secreted and intracellular HL protein, respectively). 
Statistically significant differences from the 
corresponding controls are indicated by asterisks (p < 
0.05). (C): Specific enzyme activity of HL in the 
extracellular medium (gray bars) and cell lysate (closed 
bars) was calculated from the mean HL activity and HL 
protein found for each condition in the medium and cell 
lysate, respectively. 
glycosylation state of mature HL was altered from the complex into the high-mannose type (see 
later), Taken together, these observations suggest that the catalytic activity of HL increases after its 
transport from the RER to the Golgi compartment. 
inlll1UIlOpl'ecipitation of "S·labelled HL. 
Hepatocytes were incubated for 3 h with the vnrious inhibitors, and r5S]methionine was present 
during the last 2 h. HL protein was immunoprecipitated from the celllysates and cell-free media, 
and then analyzed by SDS·PAGE and phosphor imaging. ["S]HL from control media migrated as 
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a single band of approximately 58 kDa (Fig. 4A). The "S-labelled HL secreted by CCCP- and 
colchicin-treated cells also migrated at the position of 58 kDa, although the radioactivity in this band 
was reduced to 35 and 17% of control, respectively. In the presence of monensin, secretion of 
eSS]HL was decreased to 3 % of control, and the radioactive band migrated at a slightly higher 
mobility than the 58 kDa band in the other secretion media (Fig. 4A). ["S]HL immunoprecipitated 
from controllysates appeared as two bands on SDS-PAGE, a band of approximately 53 kDa, and 
a band of 58 kDa that co-migrated with ["S]HL from the cell-free media (Fig. 4B). Thc total 
35S-radioactivity in HL immunoprecipitated from CCCP-treated cells was similar to control cells, 
whereas in monensin- and colchicin-treated cells total 35S-labelled HL was 2- to 2.5 fold higher. 
Total 35S-radioactivity in HL from media plus celilysates was reduced by approximately 50% with 
all four inhibitors compared to control, which agrees to the observed partial inhibition of protein de 
novo synthesis. In lysates prepared from CCCP-treated cclls, the radioactivity of the 53 kDa band 
was increased whereas that of the 58 kDa band was increased (Fig. 4B). In colchicin-treated cells, 
the 35S-label in the 53 kDa and 58 kDa bands were increased in parallel. In contrast, the 
accumulation of C5S]HL radioactivity in the monensin-treated cells only occurred in the 53 kDa 
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Figure 4 Effect of various inhibitors on the electrophoretic mobility of HL. 
Cells were incubated for 3 h in the absence (CON) or presence of 10 11M CCCP ~CCP), 50 11M monensin (MON) or 
50 11M colchicin (COL). During the last 2 h of the incubation, 80 p.Cilml ofTran 5S-label was present. At the cnd of 
the incubation, HL protein was inununoprecipitated from the cell-free media and celllysates, and then analysed by SDS-
PAGE and phospor imaging. The radioactivity in the immunoreactive bands was quantified. (A) and (B) show part of 
the phosphor image and the quantitative results for the cell-free media and cell lysates. respectively. The positions of 
the 58 kDa and 53 kDa bands are indicated. (B) Quantitative data for the 58 kDa and 53 kDa bands are given as upward 
and downward bars, respectively. TIle results are representative for 3 similar experiments. 
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band; in addition, the largest band rnigrated at a mobility that was slightly higher than the 
58 kDa band found in the other cells. Comparison of the data in figure 4 with the effect of the 
inhibitors on intraceHular and secreted HL activity indicated that HL activity varied in parallel with 
the expression of the 58 kDa protein fOnTI, except for the monensin-treated cells, where intracellular 
HL activity increased in parallel with the 53 kDa protein form. 
Sensitivity to Endoglycosidase H. 
The electrophoretic mobility of ["S]HL secreted in the absence or presence of CCCP, monensin or 
colchicin was not affected by overnight incubation with Endo H (Fig. SA). Hence, secreted HL was 
completely Endo H resistant. As a reference, we used e5S]Ill.. that was secreted by cells in the 
presence of I-deoxymannojirimycin, which prevents the maturation of the N-glycans from 
high-mannose to complex-type. This HL migrated as a single 53 kDa band, the mobility of which 
was almost completely shifted to 47 kDa cOl1esponding to deglycosylated HL upon digestion with 
Eudo H (Fig. SA). Of the two HL bands immunoprecipitated from control celllysates, the 58 kDa 
band was Endo H resistant whereas the 53 kDa band was sensitive to Endo H (Fig. 5B). Upon 
digestion, the 53 kDa band was completely shifted to a higher mobility, partly to the position of 
47 kDa, and partly to the position of a 51 kDa band. The mobility of the latter band was not altered 
upon prolonged incubation with extra Eodo H (not shown), and may reflect HL with one Endo H 
resistant and one Endo H sensitive oligosaccharide. Similar results were obtained with es-S]I-IL in 
lysates from CCCP- and colchicin-treated cells. With moncnsin-treated cells, however, prut of the 
es-S]IIL migrating at the 53 kDa position was not shifted to a higher mobility upon digestion with 
Endo H and thus appeared to be Endo H resistant. These data suggest that the accuIllulation of 
intracellular HL activity observed in monensin-treated cells coincides with the production of a 
53 kDa, mainly Endo H resistant form of HL. 
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Figure 5 Effect of various inhibitors on the 
Endo H sensitivity of HL. 
Experiments were performed as described in the legends 
to figure 4, except that prior to electrophoretic 
separation, the immunoprecipitated proteins were 
incubated ovcrnight at 37 °C without (-) or with (+) 
Endo H. As a positive control for Endo H activity, 
a secretion medium from a 3 h incubation of rat 
hepatocytes with 1 ruM I-deoxymannojirimycin (DMM) 
was included. (A) and (B) Phosphor images of the gels 
obtained with cell Iysates and cell-free media, 
respectively. The positions of the 58 kDa and 53 kDa 
HL protein forms, as well as the 47 kDa, degJycosylated 
form arc indicated. Data are representative for 2 similar 
experiments. 
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DISCUSSION 
The data presented here confinn our previous report that newly synthesized HL protein is apparently 
activated during maturation and secretion in rat hepatocytes (13). This was also observed for human 
HL in human HepG2 cells (Chapter 5.1). This activation was prevented by treating the cells with 
inhibitors ofRER glucosidases, which interfere with proper oligosaccharide processing of the newly 
synthesized HL (13). Upon incubation with castanospermine the specific enzyme activity of 
intracellular HL decreased, which may suggest that activation is closely coupled to glucose 
trimming in the RER. However, we show here that a fall in the specific activity of intracellular HL 
was also induced with CCCP, which interfere.';; with transp0l1 of glycoproteins out of the RER to the 
Golgi, but leaves oligosaccharide processing in the RER essentially unaffected. Hence, glucose 
trimming alone appears not to be sufficient for activation of HL, but is necessary for transport of 
HL out of the RER; HL then matures into a catalytically active protein in a vesicular compartment 
distal from the RER. The RER glucosidases have heen recently proposed to assist in the folding of 
newly synthesized glycoproteins thereby making them transport-competent (20). In contrast to 
CCCP and castanospennine, a marked increase in the specific enzyme activity of intracellular HL 
was induced by treating the cells with monensin, which interferes with intra-Golgi vesicular 
transport (24), as well as with colchicin, which interferes with post-Golgi transport in rat 
hepatocytes (25, 26). This finding clearly demonstrates that HL has acquired full catalytic activity 
when accumulating in the Golgi compartment. Our data are best explained by the model that newly 
synthesized HL must reach the Golgi before it is activated. 
Lipoprotein lipase, which is closely related to hepatic lipase, has also been shown to acquire 
catalytic activity after the glucose residues of the glycan side chains have been removed. Studies 
with CCCP and monensin in mouse brown fat adipocytes (32) and 3T3-L1 adipocytes (33) led to 
the conclusion that LPL is activated after transport of the protein from the RER into the Golgi. This 
was supp0l1ed by the observation that incubation of adipocytes with brefeldin-A, which induces the 
fusion of the RER with the Golgi compartment, results in the intracellular accumulation of fully 
active LPL (32). In our studies using freshly isolated rat hepatocytes, maturation and secretion of 
HL was not affected by BFA (data not shown), possibly due to the rapid detoxification of the drug 
by these cells (34). In HepG2 cells, BFA induced the intracellular accumulation of catalytically 
active HL (Chapter 5.1); moreover, the inactive HL that accumulated in castanospermine-treatcd 
HepG2 cells was converted to fully active HL upon co-incubation with BFA (Chapter 5.1). These 
combined data suggest that both HL and LPL require transport to the Golgi-compartment to become 
catalytically active. In contrast, Ben-Zeev et al. (35) reported that LPL accumulated intracellularly 
as a fully active enzyme when expressed as a hybrid with a C-terminal KDEL sequence. As this 
sequence was thought to function as an RER retention signal, the authors concluded that activation 
of LPL does occur before the protein reaches the Golgi-compartment. Recent studies have 
demonstrated, however. that the KDEL sequence functions rather as a retrieval signal; 
KDEL-bearing proteins are cycled back into the RER from the Golgi or even heyond (36-38). 
Therefore, the catalytically active LPL-KDEL hybrid that accumulates in the RER may have been 
activated in the Golgi before being cycled back into the RER. 
Our data indicate that catalytic activity co-varies with the presence of the 58 kDa, Endo H 
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resistant form of HL in CCCP and colchicin-treated cells, and with the 53 kDa, mainly Endo H 
resistant form in monensin-treated cells. N-glycoproteins are processed from an Endo H sensitive 
into an Bodo H resistant form upon trimming of mannose residues by Goigi mannosidases. These 
observations suggest therefore, that the activation of HL is closely Hnked to, or occurs only after, 
some of the rnannoscs on the glycan chains have been trimmed off by the Goigi mannosidases. 
However, cells incubated with l-deoxymannojirimycin secrete a 53 kDa, fully Endo H sensitive 
form ofHL whose specific enzyme activity is virtually identical to that of control HL (Fig 3; (18)). 
Therefore, trimming of the oligosaccharides on HL by the Golgi mannosidases is not crucial for the 
acquisition of triglyceridase activity. Which modification of HL is associated with the activation 
process remains unknown at present. The necessity to exit the RER 1n order to become activated is 
not unique to lipases, but has recently also been reported for two membrane-bound N-glycoproteins, 
the macrophage mannose receptor (39) and the trans-Golgi network protease furin (40). The 
modification that causes activation of these proteins has also not been identified, but was shown not 
to depend on oligosaccharide processing. It Olay involve a rather subtle covalent or non-covalent 
modification not detected by the rather course methods of SDS-PAGE and Endo H digestion. 
Alternatively, transport of the newly synthesized proteins out ofthe RER will move them away from 
the numerous RER chaperones that may block their full activation. 
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6 GENERAL DISCUSSION 
Post·transcriptionall'egulation of HL 
The studies described in this thesis focussed on regulation of HL expression in liver at the post-
transcriptional level. In chapter 2 we describe the effects of catecholamines on the synthesis and 
processing of HL. In rat liver parenchymal cells an Endo H sensitive, 53 kDa precursor of HL is 
synthesized. This protein matures into an Endo H resistant 58 kDa HL, which is active and rapidly 
secreted. As we were interested in the post-transcriptional regulation of HL expression, we studied 
the short·term effects of adrenaline. In freshly isolated rat hepatocytes, the de novo synthesis of the 
53 kDa Endo H sensitive HL precursor form was unaffected by adrenaline. Thus, HL expression 
was mainly modulated post-translationally. HL transcription andlor translation may be affected after 
long-term exposure to adrenaline, but this was not determined here. Pulse-chase experiments 
showed that adrenaline inhibited the secretion of HL by retarding the maturation of the 53 kDa HL 
precursor into the active 58 kDa protein. Further, adrenaline stimulated degradation of newly 
synthesized HL protein. The effect of adrenaline on HL secretion was mediated by the 
alB-adrenergic receptor pathway. Although alB-adrenoceptors signal via an increase in intracellular 
cAMP and calcium, only calcium mobilization could mimic the effects of adrenaline. In particular, 
calcium levels in the ER seemed to mediate the altered maturation of HL in the presence of 
adrenaline. The sequence of events that leads to degradation of the HL protein is still unclear. 
However, incubation with adrenaline and the protease inhibitor ALLN resulted in a relative 
accumulation of the 53 kDa I-IL. suggesting that mainly the 53 kDa protein is degraded in the 
presence of adrenaline. The specific enzyme activity of the secreted HL was similar in adrcnaline-
treated and control ccUs, and the apparent molecular weight of the secreted HL on SDS· PAGE 
seemed unaltered, indicating that the post-transcriptional regulation is not mediated by gross 
changes in the state of glycosylation. Our data suggest that adrenaline primarily affects exit of HL 
from the ER, and that the stimulated degradation of HL occurs by an ALLN sensitive proteases, 
which may reside in the ER (1·4). 
Besides regulation at the level of exit from the ER, we have identified two other sites of 
post-transcriptional regulation of HL expression. First, the translation efficiency of HL mRNA may 
be (indirectly) modulated by thyroid hormone. Studies with hypothyroid rats showed that 
substitution with growth hormone normalizes HL mRNA levels, but fail to restore HL de novo 
synthesis. Apparently, translation ofHL mRNA is rate-limiting in a hypothyroid state. Second, HL 
tumover may be affected by fenofibrate. The HL activity in liver homogenates of fenofibrate-lreated 
rats was only 25% reduced, despite a 75% fall in HL secretion by isolated hepatocytes. The tumover 
of HL may be decreased by changes in HL binding characteristics, intemalization andlor subsequent 
intracellular degradation. 
In figure I, the modulation of HL expression by adrenaline, thyroid hormone, growth 
hormone and fenofibrate are sununarized. Although we hypothesized that N-glycosylation of HL 
may be involved in (post-)translational regulation (Chapter 1.1.4), we have not encountered any 
condition of altered HL expression that co-incides with gross changes in glycosylation of secreted 
HL. Moreover, we have not encountered any condition in which the specific enzyme activity of 
secreted HL was altered. 
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In vivo, HL expression is determined by many factors. One aspect is the efficacy of adrenaline, 
which is modulated in the rat. The effect of adrenaline on lll., secretion by freshly isolated rat 
hepatocytes is mediated via the alB-adrenergic receptor pathway (Chapter 2.2). In rats, second 
messenger signalling of the u,-adrenoceptor pathway changes during aging. Both the cAMP 
generation and the increase of intracellular calcium, which mediates the effects on HL expression, 
are lowered during aging (5, 6). Other hormones may also interfere with the signal1ing induced by 
catccholamines. For example, EGF abolishes the effect of adrenaline on Ill., secretion in rat 
hepatocyles, probably by disrupting signalling (7). Further. changes in thyroid slatus were reporled 
to be associated with a reduction of a-adrenergic receptors in rats (8). 
Besides catccholarnines, which lower HL expression, the positive effects of insulin on Ifl... 
may contribute to the daily changes associated with feeding and fasting. However, only chronic 
insulin administration to rats increases HL activity in liver (9). Incubation of freshly isolated rat 
hepatocytes with insulin had no clear effects, both an increase and slight decrease in secretion of HL 
activity were reported (10, 11). In humans, insuline may increase Ill., expression, as in non-insulin-
dependent diabetic patients Ill., positively correlates with insulin levels (12-14). In addition, in 
nonnolipidemic male patients with coronary artery disease (REGRESS), which were divided in 
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quartiles based on plasma insuline, HL activity was increased at higher insuline concentrations. In 
the carriers of a novel mutation in the human HL promotor region, C-480T was no correlation 
between HL activity and insuline (15). 
Whether HL activity in humans also follows a cycle of high and low activity during fasting 
and feeding is not clear. There is little day-to·day variations in fasting HL activity levels (13). 
Schlierfet al (16) reported median values of368 mU/ml for postprandial and 261 mUlml for fasting 
HL activity. The difference in HL activity was not statistically significant, which might be due to 
the large variances between individuals. Whether in humans prolonged exposure to adrenaline, for 
instance during mental stress, causes decreased HL synthesis and secretion is not known. Adrenaline 
may contribute to the development and/or complications of arteriosclerosis (l7). Post-translational 
inhibition of HL expression by adrenaline may contribute to the correlation between adrenaline and 
arteriosclerosis. 
Regulation of HL in liver has many similar features as regulation of LPL expression in 
white adipose tissue, but differs on several essential points. The down-regulating effect of 
adrenaline on HL is mediated by u,-adrenoceptors (Chapter 2), and that on LPL is mediated by 
p-adrenergic receptors (18). We showed that adrenaline had no short term effects on HL translation 
and synthesis (Chapter 2.1), whereas adrenaline acutely affects the translation of LPL mRNA (19). 
Adrenaline increases the intracellular degradation of HL (Chapter 2.1), but decreases the 
degradation of LPL (20). Further, opposite regulation of HL and LPL expression was described for 
thyroid hormone. Down-regulation of HL during hypothyroidism involves impaired transcription, 
which resulted from a concomitant fall in growth hormone. Hypothyroidism may impair the 
translation of HL mRNA (Chapter 3). On the other hand, LPL mRNA translation is stimulated 
during hypothyroidism (21). For LPL the involvement of a translation repressor was suggested in 
acute down-regulation of LPL expression by adrenaline and in up-regUlation of LPL mRNA 
translation during hypothyroidism (19, 21). 
Glycosylation of HL 
We have studied several conditions where HL expression is regulated post-transcriptionally, but 
have not encountered a condition where regulation is primarily at the level of N-glycosylation. For 
human and rat HL, we and others have established that the N-glycosyJation is essential for 
maturation and activatioll of the de novo synthesized HL protein. In chapter 5, we have presented 
evidence that glucose trinulling of HL at the ER is necessary for the translocation from the ER to 
the Golgi, whereafter the proteill acquires its triglyceridase activity in the Golgi and is secreted into 
the extracellular medium. Once arrived in the Golgi, further processing of the glycan chains is not 
important for secretion of an active protein. No changes in specific activity of the secreted HL 
protein were found, suggesting that alternative processing of the glycosyJation chain, which change 
the specific enzyme activity are unlikely. 
The imp0l1ance of the intracellular pathway is underlined by the C/(UC/d syndrome in mouse. 
In these mice functional expression of LPL and HL is deficient, and both proteins remain 
intracellularly, mainly in the rough ER (22-24). Several groups have hypothesized that impaired 
transport or maturation of Ill., and LPL may originate from a dysfunctional, lipase specific 
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chaperone. Accumulation of LPL and HL in the ER of the cld/cld mouse cells may result from a 
missing chaperone that normally assists transp0l1 out of the ER into the Goigi. Altematively. an 
ER-chaperone might fail to release LPL and HL. 
A human cQunterpa11 of the mouse cld/c/d syndrome might exist. A family with combined 
reduction of LPL and HL has been described by Auwerx et al (25). The presence of both low HL 
and low LPL activity has also been reported for some isolated cases (26, 27), In the REGRESS 
population, from the 812 nonnolipidemic patients, suffering from coronary artery disease we found 
60 individuals (7.4%). which have both LPL and HL activities amount to less than 50% of matched 
controls. Furthermore, 6 out of 35 patients admitted to the cardiology department of the academic 
hospital in Rotterdam for angiography had both low LPL and HL activity (42 ± 13, 160 ± 39 
mU/ml). Combined lipase reduction in patients may originate from different complex factors. 
Patients may have accumulated mutations in both LPL and HL genes. However, the number of HL 
mutations, which intetfere with HL activity described so far is low (28, 29). The patients found with 
combined lipase reduction appears to be much higher than would be expected statistically. This 
suggests the involvement of common factors, presently unknown, which reduce expression of HL 
in liver and LPL in cxtra hepatic tissues. Such a factor could be a dysfunctional chaperone as 
suggested for the mouse cldlcld syndrome. In fact, the patient with both low HL and LPL activity, 
which was described by Fager et al (27) appears to have normal LPL synthesis, but LPL is not 
effectively transported from the ER to the Golgi. 
f!.fodel for intI'acellular eyents ill regulated HL secretion 
\Ve have shown that post-translational regulation ofHL cxpression by adrenaline involves Ca2+_ 
mediated retardation of HL maturation and subsequent degradation (Chapter 2), The degradation 
may occur in the ER or early Golgi. In HcpG2 cells (Chapter 5.1) we showed that ER-to-Golgi 
transport of HL protein was very sensitive to inhibition by CCCP, suggesting the involvement of 
ATP-dependent association with ER chaperones. In addition, we showed in pulse-chase experiments 
with rat hepatocytes that CCCP causes accumulation of the 53 kDa HL without degradation of HL 
protein (Chapter 2.3). In rat hepatocytes activation occurs only after transport from the ER to the 
Golgi (Chapter 5.1). HL enzyme activity may be masked by binding to an ER-Iocated chaperone. 
Both LPL and pancreatic lipase require a cofactor for catalytic activity (Chapter 1.1.2), which may 
prevent lipase from being active within the intracellular pathway. As HL does not depend on a 
cofactor for its enzymatic activity, a chaperone shielding HL activity may protect against breakdown 
of potential intracellular substrates of HL. Interactions of HL with ER chaperones may be an 
important regulatOlY step in the folding and secretion of active HL. Glycosylation, ATP and 
ER-Ca2+ may affect the association ofHL with chaperones. In figure 2, the sequential events in HL 
secretion, which may explain our observations are depicted. Unbroken arrows represent modulation 
of HL, which may not be sensitive to regulation. Once in the Golgi, secretion of active HL seems 
not to be regulated, and than only the inhibitors of vesicular transport, likc monensin and colchicine 
are able to prevent the secretion. The processes indicated by dash-dotted arrows 'U'C expected to be 
regulated. Thrce models may explain the observed data. First, the adrenaline-, thapsigargin- or 
EGTA-mediated decrease ofER-Ca2+ may primarily stimulate degradation (alTOW A). Thus. leaving 
less 53 kDa protein available for maturation. The degradation would occur only after stimulation 
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Figure 2 Hypothesis on the regulation of hepatic lipase secretion. 
Schematic representation of transport, processing and regulation of intracellular HL protein. Eodo H sensitive, immature 
53 kDa HL is present in the ER and carly Goigi. In the Goigi HL is modulated towards a mature, Enda H resistant 58 
kDa protein and is secreted as an active enzyme. Unbroken arrows represent modulation of HL, which may not be 
sensitive to regulation. Dash-dotted Jines are expected to be regulated in \'ivo. The arrows marked A, B, C represent 
events, which are part of the models discussed in the text. The (x) and (y) represent chaperones, which may be 
involved in folding and maturation of HL. Adr, adrenaline; TSG, thapsigargin; esp, castanospermine; MDN, 
N~methyldeoxynojirimycin; MON, monensin; COL, colchicin; Ole, glucose. 
with adrenaline, thapsigargin, A23187 and BGTA, which agrees with our experiments, which 
showed that there was no degradation in control cells. In addition, the presence of CCCP failed to 
induce degradation of the 53 kDa HL. In this model, inhibiting the formation of transportable 
53 kDa protein (with glucoses trimmed off the glycosylation chains) by castanospermine or 
N-methyldeoxynojirimycin would not necessarily stimulate HL degradation. However, 
castanospermine may cause degradation ofHL protein (30). Further, when the adrenaline-mediated 
degradation was inhibited by ALLN, the 53 leDa protein relatively accumulated, but failed to restore 
HL maturation of the 53 kDa form to mature 58 kDa HL. We therefore propose a second modeL 
In this model, decreased levels ofER-Ca2+ may inhibit normal maturation andlor folding 
(arrow B), whereafter more 53 kDa protein is available to the ALLN-sensitive degradation. In line 
with this castanospennine and N-methyldeoxynojirimycin would induce degradation of HI... protein. 
CCCP incubations would then, either inhibit the formation of degradation-sensitive 53 kDa HL 
(arrow C), or induce the accumulation of a 53 kDa Ill.. form that is no longer sensitive to proteases. 
The formation of degradation-sensitive 53 kDa HL may be ATP dependent, and thus affected by 
CCCP. An argument against this model is the finding that there was no degradation of intracellular 
HL in control cells. 
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The third model may combine both mechanisms (arrows A+B): The adrenaline-, thapsigargin- or 
EGTA-mediated decrease of ER-Ca2+ may inhibit normal maturation andlor folding, whereafter 
more 53 kDa protein is available to the stimulated. ALLN-sensitive degradation process. The 
lowered ER-Ca2+ may affect Ca2+-sensitivc proteases and chaperones (depicted as (y) in Fig.2) 
involved in the intracellular pathway ofHL. Discrimination in favour of one hypothesis may become 
possible when more is known on the interaction of HL with intracellular chaperollcs/proteases. 
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We studied hepatic lipase (HL) expression in rat hepatocytes under conditions where regulation at 
the post-transcriptional level has been implicated. Although we hypothesized that N-glycosylation 
of HL may be involved in this regulation (Chapter 1.1.4), we have not encountered a condition 
where regulation is primarily at the level ofN-glycosylation. Instead, the oligosaccharide processing 
can be used to follow the intracellular transport of HL, as the process is essential for HL folding and 
subsequent maturation and secretion. 
REGULATION OF HEPATIC LIPASE EXPRESSION AT THE LEVEL OF 
MATURATION AND SECRETION 
Modulation of hepatic lipase expression by adrenaline in rat hepatocyte.. (Chapter 2) 
In rats the daily changes in HL activity in the liver follow the diurnal rhythem of the catecholamines 
associated with feeding and fasting. We have studied the mechanism by which adrenaline lowers 
HL secretion in suspensions of freshly isolated fat hepatocytes. Adrenaline acutely inhibited the 
secretion of HL activity (Chapter 2.1). The cells secreted significantly less HL activity in the 
presence of adrenaline than with cycloheximide, which completely blocked protein de novo 
synthesis. The specific enzyme activity of secreted HL was not affected. IntraceHularly. HL activity 
was lowered by adrenaline~treatment. Pulse-labelling with e5S]methionine showed that the de novo 
synthesis of the 53 kDa EndoH-sensitive HL precursor form was unaffected by adrenaline. During 
subsequent chase of the control cells, the 53 kDa form was converted to a 58 kDa EndoH resistant 
HL protein, which was rapidly secreted into the medium. In the presence of adrenaline, formation 
of the 58 kDa protein was markedly reduced, whereas the 53 kDa protein disappeared at a similar 
rate as in controls. Tilis suggests that pat1 of the HL protein was degraded. In contrast to adrenaline, 
inhibition of HL secretion by colchicine was accompanied by an intracellular accumulation of HL 
activity and of the 58 kDa protein. We concluded that adrenaline inhibits HL secretion 
posttranslationally by retarding the maturation of the 53 kDa HL precursor into an active 58 kDa 
protein, possibly by stimulating degradation of newly synthesized HL protein. 
Adrenaline acutely inhibited the secretion of HL activity through activation of the 
aradrenergic pathway. Incubation in the presence of propranolol, a selective p-antagonist. did not 
alter the effect of adrenaline. In our isolated rat hepatocytes the acutc cffect of adrenaline was 
abolished prutly by the "lA-antagonist WB41OI, but completely by chloroethyJclonidine, a selective 
alB-antagonist (Chapter 2.2). The effect of adrenaline was mimicked by the non-selective ctl-agonist 
phenylephrine, but not by the selective alA-agonist methoxamine. Thus, adrenaline inhibited the 
secretion ofHL via alB-adrenergic receptors. This adrenoceptor subtype was recently described to 
signal through both Ca2+i and cAMP. However, the effect of adrenaline on HL expression is 
mediated via Ca2+ rather than cAMP, as similar inhibition of J-ll.. secretion was induced by elevating 
Ca2\ with vasopressin, angiotensin or A23187, but not by elevating cAMP with forskolin or 
addition of 8-Br-cAMP. 
Pulse~chase experiments with eSS]methionine showed that adrenaline, thapsigargin and 
A23187, all mediating an increase of intracellular calcium. retarded the processing of the 53 kDa, 
high man nose precursor to the mature 58 kDa HL protein, and stimulated intracellular degradation 
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(Chapter 2.2). However, lowering of intracellular Ca" by treating the cells with EGTA also reduced 
HI.. secretion by a similar mechanism. Thus, both high and low intracellular Ca2t- have similar post-
translational effects on HL. This contradiction may be explained by Ca2+-levels in the endoplasmic 
reticulum (ER). Besides altering the intracellular Ca2+, all the agents tested lower ER-Ca2+. 
As described above, adrenaline acts post-transiationally, by retarding the maturation of the 
53 kDa protein to the 58 kDa HL protein, and by stimulating intracellular degradation. The 
lysosomal degradation inhibitors leupeptin and chloroquine did not influence the effect of adrenaline 
on the secreted and intracellular HL activity (Chapter 2.3). Of several protease inhibitors tested, only 
the cysteine-protease inhibitor N-acetyl-leucine-leucine-norleucinal (ALLN) partly reversed the 
adrenaline-induced degradation. In the presence of ALLN, the adrenaline-induced intracellular 
decrease of the immature 53 kDa fonn was partly prevented, but maturation to the 58 kDa form was 
not restored. The 53 kDa protein that accumulated intracellularly seemed to have no triglyceridase-
activity. These results suggest that the adrenaline-induced degradation was a result of impaired 
maturation, and exposure to ALLN-sensitive proteases. 
REGULATION OF HL EXPRESSION AT OTHER POST·TRANSCRIPTIONAL LEVELS 
Modulation of hepatic lipase expression by growth hormone in hypothyroid rats (Chapter 3) 
During hypothyroidism hepatic lipase (HL) activity is decreased. The low HL may be due to thyroid 
hormone insufficiency or to the concomitant fall in growth hormone (GH) activity. We studied HL 
expression in hepatocytes freshly isolated from hypothyroid rats with and without additional GH-
substitution. In all animals HL mRNA was detected by RT-PCR in the hepatocytes, but not in the 
non-parenchymal cells. In hypothyroid cells HL mRNA levels were reduced by 40%, and the in vitro 
secretion of HL-activity and HI...-protein was decreased by about 50%. In cells from GH-substituted 
hypothyroid rats, HL mRNA level was normalised, but the secretion of HL remained 50% lower 
than control. The specific enzyme activity of secreted HI... was similar under all conditions. The 
discrepancy betwecn HL mRNA and HL secretion in OH-supplemented hypothyroid rats may be 
due to (post)translational effects. Therefore, we studied the HL synthesis and maturation in 
hepatocytes from hypothyroid rats with or without GR-substitution. Pulse-labelling experiments 
with CSS]methionine showed that the incorporation of eSS]methionine into HL protein was lower 
both in hypothyroid cells and in OH-supplemented hypothyroid cells than in control cells. During 
the subsequent chase, the intracellular processing and tnmsport of newly synthesized HL protein in 
the hepatocytes from hypothyroid rats, whether or not supplemented with GR, was similar to control 
cells. We conclude that in livers of hypothyroid, OH-substituted rats translation of HL mRNA is 
inhibited despite restoration of HL mRNA levels. 
Modulation of HL expression in fenofibrate·treated rats (Chapter 4) 
In rats, the fenofibrate-mediated down-regulation of HL expression is mainly induced at the 
transcriptional level. Besides regulation of HL transcription, fenofibrate has been indicated to affect 
HL post-transcriptionally. Here, we studied the effects of fenofibrate on expression of HL more 
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closely. In the fenofibrate-treated rats, HL activity in liver homogenates was 40% lower compared 
to control rats. Corrected for the increase in cell volume after fenofibrate treatment, the HL activity 
in the liver homogenate was 25% lower than control. However, the heparin-releasable pool of HL 
activity was similar to control after fenofibrate treatment. 
Secretion of HL activity by freshly isolated hepatocytes from fenolibrate-treated rats was 
inhibited up to 70% compared to control hepatocytes. Pulse-labelling experiments with 
C5S]methionine showed very low synthesis of HL in the fenofibrate hepatocytes, which is in 
accordance to the decreased mRNA levels. Further, pulse-chase experiments showed that HL 
maturation in hepatocytes from fenofibrate-treated rats was similar to controls. These results suggest 
that fenolibrate decreased HL synthesis mainly at the transcriptionalleve!. Despite the low rate of 
HL synthesis, HL activity bound to the liver on heparin-releasable sites was hardly affected. Our 
data therefore indicate that Ill., expression is post-translational regulated by changes in HL turnover. 
Post-translational regulation by fenofibrate may take place at the level ofHL binding. internalization 
and/or subsequent degradation, rather than at the level of maturation of newly synthesized HL. 
N·GLYCOSYLATION OF HEPATIC LIPASE 
We found no evidence for direct regulation at the level of N-glycosylation and oligosaccharide 
processing in any of the above described cases. However, N-linked glycosyJation of HL has been 
shown to be essential for secretion of a catalytically active protein. Hence, we closely examined the 
role of N-linked glycosylation in intracellular processing and activation of HL in rat hepatocytes and 
in the human hepatoma cell line. HepG2. 
Secretion and intmcellular processing of hepatic lipase (Chapter 5) 
In chapter 5.1, we describe our studies with human HepG2 cells. In the presence of cycloheximide, 
which completely blocks the de novo protein synthesis, processing of the pre-existing HL in the 
cells proceeded normally. However, much more HL activity appeared in the extracellular medium 
than was lost from the cells. Thus, intracellular HL is apparently activated during the secretory 
process. Preventing N-glycosylation with tunicamycin or blocking the trimming of the terminal 
glucose residues in the ER by castanospermine (CSP) or N-methyldeoxynojirimycin (MdN) resulted 
in an inhibition of HL secretion similar to cycloheximide. Intracellular HL activity was lost, 
whereas the amount of HL protein remained below the detection limit of our ELISA. The 
dependence of HL secretion on proper glucose trimming in the ER contrasts sharply with the 
secretion of IX)-antitrypsin, an unrelated N-glycoprotein. which was unaffected during incubation 
with CSP or MdN. Interfering at a later stage of the oligosaccharide-chain processing, by incubation 
of the cells with deoxymannojirimycin did not affect the secretion of HL. The effect of CSP and 
MdN on intracellular HL was mimicked by incubation with CCCP, which blocks transport ofER 
vesicles to Goigi. In contrast, the secretion of a)-antitrypsin was also unaffected by CCCP 
incubation. Blocking vesicle transport between the Golgi compartments with monensin, or merging 
the ER and Golgi compartment with brefeldin A (BFA) resulted in an intracellular accumulation 
of Ill.. activity. The apparent activation of intracellular HL in the presence of BFA also occurred 
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after incubation with either CSP or MdN, which alone caused a fall in intracellular HL activity. 
From these results we conclude that. glucose trimming at the ER of human HL is primarily 
necessary for the translocation of newly synthesized protein from the ER to the Golgi, whereafter 
the protein acquires its triglyceridase activity and is secreted into the extracellular medium. Which 
process in the Golgi compartment is responsible for the apparent activation of HL protein remains 
unknown. 
In chapter 5.2, we describe our studies of the intracellular processing of hepatic lipase in 
suspension of freshly isolated rat hepatocytes. Analogous to our studies in HepGZ cells, we 
examined the role ofN-linked glycosyJation in the secretion and activation of rat HL. Secretion of 
a catalytically active HL is depending on proper N-linked glycosylation. In particular, trimming of 
the terminal glucose residues in the ER appears to be crucial for gaining activity. Incubation of the 
hepatocytes with tunicamycin, castanospermine (CSP) or N-methyldeoxynojirimycin (MdN) 
resulted in similar inhibition of HL secretion than with cycloheximide. Although HL denovo 
synthesis was virtually unaffected, intracellular active HL protein could not be detected. Interfering 
at a later stage of the oligosaccharide-chain processing, by incubation with deoxymannojirimycin 
failed to affect the secretion of active HL. Incubation with CCCP, blocking transport of ER vesicles 
to Golgi, resulted in a similar fall in intracellular HL as observed with CSP and NdM. Blocking 
vesicular transport either between the Goigi compartments with monensin, or between the Golgi and 
the plasma membrane with colchicine resulted in an increase of intracellular HL activity. 
Unfortunately, brefeldin A was rapidly inactivated by the hepatocytes and could not be uscd to 
disrupt the ERlGoigi compartments. We conclude that the HL protein acquires its triglyceridase 
activity in the Golgi, whereafter it is secreted into the extracellular medium. \Vhich process in the 
Goigi compartment is responsible for the apparent activation of HL protein remains unknown. 
Hypothesis on the regulation of hepatic lipase secrction (Chapter 6) 
In the discussion, a model explaining our observations on the intracellular pathway of HL is 
proposed. After synthesis of the Endo H sensitive, 53 kDa HL precursor, exit from the ER requires 
proper glucose trimming. Transport from the ER to Goigi is essential for maturation to the 58 kDa, 
Endo H resitant protein and for gaining catalytic activity. Regulation by adrenaline affects the rate 
and extent of exit from the ER. The effect of adrenaline is probably mediated by lowering calcium 
levels in the ER, which may retard HL processing to a transport-competent form, and 
simultaneously enhances degradation of the 53 kDa HL protein. 
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Lever lipase (HL) is een enzym dat wordt gesynthetiseerd door de parenchym cellen van de lever 
en dat vervolgens bindt in de ruimte van Disse in de lever. HL spcelt een bclangdjke rol in het 
lipiden metabolisme. HL hydrolyseert fosfolipiden en triglyceriden in 'high-' en 'intermediate'-
'density' lipoprotei'nen. Verder is HL betrokkcn by de verwijdering van 'remnant' -partikels in de 
lever, en draagt het bij aan het omgekeerde cholesterol transport. Door deze activiteiten draagt HL 
verlaging mogelijk bij tot vervroegde atherosclcrosis. Bij hartpaticnten wordt inderdaad een inverse 
relatie gevonden tussen de lever lipase activiteit en de mate van coronaire vaatvernauwing. 
De expressie van HL activiteit wordt geregulcerd door dieet-veranderingen en verschillende 
hormonen. De regulatie kan plaats vinden op verschillende niveau's. Diverse studies hebben 
vastgesteld dat er regulatie op het niveau Vrul HL mRNA synthese (transcriptie) is, maar ook daarna 
is er regulatie (post-transcriptioneel). By de synthese van het HL eiwit wordt het voorzien van 
slIikerketens aan de twee(rat) of vier (humaan) specifieke asparagines (N-glycosylering). Additie 
en daarop~volgende modificatie van deze ketens zijn essentieel voor de secretie van een actief lever 
lipase, en spelen mogelijk een rol bij de post~transcriptionele regulatie. Verscheidene condities 
waarbij er mogelijk sprake is van post-transcriptionele regulatie van Ill.. expressie werden nader 
bestlldeerd. 
REGULATIE VAN MATURATIE EN SECRETIE VAN LEVER LIPASE IN RATTE 
PARENCHYM CELLEN. 
lVIodulatie van lever lipase expressie door adrenaline (Hoofdstuk 2). 
In de rat worden dageJijkse veranderingen in HL activiteit in de lever veroorzaakt door 
vcranderingen in catecholamines, die optreden tijden"s het rHme van voeden en vasten. \Ve hebben 
het mechanisme bestudeerd waarmee adrenaline de secretie van actief HL remt in vcrs ge'isoleerde 
lever cellen. Adrenaline verlaagde de secretie van Ill.. acuut (Hoofdstuk 2.1). In de incubaties met 
adrenaline was de secretie van HL activiteit lager dan in condities met cycloheximide, waar de eiwit 
de novo synthese volledig was geremd. De specifieke enzym activiteit was niet veranderd. Ook 
intracellulair was de activiteit van HL gedaald door de incubatie met adrenaline. Pulse~chase 
experimenten met eSS]mcthionine Hetcn zien dat de synthese van de 53 kDa, Eudo H gevoeligc HL 
precursor vorm niet beYnvloed werd door adrenaline. Tijdens de daarop volgende chase werd in 
controle cellen het S3 kDa eiwit omgevormd tot het 58 kDa Endo~resistente HL, dat snel in het 
medium werd gesecreteerd. Wanneer adrenaline aanwczig was tijdens de chase, wa') de vonning van 
het S8 kDa eiwit aanmerkelijk trager. Het 53 kDa eiwit verdwecn cchter even snel als in de contrale 
cellen. Dit suggereel1 dat een deel van het nieuw gevormde HLeiwit werd afgcbroken onder invloed 
van adrenaline. In tegenstelling tot adrenaline, ging remming van HL secretie door colchicine samen 
met een iutracellulaire ophoping van actief HL en het 58 kDa HL-eiwit. \Ve concluderen dat 
adrenaline de secretie van HL posHranslationcel remt door de maturatie van het 53 kDa eiwit naar 
58 kDa eiwit te vertragen, mogelijk door de degradatie van het nieuw gevonnde eiwit te stimuleren. 
De acute remming van de HL secretie door adrenaline werd gemedieerd door activatie van 
de uI-adrenerge cascade. Propranolol, cen selectieve p-antagonist, had geen invloed op het effect 
van adrenaline. In onze gei'soleerde ratte lever cellen was het acute effect van adrenaline gedeelteJijk 
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op te heffen door incubatie met de "lA-antagonist WB4IOI. en yoledig op te heffen met 
chloroethylclonidine. een selectieye "lB-remmer (Hoofdstuk 2.2). Gelijke effecten als met 
adrenaline werden verkregen door incubatie met de niet-selectieve ai-agonist phenylephrine, maar 
niet met de seIectieve alA -agonist methoxamine. De inhibitie van HL secretie door adrenaline 
verliep dus via ulB-adrenerge receptoren. Voor dit subtype receptoren is beschreven dat ze 
signaleren via zowel intraccllulair calcium als cAMP. Het effect van adrenaline wordt voornamelijk 
via calcium gemedieerd, omdat soortgelijke rcmming van HL oak wordt gClnduceerd door 
vcrhoging van intracellulair calcium met vasopressin, angiotensin, thapsigargin of de calcium 
ionophore A23187. maar niet door cAMP Yerhoging met forskolin of 8-Br-cAMP. 
In pulse-chase experimenten met e5S]methioninc vertraagden zowel adrenaline, A23187 
als thapsigargin (die aile een verhoging van intracelluIair calcium teweeg brengen) de processing 
van het 53 kDa, premature eiwit naar het mature, 58 kDa eiwit. Verder was de intracellulaire 
degradatie van nieuw gevormd HL gestimuleerd (Hooftstuk 2.2). Doch een verIaging van 
intracellulair calcium door incubatie van de cellen met EGTA verlaagde de HL secretie door 
eenzelfde mechanisme. Dus, zoweI haag als laag intracellulair calcium heeft dezelfde post-
translationele effecten op de HL expressie. Deze tegenstelling zou verklaard kunnen worden door 
dat al deze stoffen een verlaging van calcium niveaus in het endoplasmatische reticulum (ER) 
induceren. 
Zoals juist bcschreven werkt adrenaline post-transcriptioneel, door vertraging van de 
maturatie van het 53 kDa eiwit naar het 58 kDa eiwit en stimulatie van de intracellulaire afbraak van 
HL. Remmers van de lysosomaJe afbraak waren niet in staat het effect van adrenaline op de 
gesecreteerde en intracellulaire HL te beinYIoeden (Hoofdstuk 2.3). Van de gebruikte protease-
remmers wa') allcen de caIpain I-protease remmer N-acetyl-Ieucinc-Ieucine-norleucinal (ALLN) in 
staat om de adrenalinc-ge"induceerde degradatie gcdeeltelijk op te heffen. Als ALLN aanwezig was, 
verdween er minder 53 kDa prematuur eiwit, maar de maturatie naar het 58 kDa eiwit werd Iliet 
hersteld. De intracellulaire ophoping van het 53 kDa eiwit ging Iliet gepaard met een verhoging van 
triglyceridase activiteit. Deze resultaten suggereren dat de adrenaline-gemedieerde afbraak van HL 
het resultaat is van verstoorde maturatie en de blootstelling aan calcium-gevoelige cystei"ne proteases 
in het ER. 
REGULA TIE VAN DE HL EXPRESSIE OP ANDERE POSITRANSCRIPTIONELE 
NIVEAUS 
lVIodulatie van lever lipase exprcssie door groeihormoon tijdens hypothyro"idie (Hoofdstuk 3) 
Tijdens hypothyroYdie is de HL activiteit in de lever verlaagd. Deze lage activiteit wordt mogeJijk 
veroorzaakt door de verlaging van het schildklier hormoon of door de daarbij optredende verIaging 
van grocihormoon (GH) activiteit. \Ve hebben de HL expressie bcstudeerd in lever cellen geisoleerd 
lIit hypothyroi"de ratten met en zonder substitutie van groeihormoon (Hoofdstuk 3). In aile ratten kon 
HL mRNA met behulp van RT-PCR worden aangetoond in parenchym cellen, maar niet in de 
andere cellen van de lever. In hypothyro"ide cellen was het HL mRNA 40% verlaagd, de in vitro 
secretie van HL activiteit en HL eiwit was ongeveer 50% verlaagd. In cellen van 
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GH-gesubstitueerde hypothyrolde ratten was de hoeveelheid HL mRNA genormaliseerd, maar de 
secretie van HL bleef vedaagd. De specifieke enzym activiteit van het gesecreteerde HL was in aile 
gevallen gelijk. De discrepantie tussen HL mRNA en HL secretie in de GH-supplementeerde ratten 
zou een gevalg kUIUlen zijll van (post)translatianele effecten. Daaram werd oak de HL synthese en 
rnaturatie bestudeerd met behulp van pulse~chase experimenten. De inbouw van [3SS]methionine 
in HL in hypothyrolde cellen en GH-gesupplementeerde cellen was lager dan in controle cellen. 
Tijdens de chase verliep de intraceUulaire processing en het transport van nieuw gesynthetiseerd HL 
eiwit in parenchym cellen van hypothyrolde ratten, met of zander GH-substitutie gelijk aan die van 
controle cellen. We concluderen dat in levers van GH-gesupplementeerde hypothyrolde ratten de 
translatie van HL mRNA achterblijft ondanks het herstel van HL mRNA niveaus. 
Modulatie van lever lipase expressie in fenofibrate-behandelde ratten (Hoofdstuk 4) 
Veclaging van HL expressie door fenofibraat is voomamelijk transcriptioneel, maar er zijn ook post-
transcriptionele effecten van fenofibrate op HL beschreven. Het effect van fenafibrate op de HL 
expressie in de ratte lever werd nader bestudeerd. In fenofibraat-behandelde ratten was de 
HLactiviteit in het lever homogenaat vedaagd tot 60% van contrale levers. Oak als we corrigeerden 
voor het toegenamen cell volume, bleek de HL activiteit 25% lager dan in contrale. De HL activiteit 
in de heparine-perfusaten was echter gelijk aan die van de contrale. 
De secretie van HL activiteit door lever parenchym cellen nit fenofibraat behandelde ratten 
was 70% geremd ten opzichte van contrale cellen. Oak de incorporatie van eSS]methionine in 
pulse-chase experimenten in de fenofibraat~cellen was verlaagd. De lage synthese van HL komt 
overeen met de vedaging van de haeveelheid HL mRNA. Maturatie van het gesynthetiseerde HL 
eiwit in fenofibraat~cellen verschilde niet van dat in contrale cellen. Dus, andanks de vedaagde HL 
synthese, had fenofibraat geen effect op de HL activiteit die in de lever gebonden was op heparin-
gevoelige plaatsen. Dit wijst erop dat er post-translationele regulatie plaats vindt op niveau van HL 
turnover. Post-translationele regulatie door fenofibrate kan plaats vinden op het niveau van HL 
binding, internalisatie enlof degradatie. maar vindt waarschijnlijk niet plaats op het niveau van 
maturatie van nieuw gesynthetiseerd HL. 
N-GLYCOSYLERING V AN LEVER LIPASE 
In de condities die we hebben bestudeerd, werden geen indicaties gevonden voor de betrokkenheid 
van N-glycosylering in de post-transcriptionele regulatie van HL. Dit ondanks eerdere bevindingen 
dat N-glycosylering, het verankeren en modificeren van suikerketens, voor zowel humaan als ratte 
HL essentieel is voor de secretie van actief HL. We hebben we de rol van N-glycosylering in de 
secretie en activering van HL nader bestudeerd in een humane lever cellijn CHepG2) en in vers 
geYsoleerde ratte lever cellell. 
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Secretie en intracellulaire processing van lever lipase (Hoofdstuk 5) 
In hoofdstuk 5.1 hebben we de intracellulaire processing en activatie van Ill.. in HepG2 ceHen nader 
bestudeerd. Naast glycosylcring blijkt juiste processing van de suikerketens, in het bijzonder 
afsplitsing van de eindstandige glucoses in het ER, cruciaal voar het verkrijgen van activiteit. In 
aanwezigheid van cycloheximide, waarbij de totale denovo synthese is geblokkcerd, verloopt de 
processing van het in de eel aanwczige HL onveranderd. Tach verschijnt er meer HL activiteit in 
het medium dan er verdwijnt ult de cellen. Er vindt dus activering van HL plaats. Het femmen van 
de N-glycosylcring met tunicamycine. afhet afsplitsen van de eindstandige glucose residuen in het 
ER met castanospennine (CSP) of N-methyldeoxynojirimycin (MdN) had eenzelfde remming van 
lll.. secretie tot gevolg als incubatie met cycloheximide. De intracellulaire HL activlteit was 
verdwenen, de totale hoeveelheid HL eiwit bleef onder de detectie limiet van de ELISA. De 
afhankeHjkheid van de HL sccretie vooe de glucose trimming in het ER is totaal vcrschillend met 
de seeretie van 1X,-antitIypsine. Dit niet gerclateerde glycoprotein weed Iliet bei'nvloed door incubatie 
met CSP of MdN. Ingrijpen tijdens de latere modulering van de suikerketen, door middel van een 
incubatie van de ceHen met deoxymannojirimycine had geen invloed op de secretie van HL. De 
effecten van CSP en MdN incubatie op de intracellulaire HL activiteit waren te vergelijken met die 
van CCCP incubatie, waarbij het transport van ER-vesicles naaf het Goigi was geremd. In 
tegenstelling tot HL verliep de secretie van IX,-antitrypsine onverallderd tijdens CCCP incubatie. Het 
blokkeren van het vesiculair transport tussen de verschillende Goigi compartimenten met behulp 
van monensin. of het fuseren van het ER en Goigi gelnduceerd door brefeldin A (BFA) had een 
ophoping van intracellulaire HL activiteit tot gevolg. De activatie van het intracellulaire HL in 
aanwezigheid van BFA gebeurde ook na een incubatie met CSP of MdN, hoewel die alleen een 
veri aging van intracellulaire HL activiteit veroorzaakten. Ult deze gegevens kunnen we concluderen 
dat glucose trimming voomamelijk belangrijk is voor het transport van nieuw gevormd HL van ER 
naar Golgi. Daarna verkrijgt het eiwit zijn triglyceridase activiteit in het Goigi en wordt vervolgens 
gesecreteerd. Welke processen leiden tot de activatie van HL in het Goigi blijft nog onbekend. 
In hoofdstuk 5.2 hebben we de intraceHulaire processing van HL in suspensies van vers 
gei"soleerde rotte hepatocyten bestudeerd. Analoog aan de studies in HepG2 cellen, bekeken we de 
rol van de glycosylerlng in de activatie en secretie van HL eiwit. De secretie van een katalytisch 
actief enzym hangt af van de juiste processing van de suikerketens. Voomamelijk het trimmen van 
de eindstandige glucose residuen in het ER is essentieel voor het verkrijgen van activiteit. Incubatie 
van lever cellen met tunicamycin, CSP or MdN had eenzelfde effect op de secretie van HL als 
cycloheximide. Ondanks eell nauwelijks veranderde de novo synthese van HL kon er intracellulair 
geen actief HL eiwit worden aangetoond, mogelijk was er dus eiwit afgebroken. Interfereren later 
tijdens de processing van de suikerketens met dcoxymannojirimycine had geen effect op de seeretie 
van actiefHL. Illcubalie met CCCP, waardoor het ER-Golgi transport wordt geremd verlaagde de 
HL activiteit hetzelfde als incubatie met CSP of MdN. Het blolckeren van het transport tussen de 
versehiJIende Goigi-eompartimenten met monensin. of tussen het Golgi-eompartement en het 
plasmamembraan met colchicine, zorgde voar een intracellulaire ophoping van katalytiseh aetief 
HL. BFA werd hclaas snel gei'nactiveerd door de lever celIen, waardoor het niet bruikbaar was om 
ER en Goigi te doen versmeIten. We kunnen eoncluderen dat zowel het humane als ratte HL eiwit 
actief wordt in het Golgi, waarna er secretie plaats vind. Hoe de activatic van HL in het Golgi tot 
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stand komt blijft nog onopgehelderd. 
Hypothese over de regula tie van lever lipase secrelie (Hoofdstuk 6) 
In de discussie hebben we een model voorgesteld, dot onze bevindingen op het gebied van de 
intracellulaire processen die de HL secretie beinvloeden zou kunnen verklaren. Na de synthese van 
het Endo H gevoelige, premature eiwit van 53 kDa, is het transport uit het ER afllankelijk van de 
afsplitsing van de eindstandige glucoses. Essentieel voor de vorming van het mature, Endo H 
resistente 58 kDa HL eiwit is het transport vanaf het ER naar het Golgi-compartiment. Dat is oak 
essentieel voor het verkrijgen van enzym activiteit. Adrenaline beYnvloedt de snelheid waarmee HL 
het ER verlaat en de hoeveelheid die het ER verlaat. De effecten van adrenaline worden 
waarschijnlijk gemediCerd door een vedaging van calcium niveaus in het ER. Daardoor kan de 
vorming van transportabel HL geremd en de afbraak van het premature 53 kDa eiwit 
gestimuleerd zijn. 
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kletspraatjes waren nooit saai; aileen ooze afwas was vervelend. Delfina en Belinda, als iotgenootjes 
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met Mirjam Itch je mij de leuke kanten van het moleculaire biologic lab laten zien. De studenten van 
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STELLINGEN 
Dc acute eHecten van adrenaline op de expressie van lever lipase in de rat 
vinden plaats op cen post-transcriptioneel niveau. 
- dif proefschrift 
2 In studies naar de cxpressie van lever lipase dient ook de afbraak van 
het enzyme te worden betrokken. 
- dil proefschrifl 
3 Intracellulaire activatie van lever lipase vindt plaats fla transport van het eiwit naar het 
Golgi-compartiment. 
- dilproefschrifl 
4 'Molecular Chaperones' zijn niet per definitie betrokken bij de goede vouwing van eiwittcn. 
- R.J. Ellis (1997), Biochem. Biophys. Res. COIIIIIIUII. 238, 1'687-692 
5 Chocoladc is als rode wijn; 
heiden hebben de potentie euforic op te wckken 
en kunnen bij matig gcbruik goed Zijll voor hart en vaten 
- E. di Tomllso el 01 (1996), Nalure 382, 1'677-678 
- A.L. Walerhouse el al (1996),11" Lallcel 348, /1834 
- G.J. Soleas el 01 (1997), J. Clill. Lab. Allal. 11, 1'287-313 
6 Oak in het intracellulaire, illcmbraan-gemedieerdc eiwit transport speelt cholesterol een 
essentiCle roi. 
-K. Simolls el 01 (1997), Nature 387, p 569-572 
7 Het lolo-effect dat vaak optreedt tijdens dieten is niet beperkt tot het Jichaamsgewicht, 
maar geldt evenzeer voor het enthollsiasme over cen dieet. 
8 De basis van toe pas bare wetenschap ligt bij fundamentele kennis. 
9 Proefschriften bij het oud papier kUllllcn zeer demotiverend werken. 
10 Soms denkt men dat cen Doelcnaar van Lillo komI. 
Rottcrdnm, 15 mei 1998 
